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RNA molecules play a diverse set of crucial roles in biological systems. Studying various 
aspects of RNA biology such as RNA transport, localization, degradation, and structural 
dynamics is therefore of utmost significance. A prerequisite for studying such phenomena is 
availability of methods for labeling and visualization of the RNAs of interest. A wide array 
of RNA labeling methods has been developed over the years with promising results. 
Nevertheless, versatile, and efficient tools for covalent site- and sequence-specific labeling 
of RNA in live cell (in situ) are non-existent. 
One of the more recently emerged RNA labeling methods involves application of the 
10DM24 deoxyribozyme. The recognition arms of this DNA catalyst recognize the desired 
labeling positions in the RNA of interest via Watson-Crick base pairing. Using a wide variety 
of 2'-modified GTP analogs, 10DM24 can label the target RNA at specific internal positions, 
efficiently and accurately. Despite the success achieved using this system, the 
deoxyribozyme has never been tested for RNA labeling within live cell. The dependency of 
the deoxyribozyme on metal ions and challenges regarding maintenance and delivery of 
DNA catalysts in the cell, has so far limited its application to labeling in vitro. Therefore, 
the aim of this study was to develop ribozymes for RNA labeling with the potential for 
cellular applications. 
We established a selection method through which selection of trans-acting, site-selective 
RNA labeling ribozymes was made possible. The selection involved a partially structured 
RNA pool with a bulged adenosine nucleotide as a predetermined modification-site. For the 
development and optimization of the selection strategy, biotinylated ATP was used as the 
selection substrate. The selection using this substrate led to the identification of 
adenylyltransferase ribozymes, denoted as FH ribozymes. The characterization of these 
catalysts confirmed the success of our selection method in dictating the modification site of 
ribozymes. The selected variants were effectively directed to modify the bulged adenosine 
nucleotide by forming a 2'-5'-branched phosphodiester bond with labeled adenosines. The 
FH ribozymes could be readily converted to trans-acting variants, and the ribozyme showed 
a broad substrate scope based on Watson-Crick base-pairing between target RNA and 
ribozyme binding arms. The selected ribozymes, especially the most efficient variant 
(FH14), efficiently accepted a wide range of N6-modified-ATP analogs as labeling 
substrates, including fluorophore-conjugated derivatives. FH14 was successfully applied in 
2 
site-specific labeling of large, heavily structured cellular RNA such as 5S, 16S, and 23S 
ribosomal RNA in total cellular RNA. 
In the next stage, we attempted to develop ribozymes that utilized a more bioorthogonal 
substrate such as the antiviral ATP analog tenofovir-diphosphate. Ligation of tenofovir 
analogs to the target RNA would also result in a more enzymatically stable linkage type, in 
which the branched 2'-5'-phosphodiester is replaced by a phosphonate ester. Biotinylated 
tenofovir-diphosphate was synthesized and applied in an in vitro selection process that led 
to the identification of tenofovir-transferase (FJ) ribozymes. These ribozymes showed 
similar properties to FH14 ribozyme, in terms of site-selectivity, substrate sequence 
generality, and broad labeling substrate scope. Moreover, these ribozymes were perfectly 
orthogonal to FH14 ribozyme, a feature that was exploited for dual-color RNA labeling. The 
ribozymes FJ1 and FH14 were successfully applied in simultaneous dual-color labeling of a 
synthetic transcript at two different positions. These ribozymes have also been used for 
simultaneous, site-specific labeling of 16S and 23S rRNAs using two different fluorophores. 
Although the cellular application of these ribozymes has not yet been demonstrated, they 
possess great potential for further optimization into efficient tools for RNA labeling in situ. 
Furthermore, the established selection process paves the way for future development of other 




1.1 Non-catalytic role of RNA 
RNA is arguably the most versatile class of biomolecules in terms of the various roles it can 
assume in living systems. It is known to act as the main form of genetic information storage 
space in some life forms (Poltronieri et al., 2015). The three major classes of RNA (mRNA, 
tRNA, and rRNA) are key to converting genetic information into protein. Apart from these 
three types of RNA, there is a large variety of other classes of small and long RNA involved 
in regulating or maintaining different aspects of the central dogma of molecular biology.  
siRNA and miRNA are some of the examples of small antisense RNA molecules found in 
eukaryotic cells (Tang, 2005). They regulate the translation and stability of their target 
mRNA with the aid of a protein complex known as RISC (Kaikkonen et al., 2011; O'Brien 
et al., 2018). Analogous small antisense RNA molecules such as the Hfq and ProQ dependent 
small RNAs (sRNA) that regulate the translation and stability of their target RNA, can also 
be found in bacteria (Dutta and Srivastava, 2018).  
Various classes of long non-coding RNA (lncRNA) have been identified in higher 
multicellular eukaryotes (Fatica and Bozzoni, 2014; Laurent et al., 2015). The function and 
significance of many lncRNA are still unknown, however, some are known to regulate gene 
expression by various means (Dahariya et al., 2019; Kaikkonen et al., 2011). Xist, the most 
well-known instance of lncRNAs, is involved in the inactivation of X-chromosome in female 
mammals. It acts by recruiting chromatin remodeling complexes (Loda and Heard, 2019). 
RNA can also affect gene expression via direct interaction with micro- and macromolecules. 
Riboswitches are a great example of such RNA functionality. These relatively small RNA 
elements can be found primarily in the leader sequence of a variety of bacterial RNA. Their 
binding to the target molecule and the subsequent conformational change can inhibit or 
enhance translation by masking or unmasking of the ribosome binding site. They can also 
prevent or promote transcription elongation via the formation or destabilization of 




1.2 RNA as catalyst 
Catalytic potential of the RNA was appreciated in 1982 when Thomas Cech’s research group 
discovered that class I introns can catalyze reactions necessary for RNA maturation. The 
term ribozyme was therefore coined to refer to catalytically active RNA sequences (Kruger 
et al., 1982). In 1983 the catalytic activity of the RNA subunit of RNase P was revealed 
(Guerrier-Takada et al., 1983). Class II introns were also demonstrated to catalyze splicing 
reactions on their own. (Peebles et al., 1986). In 1992, it was shown that an E. coli ribosome 
subjected to protein extraction retains a significant portion of its peptidyl transferase activity. 
The finding hinted to the involvement of rRNA in peptide synthesis (Noller et al., 1992). 
Crystallographic studies in the early 2000s confirmed that the peptidyl transferase center 
indeed lies in 23S rRNA (Nissen et al., 2000). 
Self-cleaving ribozymes are another class of catalytic RNA abundantly found in nature. The 
first examples to be discovered were the hammerhead (Hutchins et al., 1986; Prody et al., 
1986) and HDV ribozymes (Wu et al., 1989) that were originally discovered in the genome 
of viroids and RNA viruses. Further research revealed homologous sequences with self-
cleaving activity in the genomic sequences of all domains of life (De la Peña et al., 2017; 
Jimenez et al., 2015). Hairpin and Varkud satellite ribozymes, also belong to the category of 
self-cleaving ribozymes that were discovered through biochemical means (Jimenez et al., 
2015). With the advances in bioinformatic sequence analysis, ribozymes such as twister, 
pistol, and hatchet were also discovered in various sources (Müller et al., 2016; Roth et al., 
2014). 
Except for ribosomal peptidyl transferase centers, all naturally occurring ribozymes 
discovered so far catalyze trans-esterification reactions at the RNA phosphodiester backbone 
(Müller et al., 2016). The advent of the in vitro selection methods, however, facilitated the 
discovery of artificially evolved ribozymes with a broad range of activities. The known 
catalytic repertoire of RNA was therefore dramatically expanded (Fiammengo and Jäschke, 
2005; Jäschke, 2001; Jäschke and Seelig, 2000). Discovery of such ribozymes provides 
further evidence for the existence of an “RNA world”. According to the RNA world theory 
early life forms relied heavily on RNA for biocatalysis as well as storage of genetic 
information (Cech, 2012; Gilbert, 1986). 
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1.3 Strategies for development of artificial RNA catalysts 
Artificial ribozymes are almost exclusively evolved from a random pool of RNA sequences. 
The development process of these catalysts involves an iterative accelerated evolution 
process also known as in vitro selection. One may likely find several sequences possessing 
a desired activity in a combinatorial random RNA pool of 1014-1016 unique sequences 
(Joyce, 2004; Lorsch and Szostak, 1996). The selection process is designed in a way that 
provides survival advantage for the active species of the pool while the large bulk of inactive 
sequences are rapidly eliminated. The frequency of the active sequences in an initial pool is 
extremely low. Thus, it is necessary to perform several rounds of functional selection and 
amplification. Throughout the selection rounds, the active sequences are exponentially 
enriched to the point that they comprise the majority of the pool. 
To facilitate the amplification process, the random segments of the pool are often flanked by 
constant sequences. These constant regions serve as primer binding sites during the reverse 
transcription and PCR amplification. During the PCR process, a T7-promoter is generally 
introduced at the 5'-end of the DNA template, which is essential for in vitro transcription 
using T7 polymerase. Another amplification step occurs at the in vitro transcription step as 
every DNA template can be transcribed multiple times. The selection rounds are pursued 
with increasing stringency until the most desirable variants are remaining (Joyce, 2004). The 
pool is then subjected to sequence analysis either through classical means such as Sanger 
sequencing or is directly sequenced via next-generation sequencing. The identified 
sequences are then subjected to in-depth functional and structural characterization (Joyce, 
2004). 
Aptamers are another class of functional nucleic acids that can be evolved artificially (Dunn 
et al., 2017). They are developed to specifically recognize and bind to target molecules of 
interest. While aptamers also exist naturally as part of riboswitches (Bédard et al., 2020), a 
wide variety of them have also been developed using in vitro selection methods, generally 
regarded as SELEX (Dunn et al., 2017; Tuerk and Gold, 1990). For aptamer selection mere 
target binding is desired whereas for ribozymes substrate recognition and catalytic property 
must coincide in the same oligonucleotide sequence. Thus, in vitro selection process of 
ribozymes is more complicated than that of aptamers. 
Various strategies exist for isolation of catalytic RNA from libraries of random RNA 
sequences, which will be discussed in the following section. 
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1.3.1 Selection using transition state analogs 
Before application in ribozyme selection, this strategy was utilized for the development of 
catalytic antibodies also known as abzymes (Tramontano et al., 1986). This approach relies 
on the idea that enzyme active sites are complementary to the transition state of the reaction 
they catalyze. The stable transition state analogs of the reactions of interest, are therefore, 
designed, synthesized, and used as ligands in SELEX experiments. The RNA molecules with 
binding affinity for these analogs are then screened for catalytic properties (Jäschke and 
Seelig, 2000). 
An example of RNA catalysts selected using this method is a cholesterol esterase ribozyme 
developed by Chun et al. The group first evolved strong binders to a phosphodiester analog 
of the cholesterol carbonate ester. This analog has similar geometry and charge distribution 
as the transition state of the carbonate ester being hydrolyzed (Figure 1-1 A). Two of the 
RNAs that bound to this analog were catalytically active, including the one with the highest 
binding affinity (Chun et al., 1999). 
Prudent et al also utilized this approach to select for a ribozyme that catalyzes isomerization 
of a “bridged biphenyl” substrate. A planar transition state analog of the isomerization 
reaction was used as the ligand during the selection process in this instance (Figure 1-1 B). 
Prudent et al isolated three variants that bound to the selection ligand. Only one of these 
variants demonstrated catalytic activity (Prudent et al., 1994). 
 
Figure 1-1 Selection based on transition state analogs. (A) Reaction catalyzed by the cholesterol 
esterase ribozyme and the transition state analog used for its selection. (B) Isomerization of the 
bridged biphenyl compound and the transition state analog used for the selection of the isomerase 
ribozyme. 
 
Selection using transition state analogs has a low success rate and results in catalysts with 
low activities (Jäschke and Seelig, 2000). Therefore, the alternative approach in which the 
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oligonucleotides are directly selected for catalytic activity is the preferred strategy for 
ribozyme selection. 
 
1.3.2 Selection based on tagging of the active species 
In this strategy, the selection is designed in a way that catalytic activity leads to the tagging 
of the active sequences. The tagged sequences can then be separated using a variety of means 
depending on the type of tag. Some of the most common tagging and capture methods are 
described in detail in this section. 
 
1.3.2.1 Addition of oligonucleotide tags 
Addition of sequence tags that lead to amplification compatibility has been used for the 
selection of RNA ligase ribozymes. Through their activity, the catalysts in the pool ligate a 
sequence tag to their own 5'-end. The ligated sequence is then utilized as a primer binding 
site during the amplification process leading to selective amplification of active species. The 
active species can also be further purified using beads coupled to oligonucleotides 
complementary to the sequence tag. Szostak’s group, for example, utilized this strategy to 
select for an RNA ligase ribozyme. The desired activity in this case was the ability of the 
ribozyme to catalyze 3'-5' ligation of a sequence tag to its own 5'-triphosphate end in a 
template-directed manner. The ligated sequence was first used as an affinity tag then as a 
primer binding site for specific amplification of active species (Bartel and Szostak, 1993). 
This selection experiment led to the identification of the Class I ligase ribozyme which was 
evolved further into various ligase or even polymerase ribozymes (Joyce, 2004). Other ligase 
ribozymes such as L1 (Robertson and Ellington, 1999) and R3 (Rogers and Joyce, 2001) 
were also evolved using a similar strategy. R3 ligase is a peculiar example as it was selected 
from an RNA pool that contained no cytidine nucleotides. Cytidine nucleotides were then 
incorporated during a reselection process which led to an improved version called the R3C 
ligase (Rogers and Joyce, 2001). This was further evolved and recently minimized to the 




1.3.2.2 Tagging by circularization 
During their search for aminoacyl-AMP synthetase-like activity, Yarus’ laboratory devised 
a strategy that was supposed to convert the active species to 5'-monophosphorylated form. 
The reaction product in the selection was a mixed anhydride between the free carboxyl group 
of an amino acid and the 5'-phosphate of the pool. Incubation under acidic conditions leads 
to hydrolysis of this mixed anhydride and formation of 5'-monophosphorylated ribozymes. 
The active variants could then be circularized using T4 RNA ligase (Figure 1-2 A). 
Considering the significantly lower electrophoretic mobility of circular RNA, they then used 
PAGE purification to isolate the active species (Figure 1-2 A). While the selection did not 
meet its original objective, it resulted in the isolation of a pyrophosphatase ribozyme called 
Iso-6. The ribozyme hydrolyzed its 5'-triphosphate to 5'-monophosphate (Figure 1-2 B) 
(Huang and Yarus, 1997a). Iso-6 was also shown to be capable of forming phosphoanhydride 
bonds by exchanging the 5'-βγ-pyrophosphate with a terminal phosphoryl group (Figure 1-2 
A). Various phosphorylated compounds can therefore be conjugated to the 5'-end of this 
ribozyme via a phosphoanhydride bridge. Iso-6-catalyzed conjugation of a GDP leads to 
formation of a structure analogous to the eukaryotic mRNA cap structure. The catalyst was 
thus described as a 5'-capping ribozyme (Huang and Yarus, 1997a, b). 
 
Figure 1-2 Circularization based selection of Iso-6 ribozyme. (A) Schematic representation of the 
incubation and capture steps of the capping ribozyme selection. (B) Pyrophosphatase vs capping 
functions of Iso-6. 
 
1.3.2.3 Affinity tagging 
These strategies involve activity-related addition of chemical tags, which can be captured 
through direct or indirect methods. Ribozymes selected using affinity capture strategies can 
be classified into two major groups (Jäschke and Seelig, 2000)(Figure 1-3). The first group 
includes RNA or self-modifying ribozymes. During the selection of these ribozymes, a 
segment of the catalyst is evolved to act as the modification target. In case of the ribozymes 
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evolved for tRNA 3'-aminoacylation, the tRNA substrate is also fused to the selection pool 
(Ishida et al., 2020; Saito et al., 2001). The typical reactions catalyzed by RNA/self-
modifying ribozyme are nucleophilic substitutions. The affinity-tagged substrate usually 
contains an electrophilic center coupled to a leaving group which is displaced by a 
nucleophilic group from the ribozyme (Figure 1-3 A). Exceptions can be found for the 
reactions that involve 5'-triphosphate of the ribozyme. For these reactions, the nucleophilic 
group resides on the tagged selection substrate. The 5'-βγ-pyrophosphate of the ribozyme 
assumes the role of the leaving group (Coleman and Huang, 2002; Kang and Suga, 2007). 
Ribozymes acting on non-nucleotide substrates are the second group evolved using affinity 
tagging strategy. For the selection of these catalysts, one of the reactants must be covalently 
tethered to the RNA pool while the second reactant carries the selection tag. Ribozyme 
catalyzed reaction between the two substrates results in the formation of a ribozyme bound 
product-selection tag conjugate (Figure 1-3 B).  
 
Figure 1-3 General scheme of the affinity tagging selection methods. (A) Selection of the RNA 
modifying ribozymes (LG= Leaving group). (B) Selection of ribozymes acting on non-nucleotide 
substrates. 
 
Several different tags are used for the affinity tag-based ribozyme selection. Thiol and biotin 
tags, however, are the most frequently used in the reported literature. The selection strategies 
using various affinity tags are detailed in the following section. 
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1.3.2.3.1 Thiol-reactive capture of the active species 
Modification of the active variants with thiol/thione groups facilitates direct isolation using 
thiol-reactive matrices. Pyridyl disulfide functionalized particles for example can 
immobilize thiol/thione-modified pool species via disulfide exchange. Addition of a 
reducing agent such as DTT or β-ME helps elute the attached RNA (Figure 1-4 A). Affinity 
gel electrophoresis is another method for isolating thiol/thione modified RNA. In this 
method a layer containing acrylaminophenyl mercuric acid (APM) is included in the gel 
which forms covalent bonds with thiol/thione groups (Igloi, 1988). The thiol/thione-
modified RNA is therefore trapped in this layer of the gel during PAGE and can be extracted 
(Figure 1-4 B). 
 
Figure 1-4 Thiol-reactive capture methods. (A) Pyridyl disulfide functionalized beads can form 
disulfide bonds with thiol/thione-modified RNA. Reducing agents such β-ME are then used to elute 
RNA. (B) Affinity gel-electrophoresis using an APM containing layer in denaturing PAGE. 
 
Modification with a thiophosphate has been utilized by several groups in selection of 
ribozymes with kinase activity. The RNA pool was incubated with either ATPγS (Lorsch 
and Szostak, 1994; Saran et al., 2005) or GTPγS (Curtis and Bartel, 2005) and in one case 
both (Biondi et al., 2010). The catalytically active RNAs with the ability to transfer 
thiophosphoryl group to a nucleophilic position along their length were then captured. The 
selected kinases in most cases (thio)phosphorylate themselves either at a free 5'-OH or an 
internal 2'-OH. Ribozyme K28 (Biondi et al., 2010) is believed to thiophosphorylate itself at 
two internal positions (Biondi et al., 2012). Evidence exists that at least one of the 
thiophosphorylation reactions of K28 occurs on the 2-amino of an internal guanine 
nucleotide (Poudyal et al., 2017). 
Thiol-based selection system has not however been limited to selection of kinase ribozymes. 
ATPγS has also been used as substrate for the selection of a 5'-purine nucleotide transferase 
ribozyme (Kang and Suga, 2007). A second 5'-capping ribozyme was evolved with the 
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original objective of the selection of an RNA polymerase ribozyme, using 4sUTP (Zaher et 
al., 2006). 
In 2001, Yarus et al successfully evolved aminoacyl-AMP synthetase like ribozymes using 
3-mercaptopropionic acid as substrate (Kumar and Yarus, 2001). The isolated ribozyme 
catalyzes formation of a mixed anhydride linkage by facilitating a nucleophilic attack from 
the free carboxyl group of the 3-mercaptopropionic acid onto the α-phosphate of the 5'-
triphosphate of the ribozyme itself. 
 
1.3.2.3.2 Biotin as a capture tag 
Biotin tagging is the most frequently reported selection system in literature (Figure 1-5). 
The system relies on the extremely high affinity of streptavidin for biotin (Kd= 10-15 M) 
(Holmberg et al., 2005). The high affinity of interaction allows efficient retainment of the 
minuscule amounts of active variants in the initial selection rounds. The complex has also 
been shown to be extremely resistant to denaturants such as guanidinium hydrochloride and 
urea (González et al., 1999). Owing to this stability, harsh washing steps can then be 
performed to remove non-specific binders from the affinity matrix (Joyce, 2004). 
Three self-alkylating ribozymes have been selected using biotinylated substrates containing 
reactive groups such as: iodoacetamide (Wilson and Szostak, 1995), chloroacetamide 
(Ameta and Jäschke, 2013) and disubstituted epoxide (McDonald et al., 2014) (Figure 1-5 
B). Selection using these substrates led to identification of ribozymes that self-alkylated at 
specific internal guanine residues, at N7-position (Figure 1-5 D). 
Self-aminoacylating or aminoacyl transferase ribozymes have also been evolved using 
biotinylated amino acids with various forms of α-carboxy activation (Figure 1-5 C). 
Activated amino acids used in these experiments were in the form of mixed anhydrides with 
AMP (Chumachenko et al., 2009), thioesters with CoA (Li and Huang, 2005), cyanomethyl 
esters (Ishida et al., 2020; Murakami et al., 2003; Saito et al., 2001), dinitrobenzyl esters 
(Murakami et al., 2006), 2'-aminoacyl-AMP (Jenne and Famulok, 1998) and amino acids 
esterified to the 3'-OH of short oligonucleotides (Lohse and Szostak, 1996). Most recently 
self-aminoacylating ribozymes have also been selected using a biotinylated oxazolone 
analog of tyrosine (Figure 1-5 C). The selected ribozymes are esterified at either the 3'-OH 
positions or at an internal 2'-OH (Figure 1-5 E). (Pressman et al., 2019). Biotin, in most 
cases, is attached to the α-amino group of the aminoacyl substrate, except for two cases 
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where an amino group in the side chain was biotinylated (Li and Huang, 2005; Murakami et 
al., 2006). The most famous group of tRNA-aminoacyltransferase ribozymes are flexizymes 
(Ohuchi et al., 2007). These artificial RNA catalysts use dinitrobenzyl-ester forms of amino 
acids (Murakami et al., 2006), regardless of the sidechain, to charge tRNA molecules. These 
ribozymes have been used for incorporation of unnatural amino acids into polypeptides 
through in vitro translation systems (Murakami et al., 2006). 
Yarus’ laboratory selected another capping ribozyme with similar activity to Iso-6, using 
biotin conjugated to a terminally phosphorylated linker (Huang et al., 2000). In 2014, an 
RNA 5'-hydroxyl triphosphorylating ribozyme was identified by Morretti et al. During the 
selection, the activity of the sequence converted it to a substrate for the R3C RNA ligase 
ribozyme. R3C then ligated a biotinylated capture oligonucleotide to the 5'-
triophosphorylated ribozymes, allowing them to be isolated using streptavidin-coated 
magnetic beads (Moretti and Müller, 2014). In a subsequent report the ribozyme was 
minimized and improved via partial randomization and reselection under more stringent 
conditions, using the same capture strategy (Dolan et al., 2015). These reports are intriguing 
examples of an artificial ribozyme being used as a tool for in vitro selection of novel RNA 
catalysts. 
 
Figure 1-5 Biotinylated substrates used in selection of RNA-modifying ribozymes. Biotin tag is 
marked in blue, the transferred moieties and the leaving groups are marked in green and red, 
respectively. Arrows indicate the electrophilic centers. (A) General design of the selection substrate 
(LG= leaving group). (B) Selection substrates for reported self-alkylating ribozymes. (C) Selection 
substrates for aminoacyl transferase ribozymes. (D) Reaction products of self-alkylating ribozymes. 
(Top: epoxide substrate product, bottom: chloro/iodoacetamide substrate product. (E) 3'-end (top) 
and internal (bottom) aminoacylation by aminoacyl transferase ribozymes. 
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Ribozymes acting on non-nucleotide substrates have also been selected using biotin-
streptavidin based capture systems (Figure 1-6). Instances of these ribozymes (Figure 1-6 
A) include: A Diels-Alderase ribozyme (Seelig and Jäschke, 1999), A peptidyl synthetase 
like ribozyme (Zhang and Cech, 1997), thioester forming or acyl-CoA synthesizing 
ribozymes (Coleman and Huang, 2002; Jadhav and Yarus, 2002), a ribozyme catalyzing an 
aldol condensation reaction (Fusz et al., 2005) and a thiamine-dependent pyruvate 
decarboxylase like ribozyme (Cernak and Sen, 2013)  
The examples mentioned so far involved reaction substrates directly tagged to biotin. 
Indirect tagging methods also exist in which a ribozyme-tethered functional group, 
orthogonal to RNA is formed, due to the catalytic activity. The reactive group is then 
derivatized using suitable forms of biotin. The NAD+-dependent alcohol-dehydrogenase 
ribozyme, for instance, was identified through indirect biotinylation. Active species in this 
selection converted a tethered benzyl alcohol to benzaldehyde. The resulting aldehyde was 
then reacted with biotin-hydrazide which led to biotinylation of the ribozymes through 
Schiff-base formation (Figure 1-6 B) (Tsukiji et al., 2003, 2004). 
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Figure 1-6 Reactions catalyzed by ribozymes with non-nucleotide substrates. (A) Direct capture 
strategy. X = the biotinylated substrate, Y= ribozyme tethered substrate and P = reaction product. 
(B) In direct capture strategy of the alcohol dehydrogenase ribozyme. 
 
The method of choice for conjugation of the reactants to the RNA pool is transcriptional 
priming (Schlatterer and Jäschke, 2006). GMP nucleotides modified with orthogonal 
reactive groups on α-phosphate are used for transcriptional priming of the pool before each 
round. The substrate derivatized with the appropriate functionalities is then conjugated to 
the primed pool variants. 
In another interesting example of artificial ribozymes being used as tools for ribozyme 
selection was reported by Jadhav et al. They utilized an improved Iso-6 ribozyme, called 
Iso-6-1, for 5'-conjugation of coenzyme-A to a selection pool. Acyl-CoA forming ribozymes 
were then evolved from the pool using biotinyl-AMP (Jadhav and Yarus, 2002). 
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1.3.2.4 Selection using other tags 
Reports exist of ribozymes selected utilizing other types of tags. For example, a urea 
synthetase ribozyme was selected using a peptide-phosphonate. The selection substrate was 
activated at its N-terminus using weakly reactive N-hydroxysuccinimide carbamate ester. 
The ribozyme catalyzes formation of a urea bond between the peptide-phosphonate and the 
N4 of a cytidine nucleotide at its 3'-end. The selection substrate is a suicide inhibitor of 
human neutrophil elastase (HNE). It forms a covalent bond with a critical serine residue at 
the active site of the enzyme. HNE coupled beads were therefore used as the capture matrix 
for the active sequences (Figure 1-7 A). This capture method led to direct identification of 
urea synthase ribozymes with stereoselectivity towards the peptide substrate (Nieuwlandt et 
al., 2003). 
Sharma et al developed another example of ribozymes selected using unusual affinity tags. 
The group reports using fluorescein-iodoacetamide as the selection substrate followed by 
immunocapture by anti-fluorescein antibody-coated magnetic beads (Figure 1-7 B). The 
approach was regarded as Immunoprecipitation (IP)-SELEX (Sharma et al., 2014). 
Illangasekare and coworkers at Yarus’ research group utilized a completely different 
approach for identification of a self-aminoacylating ribozyme. They reported selection of a 
3'-selfaminoacylating ribozyme using phenylalanyl-AMP as substrate. The free α-amino 
group of 3'-phenylalanyl-ribozyme product was then conjugated to a hydrophobic 
naphthoxyacetyl group. The reacted ribozymes were then separated from the inactive species 
using reverse phase-high performance liquid chromatography (RP-HPLC) (Figure 1-7 C) 
(Illangasekare et al., 1995). 
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Figure 1-7 Unusual tagging strategies in ribozyme selection. (A) Selection of the urea synthase 
ribozyme using a suicide inhibitor of HNE. HNE coupled beads used for the capture step. (B) 
Selection of a self-alkylating ribozyme using fluorescein-iodoacetamide and IP-SELEX. (C) Capture 
by naphthoxyacetyl derivatization and HPLC purification. 
 
1.3.3 Selection based on in vitro compartmentalization 
The traditional selection methods have been used to evolve countless examples of RNA 
catalysts from large pools of RNA however, they are not without limitations. The ribozymes 
identified through these methods often fail to act as true enzymes due to the low turnover 
number or lack of it. The absence of trans-activity is also an issue regarding many ribozymes 
selected using these strategies (Griffiths and Tawfik, 2000). 
In vitro compartmentalization methods facilitate direct selection of catalysts with high 
turnover numbers and improved activity in trans. These groups of strategies were initially 
applied to the directed evolution of protein enzymes (Griffiths and Tawfik, 2000) prior to 
RNA catalyst development. For ribozyme selection using these methods, the DNA templates 
coding for individual variants are trapped in separate compartments. The compartments are 
mostly in the form of droplets in a water-mineral oil emulsion. The templates are then 
amplified within the droplets and transcribed while the compartments are still maintained. 
The selection is designed in a way that the DNA template is tagged in-trans due to the activity 
of its corresponding transcript. The emulsion is then broken, and the tagged dsDNA 
templates are captured using an affinity matrix. The direct tagging of the dsDNA template 
has been used for improving turnover number of a Diels-Alderase ribozyme. One of the 
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reactants in this case was conjugated to the template rather than the RNA pool, before each 
round (Agresti et al., 2005). Compartmentalization based methods have also led to a 
dramatic increase in the processivity of an RNA polymerase ribozyme by direct tagging of 
the DNA template (Zaher and Unrau, 2007). 
The dsDNA templates can also be tagged indirectly via co-immobilization, on beads with 
the tagged reaction product. This strategy was used for improving the trans-activity of an 
RNA ligase ribozyme. The capture step in this experiment was performed using FACS of 
the beads coated with individual ribozyme templates and the fluorescently labeled ligation 
product (Levy et al., 2005). 
Due to the retainment of the DNA template in these techniques, the reverse transcription step 
is no longer needed. Omitting the reverse transcription step provides a higher likelihood for 
the selection of species with more complex structures. During the reselection of the Diels-
Alderase ribozyme for example, a higher level of structural diversity was observed in 
isolated clones than the variants from the traditional selection (Agresti et al., 2005). This is 
due to the fact that reverse transcriptases are known to have difficulty reverse transcribing 
stably structured RNA. The RNA species with complex and stable structures are, therefore, 
at a selective disadvantage in conventional selection methods (Agresti et al., 2005; Joyce, 
2004; Porter et al., 2017). 
 
1.4 RNA imaging methods 
Modern high throughput transcriptomic techniques such as microarray (Jaksik et al., 2015) 
and next-generation sequencing (Kukurba and Montgomery, 2015) provide invaluable 
information regarding changes in the cellular level of various RNA. These analyses, 
however, provide no information regarding RNA transport, localization, stability, 
interactions, and conformational dynamics. The diverse roles of RNA are inseparable from 
these aspects of RNA biology. Studying these phenomena and the underlying mechanisms 
leads to a more profound understanding of the function of coding and especially non-coding 
RNA. The study of such facets of RNA function and metabolism has only been made 
possible with the advent of RNA labeling and visualization techniques (Baker, 2012; 
Muthmann et al., 2020; Urbanek et al., 2014). 
A wide range of tools has been developed that facilitate RNA visualization and tracking. The 
RNA labeling tools and strategies can be classified into two major groups of covalent and 
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non-covalent methods. In the following section, some of these methods will be described in 
detail. A major focus, however, is placed on the vector-encodable systems. 
 
1.4.1 Non-covalent labeling methods 
1.4.1.1 Hybridization based methods 
1.4.1.1.1 FISH 
This method is one of the oldest ways of visualizing specific RNA sequences in fixed cells. 
It is based on the use of a fluorescently labeled oligonucleotide complementary to a segment 
of the RNA of interest (ROI). The cells are typically fixed, and their membranes are 
permeabilized allowing for the entry of the oligonucleotide probe. The excess of the unbound 
probe is then washed away allowing sequence-specific visualization of the targeted RNA 
molecules (Figure 1-8 A). Signal intensity can be increased in this method by increasing the 
number of probes annealed to a single RNA. The method also facilitates simultaneous multi-
color imaging of several target RNA when multiple probes are used, with each probe 
conjugated to a different fluorescent dye (Lawrence and Singer, 1986). This method however 
can only be used for static imaging of RNA localization in the cell and does not provide 
information about the dynamics of RNA metabolism or transport in live cells. 
 
1.4.1.1.2 Molecular beacon 
Like FISH, molecular beacon imaging method is based on complementary oligonucleotide 
probes. In this method the probe is flanked by short self-complementary segments that allow 
formation of a stem. A fluorophore is conjugated to one end of the probe and a quencher to 
another. When unbound the fluorophore and quencher are brought to proximity due to 
formation of a short basal stem. Binding of the probe to the target sequence prevents 
formation of this stem, and the fluorophore is unquenched (Figure 1-8 B). This method 
reduces the background signal quite significantly compared to FISH, obviating the need for 
a washing step when imaging fixed samples. It also makes possible imaging of RNA in live 
cell, however, the probe is not readily cell-permeable and it requires special cellular delivery 
methods (Monroy-Contreras and Vaca, 2011). 
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Figure 1-8 Hybridization-based RNA imaging methods. (A) Schematic representation of FISH. A 
washing step is needed to eliminate the background from the unbound probe. (B) Scheme of the 
molecular beacon imaging system. The unbound probe remains in a quenched state, thus, there is no 
need for the washing step. 
 
1.4.1.2 RNA binding protein-based methods 
1.4.1.2.1 MS2-tagging 
Originally developed in 1998 by Singer and coworkers (Bertrand et al., 1998), MS2-tagging 
(aka. MS2-MCP system) has become the gold standard of live cell RNA imaging methods 
(Figure 1-9). Since its invention, this system has been extensively used in various types of 
cells including S. cerevisiae (Bertrand et al., 1998), E. coli (Golding et al., 2005), 
mammalian cell-lines (Ben-Ari et al., 2010; Darzacq et al., 2007; Grünwald and Singer, 
2010) and even whole organisms such as Drosophila (Bothma et al., 2015) and mouse 
(Lionnet et al., 2011; Park et al., 2014). MS2-tagging is based on high affinity and specificity 
of the RNA bacteriophage MS2 coat protein (MCP) for its 19-nucleotide stem-loop binding 
site, in the bacteriophage genome (Valegård et al., 1997). 24 copies of the MS2 binding site 
(MBS) are typically inserted in the mRNA of interest. The MBS containing RNA is then co-
expressed inside the cell along with the MCP fused to a fluorescent protein (MCP-FP). The 
MCP-FP fusion protein binds to each MBS, as a homodimer, therefore tagging the RNA of 
interest with several FP molecules (Figure 1-9 A & B). A nuclear localization signal (NLS) 
is also added to the MCP-FP fusion protein to ensure nuclear segregation of the unbound 
probe, therefore, reducing the cytosolic background (Figure 1-9 A & B). Apart from FPs, 
fluorogenic protein small molecule reactive/binding domains such as SNAP-tag and DHFR 
have also been used as MCP fusion (Carrocci and Hoskins, 2014). Optimized versions of 
this system have recently been reported in which the affinity of the MBS for MCP has been 
reduced. The linker sequence length between the stem-loops has also been optimized. These 
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systems allow more dynamic mRNA tracking with less interference on mRNA degradation 
rate (Tutucci et al., 2018a; Tutucci et al., 2018b). 
Singer and coworkers also developed an analogous system based on bacteriophage PP7 coat 
protein (PCP) and its binding site (PBS) (Larson et al., 2011), allowing simultaneous two-
color RNA tracking (Hocine et al., 2013). Combining these two systems facilitated 
engineering of a fluorogenic system based on split EGFP (Wu et al., 2014). These systems 
are denoted as trimolecular fluorescence complementation (TriFC) (Figure 1-9 C). More 
recently Park et al, have reported a system based on tripartite superfolder GFP that is only 
complemented and made fluorescent upon binding to the target RNA. Analogous to TriFC 
these systems are regarded as tetramolecular fluorescence complementation (TetFC) (Park 
et al., 2020). (Figure 1-9 D). 
 
Figure 1-9 MS2-tagging system in RNA imaging. (A) MCP is fused to GFP. MBS is inserted in 
multiple copies in the 3'-UTR of the RNA of interest. Binding of the MCP-GFP to RNA facilitates 
imaging. NLS is to ensure accumulation, in the nucleus, of unbound MCP-GFP. (B) Schematic 
representation of MS2-tagging in tracking of the Ash1 mRNA in budding yeast (Bertrand et al., 
1998). (C) And (D) Fluorogenic MS2-tagging systems based on trimolecular and tetramolecular 
complementation. 
 
1.4.1.2.2 Pumilio domain 
A drawback of the MS2-tagging is the requirement of exogenous expression of target RNA 
with multiple copies of MBS inserted in their 3'-UTR (George et al., 2018). An alternative 
system is based on the pumilio domain, which can be engineered for binding to any desired 
sequence. The RNA binding domain, pumilio, belongs to the PUF family of proteins. These 
proteins bind to their specific 8-nucleotide recognition motifs that lie in 3'-UTR of their 
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target mRNA. Upon binding they regulate translation and/or stability of their target mRNA. 
The pumilio domain consists of eight repetitive structural modules, each made of three α-
helices. Three amino acid side chains in each module are responsible for recognition of a 
single nucleobase. Each nucleobase has a fixed binding code and therefore replacing these 
three amino acid residues alters the binding specificity towards a different sequence (Cheong 
and Hall, 2006). While recognition modules for A, G, and U naturally exist, the binding code 
for C nucleotide was evolved artificially (Dong et al., 2011). Various cellular and viral RNAs 
have been imaged in live mammalian and plant cells using pumilio based TriFC systems 
(Figure 1-10 A) (Adamala et al., 2016; Ozawa et al., 2007; Tilsner et al., 2009). 
Rentmeister’s group has also engineered a TetFC strategy based on this domain (Figure 
1-10 B) (Kellermann et al., 2013; Kellermann and Rentmeister, 2016). Binding specificity 
of the pumilio TetFC system has been confirmed using FACS on E. coli cells (Kellermann 
and Rentmeister, 2017).  
 
Figure 1-10 Pumilio-based RNA imaging system. (A) Scheme of the pumilio-based TriFC imaging 
system. (B) pumilio TetFC imaging system. Each pumilio domain is composed of eight modules. 
Each module is responsible for recognizing on nucleotide within the 8-nucleotide binding site. 
 
1.4.1.2.3 CRISPR-Cas based systems 
Cas proteins are a group of RNA guided endonucleases found in bacteria (Wiedenheft et al., 
2012). They can be targeted towards any desired sequence simply by designing their guide 
RNA complementary to the sequence of interest. The originally discovered Cas proteins, 
such as Streptococcus Pyogenes Cas9 protein, were specific towards double-stranded DNA 
and therefore were extensively utilized for genomic editing applications (Savić and 
Schwank, 2016). Nuclease deficient mutant variants of Cas9 (dCas9) fused to various 
functional domains have been used for other purposes. The applications include regulation 
of gene expression (Qi et al., 2013) or introduction and removal of epigenetic marks (Lo and 
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Qi, 2017). dCas9, either in the form of an organic dye conjugate (Deng et al., 2015) or as a 
fusion with an FP (Chen et al., 2013), has been applied for imaging of the genomic loci.  
Imaging and tracking RNA molecules in the cell using dCas9 based systems, is however 
more challenging for two main reasons: The first reason is that the dCas9-gRNA complex 
recognizes a double-stranded target sequence rather than the single-stranded RNA. The 
second reason is the requirement for the 5'-NGG-3' PAM motif on the non-target strand. 
Nelles and colleagues presented a solution to these problems by introducing PAM containing 
DNA oligonucleotides partially complementary to the target site. These oligonucleotides 
called PAMmers facilitated imaging of three different mRNAs using dCas9-GFP-gRNA 
complex (Figure 1-11 A). The absence of the PAM sequence in the genomic locus of the 
targeted RNA segment determines the specificity of  the CRISP-dCas9-PAMmer system for 
RNA imaging (Nelles et al., 2016). 
More recently Cas13a, formerly known as C2c2, was confirmed as a single-stranded RNA 
binding CRISPR-Cas complex (Abudayyeh et al., 2016). Cas13a allows selective cleavage 
or imaging of a target RNA without the need for the introduction of PAMmers (Figure 1-11 
B) (Abudayyeh et al., 2017). dLwaCas13a has been successfully used by Abudayyeh et al, 
to image localization of abundant β-actin mRNA under stress conditions (Abudayyeh et al., 
2017). In their more recent report, they tested Cas13a systems from various sources. As a 
result, dPspCas13 and dPguCas13 were revealed as more efficient RNA targeting systems 
(Yang et al., 2019). Since these Cas systems recognize mutually orthogonal gRNA 
sequences it is possible to use them for simultaneous dual-color imaging of RNA molecules 
in live cells (Yang et al., 2019). 
 
Figure 1-11 RNA guided CRISPR-Cas based imaging methods. (A) dCas 9 system requires addition 
of PAMmers for RNA binding. (B) dCAs13a based system allows direct RNA recognition. 
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1.4.1.3 Fluorogenic aptamers 
While protein-based probes have been extensively studied and applied for imaging or 
tracking of various target RNAs the main limitation of these systems is the large size of 
probes and often-high background emission at the unbound state (Neubacher and Hennig, 
2019; Rau and Rentmeister, 2017). The complexity of the system due to the number of the 
transfected vectors is also another disadvantage (George et al., 2018). Fluorogenic activating 
aptamers (FLAPs) have emerged as viable alternatives to the protein-based methods. Upon 
target binding, these aptamers activate or enhance fluorescent properties of their cognate 
ligand (Neubacher and Hennig, 2019). The fluorescent activation could be a direct result of 
the aptamer-dye complex formation or relieving of the quenching effect upon binding to 
dye-quencher conjugate (Figure 1-12 A) (Su and Hammond, 2020). Fluorogenic property 
of FLAPs turns them into ideal live-cell RNA imaging tools due to the low background of 
unbound dye. For live-cell applications, FLAPs are typically placed into a stably folded RNA 
scaffold. The FLAPs within the RNA scaffold are then inserted in multiple copies, into non-
essential regions of the target RNA. (Figure 1-12 B) (Neubacher and Hennig, 2019). The 
scaffold minimizes the effect of the flanking sequences on aptamer folding and protects the 
aptamer from nuclease degradation (Martell et al., 2002; Ponchon and Dardel, 2007). The 
most frequently utilized scaffold is the human lysine tRNA (tRNALys3) whose application is 
not limited to fluorogenic aptamers (Ponchon and Dardel, 2007). Aptamers are usually 
inserted into the anticodon loop of this tRNA. Filonov et al, demonstrated in 2015 that the 
tRNA scaffold undergoes endonucleolytic processing in human and E. coli cells. They 
therefore engineered an alternative RNA scaffold called F30. This scaffold promotes more 
stable levels of fluorogenic aptamer expression in cells (Filonov et al., 2015). 
 
Figure 1-12 Fluorogen activating aptamers. (A) Direct vs indirect fluorogenic activation. (B) FLAPs 




1.4.1.3.1 GFP fluorophore analog binding aptamers 
The malachite green binding aptamer, developed in 2003 (Babendure et al., 2003) is the first 
ever reported case of a FLAP. This class of functional RNAs however, became a major focus 
of research after Samie R Jaffrey’s group published their report on FLAP development in 
2011. The group revealed that certain RNA aptamers can activate fluorescence of synthetic 
GFP fluorophore (HBI) analogs upon binding (Paige et al., 2011). They used SELEX to 
evolve RNA aptamers with binding affinity towards various synthetic HBI analogs (Figure 
1-13). The binders were then screened for their fluorogenic properties. These efforts led to 
the discovery of several FLAPs with binding specificity for various HBI analogs and distinct 
spectral properties. They named the most well characterized aptamer “Spinach”. The 
aptamer emits green fluorescence when bound to its ligand, DFHBI (Paige et al., 2011). 
Other DFHBI derivatives have also been shown to bind this aptamer with slightly red-shifted 
fluorescence (Song et al., 2014). Spinach2 is a superfolder version of this aptamer developed 
via functional mutagenesis. This aptamer demonstrates improved fluorescence emission and 
thermal stability compared to the original Spinach (Strack et al., 2013).  
X-ray crystallographic studies of Spinach revealed a binding core with a two-tiered G-
quadruplex structure. Based on these studies Samie R. Jaffrey’s group managed to rationally 
minimize Spinach by removing non-essential nucleotides (Warner et al., 2014). The 
minimized version was called baby Spinach and showed superior fluorogenic properties 
compared to Spinach and Spinach2. 
Broccoli is another aptamer of the Spinach family, which was selected directly for 
fluorogenic activity. The selection was done using FACS on E. coli cells expressing a pre-
enriched RNA pool of DFHBI-1T binders (Figure 1-13). Owing to this new selection 
strategy, Broccoli aptamer was directly selected for fluorogenic activation. Broccoli is less 
dependent on Mg2+ compared to spinach and was more stably folded and maintained in live 
cell. It has also been shown to be less dependent on the RNA scaffold when expressed in 
cell (Filonov et al., 2014). 
Corn is an RNA analog of red fluorescent protein DsRed that was evolved in a similar 
fashion as broccoli (Song et al., 2017). It was selected against DFHO (Figure 1-13) and binds 
to its ligand as a homodimer (Warner et al., 2017). 
Chili is another member of the HBI binding family of fluorogenic aptamers. This aptamer is 
based on the previously reported 13-2 aptamer (Paige et al., 2011) which was further 
minimized in Höbartner’s group. Novel large Stokes shift HBI derivatives were tested for 
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binding to this aptamer and fluorescence activation. The aptamer produces a variety of 
emission colors upon binding to these ligands. The cationic nature of these HBI analogs 
resulted in improved affinity and less dependence on Mg2+. Strongest fluorescence activation 
in the case of this aptamer is achieved with DMHBI+ dye (Figure 1-13) (Steinmetzger et al., 
2019a; Steinmetzger et al., 2019b). Despite some promising features such as large Stokes 
shift and lower dependency on Mg2+, this aptamer has not yet been tested in cellular systems. 
 
1.4.1.3.2 Thiazole-orange binding aptamers 
Standard thiazole orange dye, TO1, has a natural tendency to bind to double-stranded nucleic 
acids and become fluorescent (Nygren et al., 1998). Dolgosheina and coworkers synthesized 
TO1-biotin, based on TO1-acetate, which was previously known to show dramatically lower 
non-specific binding capacity for RNA or DNA. They then developed aptamer Mango which 
can bind and activate fluorescence of TO1-biotin (Figure 1-13) (Dolgosheina et al., 2014).  
In 2018, Autour et al, reselected the round 12 pool from Mango aptamer selection through 
several rounds of a microfluidic in vitro compartmentalization (µIVC) based approach 
(Autour et al., 2018). In this method, individual DNA templates of the pool were 
compartmentalized in single droplets. PCR amplification was then performed on these 
compartmentalized templates within the thermal cycling module of the microfluidic device. 
The droplets containing amplified templates were then fused to the ones containing the 
transcription mix and the TO1-biotin. After a certain incubation period the droplets were 
sorted based on their fluorescence emission. Mango II-IV were identified through these 
selection experiments with improved fluorescence and reduced dependency on salt 
concentration. Mango III was successfully used for live-cell RNA imaging within F30 and 
U6 scaffolds (Autour et al., 2018). Arrays of up to thirty-six mango II aptamers, without a 
scaffold, were used to localize β-actin mRNA and the non-coding NEAT-1 RNA in live cell 
(Cawte et al., 2020). 
 
1.4.1.3.3 Silicon rhodamine binding aptamer 
SiRA aptamer is one of the newest additions to the pallet of fluorogenic aptamers. The 
aptamer binds to the environment-sensitive silicon rhodamine dye (Wirth et al., 2019) 
(Figure 1-13). SirA binding stabilizes the zwitterionic state of the dye, which is significantly 
more fluorescent than the spirolactone form. A fluorescence activation of roughly 7-folds is 
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therefore observed. SirA can also bind to other 5-carboxy rhodamine dyes such as TAMRA 
and carborhodamine. Five copies of SirA within the tRNA scaffold, inserted into GFP 
mRNA, allowed successful localization of the mRNA using confocal and superresolution 
microscopy (Wirth et al., 2019).  
 
1.4.1.3.4 DNB aptamers 
Dinitroaniline (DN) acts as a general contact-mediated quencher when coupled to a wide 
range of fluorophores. Arora et al reported the selection of dinitroaniline binding aptamer 
called DNB (Figure 1-13). Since the aptamer is only specific for the quencher moiety, it can 
activate fluorescence of a wide range of fluorescent dyes albeit with varying efficiency. 
From the dye-DN conjugates tested, TMR-DN, SR-DN, and TR-DN showed the highest 
fluorescent enhancement. DNB transcribed in live E. coli cells within the context of a tRNA 
scaffold demonstrated fluorogenic activation of the tested Dye-DN conjugate. (Arora et al., 
2015). 
 
1.4.1.3.5 BHQ aptamers 
Black Hole Quenchers (BHQs) have a wide absorption range throughout the visible light 
spectrum. As a result, they can strongly quench numerous fluorophores when physically 
coupled to them. BHQ binding aptamers have also been shown to activate the fluorescence 
of dye-BHQ conjugates (Figure 1-13) (Murata et al., 2011). These aptamers were designed 
for target RNA recognition in trans. In this system hybridization to the target RNA stabilizes 
the basal stem of the BHQ binding aptamer resulting in dye-quencher binding and 
fluorescence activation (Sato et al., 2015). 
 
1.4.1.3.6 SRB-2 aptamer 
SRB2 is a rhodamine binding aptamer originally selected for binding to sulforhodamine 
(Figure 1-13) (Holeman et al., 1998). The aptamer lacks direct fluorogenicity, however, 
when bound to dinitroaniline conjugated sulforhodamine, it could induce a fluorescent turn-
on of roughly 100-folds (Sunbul and Jäschke, 2013). Binding affinity of this aptamer is not 
limited to sulforhodamine but rather it can bind to a variety of organic dyes with “xanthene-
like” core structure. Coupling of each of these dyes to dinitroaniline quencher led to SRB-2 
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mediated fluorescence activation. SRB-2 aptamer has been used for RNA imaging in live E. 
coli cells and mammalian cell-lines (Sunbul and Jäschke, 2018). 
 
1.4.1.3.7 o-Coral 
Inspired by strong fluorogenic activation of SRB-2 aptamer, Bouhedda et al attempted a 
further improvement. They synthesized a dimeric self-quenched form of sulforhodamine B 
called Gemini-561. Through alternating rounds of PCR mutagenesis, SELEX, and functional 
µIVC, o-Coral was isolated for binding to Gemini-561 and direct fluorescence activation. 
The o-Coral aptamer is essentially a dimerized SRB-2 aptamer with a few mutations. 
Binding of this aptamer to Gemini-561 results in roughly 10 times fluorescence enhancement 
presumably by relieving the self-quenching effect (Figure 1-13). Due to the exceptional 
brightness of the aptamer-dye pair, even a single copy of o-Coral facilitated imaging and 




Riboglow is another example of quencher binding aptamers derived from the natural 
bacterial cobalamin (Cbl) riboswitch (Braselmann et al., 2018). Braselmann and colleagues 
reported that Cbl could act as an efficient quencher for a variety of synthetic fluorophores. 
The dye is conjugated via a linker, to the 5'-hydroxyl group of Cbl, which remains accessible 
when bound to the riboswitch (Figure 1-13). The binding of the aptamer to Cbl turns on the 
fluorescence of the conjugated dye. Riboglow system has several advantages over artificially 
selected aptamers. Since it is derived from a natural source, the aptamer can retain its active 
folded structure within the cell without the need for an additional scaffold. This system has 
been used successfully, to localize β-actin mRNA and U1 snRNA. The main disadvantage 
of this system is the cell impermeability of the Cbl-fluorophore conjugates and the rather 
low turn-on ratio. Special delivery methods such as bead-loading is therefore required to 




Figure 1-13 Fluorogenic aptamer-dye pairs (A) Chemical structure of the ligands recognized by 
FLAPs. Written on top of each structure is the name of the ligand and the name of the binding aptamer 
is written at the bottom of each structure. Asterix indicates direct fluorogenicity of the aptamer (B) 
approximate emission maxima of the direct FLAP-dye pairs. 
 
1.4.2 Covalent methods 
1.4.2.1 Polymerase mediated incorporation of labeled nucleotides 
RNA polymerases can incorporate NTP analogs with certain modifications in vivo and in 
vitro (Anhäuser and Rentmeister, 2017; Holstein and Rentmeister, 2016). Pyrimidines with 
bioorthogonal modification at C5, such as alkyne or azide are some of the most frequently 
used examples of these types of NTPs (Asare-Okai et al., 2014; Qu et al., 2013; Sawant et 
al., 2016). The alkynyl and azido groups allow derivatization using copper(I)-catalyzed 
alkyne-azide cycloaddition reaction (CuAAC) (Muthmann et al., 2020). The azido moieties 
can also be derivatized using strain-promoted alkyne-azide cyclo-addition (SPAAC) (Figure 
1-14 A) (Muthmann et al., 2020). 4-sUTP is another example of pyrimidines that has been 
successfully incorporated into RNA and derivatized by various means (Duffy et al., 2019). 
Purine analogs such as N6-propargyl-ATP have also been used to derivatize RNA transcripts 
in live cell. These analogs can be incorporated either by cellular polymerases or via the action 
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of the Poly-A polymerase (Grammel et al., 2012). 2'-Azido-ATP (Anhäuser et al., 2019) and 
2-ethynyl-ATP (Curanovic et al., 2013) on the other hand have been incorporated 
specifically into the poly-A tail of mRNA via the action of poly-A polymerase. 
Polymerase based approaches do not result in site or sequence-specific labeling of RNA, but 
rather result in random labeling of all actively transcribed RNAs. Unnatural orthogonal base-
pairs have been used for site- and transcript-specific labeling of RNA in vitro, however, 
application of these systems for live-cell RNA imaging is extremely challenging 
(Hamashima et al., 2018). 
 
1.4.2.2 RNA modifying enzymes 
1.4.2.2.1 RNA methyltransferases 
Numerous examples of methyltransferase enzymes have been applied for labeling of various 
target molecules such as proteins and DNA and more recently RNA (Holstein and 
Rentmeister, 2016; Lukinavičius et al., 2007; Muthmann et al., 2020). The common feature 
among these enzymes is the use of S-adenosyl-methionine as the methyl group donor. A 
number of these enzymes have been reported in literature, which can transfer extended alkyl 
chains from the various synthetic analogs of SAM to their target molecule. The most notable 
examples of such extensions include bioorthogonal functionalities and chemical probes 
(Muthmann et al., 2020). Motorin et al published the earliest report on application of such 
enzymes for RNA labeling. They reported that the RNA methyltransferases Trm1 and Trm11 
could transfer beta-unsaturated carbon chains with terminal alkynyl functionality. Trm1and 
Trm11 modify N2-groups of tRNAPhe at positions 26 and 10, respectively (Figure 1-14 B & 
C). Alexa fluor 594 azide was then subsequently conjugated to these modified positions 
using CuAAC reaction (Motorin et al., 2011). 
Protein engineering techniques can sometimes be employed to improve the reactivity of 
RNA methyltransferases towards the unnatural SAM analogs. Schulz et al, for example 
engineered Giardia lamblia trimethyl guanine synthase 2 (Gla-Tgs2) for efficient labeling 
of mRNA cap-structures (Schulz et al., 2013). The engineered enzyme Gla-TGs2-Var1 
demonstrates three times higher turnover number, Km and kcat for S-AdoPropen compared to 
the wild type. Such improvement was achieved with only one single amino acid substitution 
(V34A). Gla-Tgs2-Var1 was then applied for functionalization of the N2-position in the m7G 
of the mRNA cap structure. The groups transferred using this enzyme include alkynyl 
(Schulz et al., 2013), azido (Holstein et al., 2014), and 4-vinylbenzyl (Holstein et al., 2015) 
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functionalities. The functionalized cap can subsequently be derivatized with chemical probes 
using CuAAC, SPAAC, or iEDDA (Inverse electron-demand Diels-Alder) reactions (Figure 
1-14). 
Ecm1 is another cap methyltransferase with an inherent ability to transfer bulky moieties 
from their corresponding SAM-analogs. This enzyme has been exploited by Rentmeister’s 
research group, to transfer a wide variety of bioorthogonal functionalities to N7 of the cap 
guanine (Holstein et al., 2016; Muttach et al., 2017). Functional groups as bulky as a 
norbornene connected to a benzylic linker have been transferred using this enzyme (Figure 
1-14). The modified cap-structure was then labeled using rapid and fluorogenic iEDDA 
reaction in cell lysate (Muttach et al., 2017). 
Perhaps the most versatile example of methyltransferase enzymes reported so far is the C/D-
box dependent archaeal methyltransferase. This RNA guided enzyme alkylates internal 2'-
OH positions of RNA based on complementarity to the guide C/D box guide RNA. The 
approach shows great promise for versatile site-specific labeling of RNA. However the 
reactivity of the enzyme is extremely low towards the tested SAM analogs (Figure 1-14) 
(Tomkuvienė et al., 2012). This drawback may be circumvented using protein engineering 




Figure 1-14 RNA methyltransferases in RNA labeling. (A) Common bioorthogonal reactions 
employed for indirect labeling of RNA, derivatized using RNA modifying enzymes. (B) General 
architecture of SAM analogs and the side chains transferred using various methyltransferases. (C) 
Schematic depiction of RNA methyltransferase-catalyzed RNA labeling. Gla-Tgs2-Var1 and Ecm1 
are specific for mRNA cap structure. C/D RNP can be targeted towards different RNA sequences 
based on guide RNA complementarity. Trm1 and Trm11 methyltransferases modify specific G-
nucleotides within their cognate tRNA. 
 
1.4.2.2.2 Other tRNA-modifying enzymes 
Except for RNA methyltransferases other classes of tRNA modifying enzymes also exist 
which have shown great potential for RNA labeling. The archaeal tRNAIle2- agmatidine 
synthetase (Tias) is one example of such enzymes. The enzyme naturally catalyzes ATP 
dependent substitution, with agmatine, of the O2 at C34 of its cognate tRNA (Figure 1-15 
A) (Osawa et al., 2011). Li et al demonstrated that the enzyme can readily accept a variety 
of alkynyl or azido functionalized agmatine analogs, including propargylamine (Figure 1-15 
A). They then co-expressed Tias with a 5S rRNA-tRNAIle2 fusion transcript in a mammalian 
cell-line. The cells were then treated with propargylamine. Following this treatment, the cells 
were fixed. CuAAC reaction was then used to label propargylamine modified RNA in situ 
with SulfoCy5-Azide (Figure 1-15 B) (Li et al., 2015).  
Another tRNA modifying enzyme-based system, developed by Alexander et al, is called 
RNA-transglycosylation at guanine (RNA-TAG) (Alexander et al., 2015). In this method, 
bacterial tRNA guanine transglycosylase (TGT) is taken advantage of for RNA labeling. 
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This enzyme is responsible for the substitution of specific guanine nucleotides with the 
noncanonical guanine analog PreQ1 (Figure 1-15 C). Various PreQ1 analogs with 
modifications at their exocyclic primary amine have been shown to be efficiently accepted 
as TGT substrate. Direct attachment of bulky moieties such as Cy7, bodipy, thiazole-orange, 
or biotin has also been possible using this enzyme. In case of the thiazole-orange conjugated 
PreQ1, a 40-fold increase in fluorescent intensity was observed upon RNA labeling. The 
enzyme recognizes a 17-nucleotide stem-loop called ECY-A1 as the core target sequence. 
Insertion of ECY-A1 into the 3'-UTR of the mCherry mRNA led to its TGT mediated 
labeling in vitro (Figure 1-15 D) (Alexander et al., 2015). Photocleavable groups have also 
been attached to 5'-UTR of an in vitro transcribed EGFP mRNA. The mRNA was transfected 
into a mammalian cell-line and its translation was induced upon photocleavage (Zhang et 
al., 2018). 
 
Figure 1-15 tRNA-modifying enzyme-mediated RNA labeling. (A) Agmatidine synthetase activity 
of Tias and the substrate scope of the enzyme. (B) Insertion of the tRNAIle2 into the RNA of interest 
(ROI), allows Tias-mediated two-step labeling of target RNA. (C) TGT mediated RNA labeling. The 
exocyclic amine of PreQ1 substrate can be derivatized directly with a variety of bulky moieties. (D) 
Insertion of the ECY-A1 stem-loop into ROI allows TGT mediated direct labeling of RNA. 
 
1.4.2.3 Catalytic nucleic acid-based RNA labeling 
1.4.2.3.1 Ribozyme based methods 
Self-alkylating fluorescein-iodoacetamide reactive ribozyme selected by Sharma et al, is an 
example of a catalytic RNA that was directly selected for RNA labeling. The selection was 
performed using fluorescein-iodoacetamide and IP-SELEX (Figure 1-7 B) as mentioned in 
1.3.2.4. The outcome of this selection were two ribozymes denoted as 1FR1 and 5FR1. These 
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ribozymes were able to self-alkylate at an undetermined internal position, in the presence of 
fluorescein-iodoacetamide. The fusion of these two ribozymes to a transcript coding for a 
part of the mCherry protein resulted in the labeling of the fusion construct in vitro and in cell 
lysate (Figure 1-16 A) (Sharma et al., 2014). The high specificity of these ribozymes 
towards Fluorescein-IA limits their application to single-color and single-probe labeling 
reactions. 
Another example of self-alkylating ribozymes with the potential for RNA labeling is a 42-
nucleotide long RNA catalyst derived from Aeropyrum pernix genomic RNA sequences 
(McDonald et al., 2014). To identify this ribozyme, McDonald et al. used a mixture of eight 
biotinylated compounds with electrophilic functionalities, in combination with an RNA pool 
of transcriptomic fragments derived from 9 different species. The self-alkylating ribozyme 
was isolated within 6 rounds of selection. Further characterization on this ribozyme revealed 
its specific reactivity towards di-substituted cis-epoxides (Figure 1-5 B). The self-alkylation 
was still observed even when the biotin was replaced by other moieties containing alkynyl 
or azido functionalities or even fluorescent dyes such as TAMRA. 5S rRNA and ASH1 
mRNA were transcriptionally fused to this catalyst and were shown to be successfully 
labeled as pure transcript or in the context of total cellular RNA (Figure 1-16 B) (McDonald 
et al., 2014). 
 
Figure 1-16 Cis-reacting self-alkylating ribozymes as RNA labeling tools. (A) Fluorescein 
iodoacetamide reactive ribozyme can be inserted into target RNA, allowing fluorescein labeling at 
internal positions. (B) Insertion of the epoxide reactive ribozyme into the ROI allows labeling using 
various epoxide containing chemical probes. 
 
The Twin-ribozyme is an engineered form of the hairpin ribozyme, which has also been 
applied to RNA labeling in trans. As mentioned in 1.2, the hairpin ribozyme is a self-cleaving 
ribozyme. The cleavage reaction generates a 2'-3' cyclic phosphodiester and a 5'-OH at the 
ends of the RNA fragments, which can be rejoined, since the hairpin ribozyme can also 
catalyze the re-ligation reaction (Hampel and Tritz, 1989). The ribozyme can be engineered 
into a trans-acting variant consisting of a conserved catalytic core and a pair of binding arms. 
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The arms can be used to target the ribozyme to RNA sequences of interest (Walter and 
Burker, 1998). This engineered variant can catalyze a similar cleavage/re-ligation reaction 
on an independent RNA molecule in-trans. The twin-ribozyme was developed by tandem-
connection of two copies of the hairpin ribozyme via a linker sequence (Schmidt et al., 2000; 
Welz et al., 2003). The arms and the linker are designed complementary to the target RNA. 
Upon hybridization, twin-ribozyme facilitates excision of an RNA segment and its 
replacement with a synthetic piece carrying a label at a desired position. For re-ligation to 
occur, the ligated patch needs to carry a 2'-3'cyclic phosphodiester at its 3'-end. Since the 
original piece can also be ligated back, the linker is designed to form an unpaired tetraloop 
when bound to target RNA. The synthetic patch, however, is made fully complementary to 
the linker sequence. This is to ensure that the synthetic piece can replace the excised 
fragment more efficiently (Figure 1-17) (Vauléon et al., 2005).  
 
Figure 1-17 Twin-ribozyme based RNA labeling. Twin-ribozyme labels target RNA via strand 
exchange mechanism. A synthetic RNA piece carrying a variety of labels (red)can be used to replace 
a target segment (cyan). 3'-cyclic phosphodiester (cp) is essential to the targeting reaction. The 
tetraloop region (green) remains unpaired to the original segment while pairing to the synthetic piece 
to allow efficient strand exchange. 
 
Samanta et al, report another RNA labeling method using a polymerase ribozyme (Samanta 
et al., 2018). Polymerase ribozymes are a class of artificial RNA catalysts that can catalyze 
template-based extension of DNA or RNA primers using NTPs (McGinness and Joyce, 
2003). Samanta et al, exploited polymerase ribozyme 24-3, for template-dependent addition 
of labeled nucleotides to 3'-end of RNA or DNA (Figure 1-18). The RNA of interest in this 
system acts as a primer annealed to a template oligonucleotide. The template oligonucleotide 
and the ribozyme are designed complementary at their 5'-end (Figure 1-18). The segment 
of the ribozyme complementary to the template is called tag sequence. This complementarity 
facilitates primer-template pair recognition by the polymerase ribozyme. The template is 
designed in a manner that only a single nucleotide extension to the RNA of interest is 
permissible. The NTP analogs added using this strategy could bear a diverse set of 
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functionalities and modifications at various positions. This system has only so far been used 
in vitro. Live-cell application of this ribozyme is challenging due to the lack of orthogonality 
towards natural NTPs (Samanta et al., 2018). the application of this ribozyme is also only 
limited to the 3'-end labeling. This may cause additional complications particularly when it 
comes to specific targeting of 3'-polyadenylated RNA. 
 
Figure 1-18 24-3 polymerase ribozyme mediated RNA labeling. Tag sequence (green) at 5'-end of 
the ribozyme is designed complementary to the 5'-end of the template. The ROI in this method acts 
as a primer. Annealing of ROI to the template allows one nucleotide extension in the presence of the 
appropriate NTP analog. The NTP analog can carry a variety of labels at various positions. 
 
1.4.2.4 Deoxyribozyme based RNA labeling methods 
DNA has also been shown to possess catalytic potential like RNA. No natural catalytic DNA 
sequence has so far been identified, and therefore all the existing deoxyribozymes have been 
artificially developed through in vitro selection efforts (Silverman, 2009). PAGE 
purification seems to be the prevalent method of choice for deoxyribozyme selection. Many 
deoxyribozymes with a wide variety of activities have been selected so far. The instances of 
these functions include RNA (Santoro and Joyce, 1997) or DNA (Carmi et al., 1996) 
cleavage, RNA ligation (Coppins and Silverman, 2004b), amide and ester bond hydrolysis 
(Brandsen et al., 2013), depurination (Höbartner et al., 2007), tyrosine phosphorylation 
(Dokukin and Silverman, 2014) or nucleotidylation (Wang and Silverman, 2016) and so on. 
A 3'-5' RNA ligase deoxyribozyme, called 9DB1, the first deoxyribozyme whose crystal 
structure has been resolved (Ponce-Salvatierra et al., 2016), was applied for RNA labeling 
in vitro. The labeling is performed through ligation of a labeled synthetic RNA piece to a 5'-
triphosphorylated in vitro transcribed RNA (Büttner et al., 2013). The more extensively 
utilized deoxyribozyme is 10DM24 with 2'-5'-ligation activity which leads to the formation 
of a branched RNA (Zelin et al., 2006). 10DM24 was used for RNA labeling at 2'-hydroxyl 
of specific internal adenosines, using short labeled oligonucleotide (Baum and Silverman, 
2007). Further engineering of these catalysts led to its ability to ligate single GTP to the 
target RNA forming a 2'-5'-mononucleotidyl branch (Höbartner and Silverman, 2007). The 
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incoming GTP is recognized by Watson-Crick base-pairing to a C nucleotide in the 10DM24 
catalytic core. Mutations to this nucleotide allows ligation of other NTPs. Purine based NTPs 
however are more efficiently ligated (Höbartner and Silverman, 2007). In 2014 Büttner et al 
showed that 10DM24 tolerates a wide range of modifications at 2'-position of GTP allowing 
efficient ligation of various derivatizations such as bioorthogonal functional groups or even 
bulky fluorescent dyes such as Cy3 and Cy5 via a (d)GMP linker (Figure 1-19) (Büttner et 
al., 2014). 10DM24 based RNA labeling is possibly the most versatile and efficient method 
for labeling of unmodified RNA. Targeting of the position to be labeled is based on Watson-
crick base-pairing of a pair of binding arms to the target position. The arms flank an unpaired 
adenosine which serves as the modification site for the deoxyribozyme.10DM24 allows site-
specific and efficient installation of relatively small chemical probes onto the target RNA 
without the need for insertion of exogenous segments. The effects of this labeling technique 
on the structure and function of the target RNA is therefore minimal. This deoxyribozyme 
however has never been applied in live cell due to challenges regarding delivery and 
maintenance of single stranded DNA in cells. The other limitations of the catalyst is the 
requirement of a helper oligonucleotide for formation of a rather complicated 3-helix 
junction structure (Figure 1-19) and toxic Tb3+ ions for optimal activity. 
 
Figure 1-19 10DM24 mediated labeling of an RNA of interest. The target RNA is recognized by a 
pair of binding arms (red). The modified A-nucleotide remains unpaired and, therefore, bulges out. 
A helper oligonucleotide pairs to a third binding arm (light blue). The first four nucleotides of the 
helper oligonucleotide pair to a segment of 10DM24 catalytic core (light orange). This arrangement 
leads to the formation of a three-helix-junction surrounding the targeted A-nucleotide. GTP 
nucleotides carrying a vast range of functionalities and labeled at their 2'-positions can be ligated to 
the bulged A using this method. The recognition of GTP is made via W:C pairing to a C nucleotide 
in the catalytic core. 
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2 Aim of the study 
Various RNA labeling and visualization methods have been developed over the last few 
decades. Despite the advances made in the field of RNA imaging, flexible and site-selective 
labeling strategies are still in high demand. The main limitation of most existing non-
covalent and covalent methods is the need for insertion of exogenous sequences into the 
target RNA. On the other hand, low labeling efficiency is an obstacle in case of more 
generalizable covalent labeling methods such as the C/D RNP methyltransferase approach 
(Tomkuvienė et al., 2012). 
Among the tools reviewed in 1.4, the 10DM24 deoxyribozyme RNA labeling system offers 
an attractive choice. This system provides one of the most versatile and flexible options for 
site-specific RNA labeling at internal adenosine nucleotides. The deoxyribozyme can be 
easily targeted to desired positions through Watson-Crick complementarity of its recognition 
arms to the target section (Büttner et al., 2014; Höbartner and Silverman, 2007). The 
deoxyribozyme also offers a wide range of possibilities regarding the choice and type of the 
label. 10DM24 readily accepts GTP substrates conjugated to various types of small and 
bulky modifications (Büttner et al., 2014). Additionally, the reaction efficiency of 10DM24 
is exceptionally high, compared to other systems guided by complementarity such as the 
C/D RNP methyltransferase (Tomkuvienė et al., 2012) or the Twin-ribozyme (Vauléon et 
al., 2005). The labeling reaction does not require manipulation of the linear RNA sequence 
and the size of the label is quite small. The interference of such labeling system in function 
or folding of the target RNA is therefore expected to be minimal (Büttner et al., 2014). 
10DM24 however has only been used for RNA labeling in vitro or in cellular extracts 
supplemented with catalyst’s metal ion cofactors. 
Tools with similar properties as 10DM24 for cellular applications have not yet been reported. 
Thus, as the main goal of this thesis, we decided to develop ribozyme analogs of 10DM24 
with potential for future cellular application. The main advantage of ribozymes over 
deoxyribozymes is their vector encodability. RNA catalysts can be converted into their 
coding dsDNA sequences, which can be cloned into appropriate expression vectors. The 
resulting “ribozyme gene” can be transcribed into the active ribozyme within the cell (Park 
et al., 2019). Engineered self-cleaving ribozymes have been reported in numerous examples 
that have been encoded into DNA vectors and successfully expressed within the cell (Felletti 
et al., 2016; Ogawa and Maeda, 2008). 
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For ribozymes with similar function as 10DM24, we imagined a pair of recognition arms 
that recognize the target RNA sequence, based on complementarity. Analogous to 10DM24 
the ribozymes should also possess catalytic cores with broad labeling substrate scope 
(Figure 2-1). In this thesis, we designed a selection process through which 10DM24-like 
ribozymes can be evolved. There are undesirable aspects to 10DM24 based system as well 
such as the dependency on Tb3+ and the complex three-helix junction structure (Büttner et 
al., 2014). We, therefore, focused on developing ribozymes that do not require such metal 
cofactor and have more simplified structures. 
Our first objective was to establish and optimize the selection process. At first, as proof of 
principle, we initiated a selection process using ATP based substrates. This selection 
experiment led to the identification of adenylyltransferase ribozymes with many desirable 
properties. We then switched our focus to substrates more orthogonal to the biological 
system, such as antiviral nucleotide analogs. The FDA approved antiviral ATP analog, 
tenofovir-diphosphate (Gallant and Deresinski, 2003), was chosen in the next stage as a 
candidate for ribozyme development. Unlike ATP analogs, tenofovir is not enzymatically 
incorporated into RNA. Presence of a phosphonate instead of α-phosphate in this analog, 
would also result in formation of a less enzymatically labile linkage. Selection using 
tenofovir-diphosphate-based substrates was initiated to develop tenofovir transferase 
ribozymes. 
The developed ribozymes were then characterized and tested for their RNA labeling 
potential in vitro. 
 




3.1 General design of the selection strategy 
3.1.1 The design of the selection pool 
The selection pool was designed to include five major segments (Figure 3-1 A): 1) A 
hypothetical substrate sequence to which the modification was to be directed. 2) A 14-
nucleotide connecting loop. 3) A pair of binding arms. 4) A 40-nucleotide random region. 
5) An 8-nucleotide unpaired 3'-extension. 
The 19-nucleotide substrate sequence was designed in a way that it could not form stable 
intramolecular secondary structures based on mfold predictions (Gallant and Deresinski, 
2003). The substrate sequence was initiated with a 5'-GG, to serve as transcription start-site 
for T7 RNA polymerase. The recognition arms, flanking the 40-nucleotide random region, 
were designed complementary to the substrate sequence. They paired to the substrate 
sequence leaving the desired modification-site adenosine unpaired. The adenosine 
nucleotide was placed within a 5'-GAG-3' context. This design was analogous to the complex 
formed by 10DM24 and its target sequence, in which the modification site A is bulged out. 
GAG modification context is also labeled most efficiently by 10DM24 (Büttner et al., 2014). 
To facilitate priming during the reverse transcription step, the 3'-binding arm was further 
extended by an additional 8-nucleotides. 
To ensure the physical connection of the modified substrate sequence to the evolved catalytic 
core a 14-nucleotide connecting loop was introduced. The sequence of the connecting loop 
was also designed arbitrarily. The mfold secondary structure predictions confirmed that the 
loop does not interfere with the secondary structure of the constant region of the pool. 
 
3.1.2 Construction of the selection pool 
The DNA template for the starting pool was 119 nucleotides long, including the T7 
promoter. A DNA sequence of this size is challenging to synthesize with high efficiency and 
accuracy using standard solid-phase synthesis method, and was thus constructed from two 
synthetic fragments (Figure 3-1 B). The first piece (forward pool primer), was synthesized 
in the sense direction, and included the T7 promoter, the substrate sequence, and the 
connecting loop. The other piece (reverse pool primer), was synthesized in the antisense 
direction, coded for the binding arms and the random region and the connecting loop. The 
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two pieces were complementary at their 3'-end in the connecting loop segment (Figure 3-1 
B). This complementarity allowed overlap synthesis of the full-length pool template using 
Klenow fragment. The 14-nucleotide length of the connecting loop was chosen to provide 
enough priming range for efficient overlap synthesis. The substrate sequence and the binding 
arms were not included in the overlap region to avoid 3'-self-complementarity of the primers. 
After Klenow extension, 450 pmol of the double-stranded DNA pool (corresponding to ~2.7 
x 1014 unique variants) was transcribed in vitro. The transcription yielded ~17 nmol of the 
starting pool used in selection experiments (Figure 3-1 B). 
 
Figure 3-1 Pool design and construction. (A) Schematic representation of the selection pool. Red 
shows hypothetical substrate sequence Predetermined modification site shown in bold font. Cyan 
signifies the connecting loop and purple indicates the binding arms. The green line represents the 40 
nucleotide (N40) random region. (B) Construction of the transcription template of the selection pool. 
The complementarity of the connecting loop sequence at 3'-end of each primer made possible the 
assembly of the two pieces via overlap extension using Klenow fragment. 
 
3.1.3 Overview of the selection process 
The selection involved four major steps: incubation, capture, and amplification. The main 
features of each step are explained in more detail in the section below. The schematic 
representation of the selection process is depicted in (Figure 3-2) 
During the incubation step, the RNA pool was dissolved in the selection reaction along with 
the biotinylated selection substrate. At this stage, the active pool variants react with the 
selection substrate. The reaction leads to “self-biotinylation” of the active pool species. All 
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the incubation rounds were performed at 37°C. For the first few rounds of selection, the 
incubation was done overnight to provide enough time for all the active species in the pool 
to be tagged. After a certain enrichment level was reached, the selection was made more 
stringent by gradually reducing the incubation time. This is to ensure only the fastest and 
most efficient variants survive the selection. 
The selection buffer contained 120 mM KCl and 5 mM NaCl. The monovalent K+ and Na+ 
are known to neutralize the negative charge of the RNA phosphate backbone, leading to 
secondary or tertiary structure stabilization (Woodson, 2005). They are commonly added to 
functional nucleic acid selection buffers to promote efficient folding of the active pool 
species. 
Bivalent ions play more critical roles in the activity of the functional nucleic acids, 
particularly ribozymes (Woodson, 2005). Apart from structural stability, these metal-ions 
have also been known to be directly involved in catalysis. Different types of bivalent metal 
ions are included in ribozyme selection reactions. The isolated variants often heavily rely on 
these metal ions for their activity. Examples of these metal ions are Mg2+, Ca2+, Zn2+, Mn2+, 
and Ba2+. Among the listed bivalent ions, Mg2+ is the most abundant in living systems 
(Maguire and Cowan, 2002). Natural ribozymes rely on this metal ion for catalysis. In many 
cases of such ribozymes, Mg2+ is directly involved in the catalytic process (Bowman et al., 
2012). Since our final goal was to develop ribozymes with potential for cellular applications, 
we decided to include only the Mg2+ as the bivalent metal-ion cofactor. 
The active pool species that managed to get “self-biotinylated” during the incubation step 
were separated from the rest of the pool at the capture step. To capture the biotinylated pool 
members, we employed streptavidin or neutravidin coated magnetic beads. Neutravidin is 
another biotin-binding protein with similar properties to streptavidin (Hiller et al., 1990). To 
avoid selection of streptavidin or neutravidin binders, the affinity matrix was alternated 
between neutravidin and streptavidin-coated beads every two rounds. To avoid non-specific 
binding of pool species, the beads were treated with E. coli tRNA before every capture step. 
This was to ensure that all the potential sites for nonspecific interactions would be blocked 
by tRNA. 
After binding of the biotinylated pool species, the beads were washed extensively using the 
denaturing wash buffer. The wash buffer was supplemented with 8 M urea as the denaturant. 
At this stage, species of the pool with binding affinity for streptavidin/neutravidin were 
denatured and released. Biotinylated variants, on the other hand, remained tightly bound. 
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After the bulk of the inactive species were removed through the washing step, the active 
species were eluted. Extreme denaturing conditions were therefore applied to disrupt biotin-
streptavidin/neutravidin interactions. For this purpose, a combination of heat (95°C) and an 
elution buffer containing 95% formamide was used. 
 
Figure 3-2 Overview of the selection process. During the incubation step the active species react 
with the biotinylated substrate. The “self-biotinylated” reactive species are immobilized onto 
streptavidin/neutravidin magnetic beads. The inactive species are washed extensively, and the active 
species are eluted from the beads. The eluted RNA is then subjected to reverse transcription and 
PCR, in the amplification step. The double-stranded DNA produced is then transcribed to generate 
the enriched pool of the next selection round. 
 
The recovered RNA from elution was ethanol-precipitated and subjected to a two-step 
amplification protocol. The first step involved a one-pot RT-PCR reaction during which the 
recovered RNA was reverse transcribed to cDNA, followed by 10 cycles of PCR. This 
number of cycles was chosen to ensure complete second strand synthesis and limited 
amplification to avoid introducing amplification bias. The number of cycles was maintained 
for the first few rounds of selection where the amount of eluted RNA was vanishingly small. 
As the selection progressed and the amount of eluted RNA was increased, the number of 
cycles was also reduced from 10 to 5 and eventually to 2 cycles. A portion of the one-pot 
RT-PCR product was then used in a second PCR reaction and the rest of the sample was 
stored as the backup of the selection round. The second PCR amplification generates the 
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full-length template, from which RNA entering the subsequent selection round is 
transcribed. 
Two separate forward primers were designed to ensure the amplification of ribozymes that 
modify the substrate sequence, while ribozymes that modify internal nucleotides in the core 
would not be amplified efficiently. The forward primer used in the RT-PCR step covers the 
connecting loop while only partially covering the substrate sequence (Starting at 2 
nucleotides 3' to the predetermined modification site). In the second PCR reaction the 
forward pool primer was used to restore the substrate sequence to its full-length. This primer 
also carried the T7 promoter sequence at its 5'-end. The reverse primer was the same in both 
amplification steps. The priming scheme during the amplification process is depicted in 
(Figure 3-3) 
 
Figure 3-3 Priming scheme of the amplification process. Alternative forward primers were included 
in the first PCR reaction. This was to provide equal amplification chance for the incomplete cDNA 
of the modified species and the full-length cDNA of the carry-over RNA. A 2nd amplification cycle 
restores the cDNA to its full-length and adds the T7 promoter. 
 
To monitor the progress of the selection procedure, a fraction of the pool before each round, 
was labeled at 3'-end using lucifer yellow. By measuring the fluorescence intensity of the 
eluted sample and comparing it to the total intensity of the selection sample, we estimated 
the percentage of active species of the pool, at the end of each capture step. 
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3.2 Selection of the nucleotidyltransferase ribozymes 
 
Figure 3-4 Selection substrate and the desired reaction for adenylyl transferase ribozymes. N6-biotin-
ATP was used as the selection substrate in this selection. The desired reaction is the formation of a 
2'-5' phosphodiester linkage between the 2'-OH of the predetermined modification site and the AMP 
moiety of the selection substrate. 
 
3.2.1 Selection process 
The selection started with ~2.7 x 1014 unique variants with an average copy number of 7. 
The incubation step of each selection round was performed in the selection buffer including 
200 µM concentration of the N6-aminohexyl-ATP-biotin (N6-biotin-ATP) (Figure 3-4) and 
40 mM MgCl2. The first sign of enrichment was observed at round 4 when about ~3.5% of 
the pool RNA was eluted from the streptavidin beads. This amount was almost doubled in 
the next round and reached around 8%. This enrichment level did not change substantially 
at round 6 and 7, presumably due to saturation of the beads. Up to this point, the 
concentration of the RNA pool in the reaction was maintained at ~50 µM (Including 150-
300 pmol of the LY-labeled pool RNA). At round 8, the total amount of RNA was reduced 
by half, while the amount of the labeled fraction remained the same. The amount of eluted 
RNA at this round reached approximately 16%. Therefore, we decided to increase the 
selection stringency by reducing the incubation with the biotinylated substrate in subsequent 
rounds. This was done to provide survival advantage for the faster reacting, more efficient 
species in the pool. The duration of incubation was overnight until round 8, while at round 
9, it was reduced to 3.5 hours. This led to an initial dramatic reduction in the amount of 
eluted RNA presumably due to the slower reacting variants being eliminated. The incubation 
time was further reduced to 1.5 hours, throughout the selection rounds 9 to 13. Despite the 
reduction in the incubation time, the amount of eluted fraction rose steadily throughout these 
rounds. This was an indication that faster-reacting ribozymes being enriched. At round 12 
and 13, the amount of RNA was further reduced to only 150-300 pmol of the LY-labeled 
fraction. After 13 rounds of selection, the pool was cloned, and selected representatives were 
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sent for sequencing. The summary of the selection progress can be seen in (Figure 3-5). 
Details of the selection rounds are listed in (Table 3-1) 
 
Figure 3-5 Selection progress of the adenylyltransferase ribozyme. The percentage of the eluted 
RNA after each round was estimated using fluorescence measurement. The selection stringency was 
increased by reducing the incubation time after a certain enrichment level was achieved. 
 
Table 3-1 Details of the adenylyltransferase ribozyme selection rounds. 
Selection round 1 2 3 4 5 6 7 8 9 10 11 12 13 
Pool concentration (µM) ~ 50 ~25 ~12.5 
Incubation time (h) Overnight 3.5 2 1 
Eluted % - - - 3.5 8 10 8.7 16.4 9 12 12.7 17 - 
 
3.2.2 Activity assay on the enriched pool 
3.2.2.1 Cis-activity assay 
Estimation of the enrichment level using fluorescence emission of the eluted and initial 
fractions was prone to underestimation due to several reasons. Factors such as saturation of 
the streptavidin/neutravidin beads, loss of beads during washing steps, and competition 
between the LY labeled and unlabeled fraction of the pool may lead to underestimation of 
the active portion. Therefore, we utilized streptavidin gel-shift to estimate the Cis-activity 
level directly and more accurately (Figure 3-6 A). To do so, the 3'-lucifer yellow labeled 
round 12 pool, was incubated with the biotinylated substrate under selection conditions. 
Time-point samples were taken at 0, 1, 2, and 6 hours. After ethanol precipitation, the pellet 
from the time point samples was incubated with a large excess of streptavidin, followed by 
resolution on 10% native PAGE. Fluorescent imaging of the gel revealed that over 75 % of 
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the pool species in the 6-hour time-point were shifted. The majority of the pool species were, 
therefore, determined to be active and efficient enough to self-biotinylate within 6 hours 
(Figure 3-6 B). The presence of more than one shifted band is due to the oligomerization of 
streptavidin which can be observed on native gels (Humbert et al., 2005). 
 
3.2.2.2 Trans-activity assay of the pool 
Up to this point, it was established that the evolved variants can self-biotinylate efficiently 
under the selection conditions and the presence of the N6-Biotin-ATP. It was not however 
clear whether the ribozymes modify the substrate sequence and if so, whether they can 
modify it in trans. (Figure 3-6 A). To answer these questions, the RNA pool from round 13 
was reverse transcribed. The resulting cDNA was PCR amplified using a new forward 
primer. The primer was designed to remove the substrate sequence and add a T7 promoter 
along with a 5'-GG start site to the beginning of the connecting loop (Figure 3-6 C). The 
PCR product was ethanol precipitated and in vitro transcribed. Thus, the final product was a 
ribozyme pool, which lacks the substrate sequence segment. This transcript was mixed with 
3'-lucifer yellow labeled selection substrate at an approximate ratio of 1:2 and incubated in 
10 µL of the selection buffer. The reaction mixture included 40 mM MgCl2 and 200 µM N6-
Biotin-ATP. The excess of the substrate sequence was to ensure that all pool species were 
annealed to it. Timepoint samples were taken at 0, 30 minutes, 2 hours, and after overnight 
incubation. In this case due to the small size of the substrate sequence, the branching reaction 
creates a significant enough mass shift that can be resolved using gel electrophoresis. The 
samples were resolved on a 20% denaturing PAGE and subjected to fluorescent imaging. 
The results of this experiment clearly showed that the modification site has successfully been 
localized to the substrate sequence. The results also confirmed that the enriched pool from 
round 13 was trans-active (Figure 3-6 D). 
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Figure 3-6 Cis- and Trans-activity of the enriched pool. (A) Cis- activity, defined as ribozyme 
modifying a part of itself, whereas trans-activity means the ribozyme modifies a target RNA as a 
separate entity. (B). Cis-activity assay of the enriched pool. Streptavidin gel-shift assay of the round 
12 pool. Reaction conditions: 15 µM Round 12 RNA Pool labeled with LY-CH in selection buffer 
including 200 µM biotinylated ATP and 40 mM MgCl2. Timepoints taken at 0, 1, 2, and 6 hours, and 
subjected to streptavidin gel-shift on 10% PAGE. (C) Generating the trans-active enriched pool from 
round 13. (D) Trans-activity assay of the enriched pool. Reaction conditions: LY- labeled substrate 
sequence (24 µM) and trans-active round 13 pool (12 µM) in 10 µL of the selection buffer containing 
200 µM of the biotinylated ATP and 40 mM of MgCl2. Timepoints taken at 0, 0.5,2 hours and after 
overnight incubation, were resolved on a 20 % denaturing PAGE. 
 
3.2.3 Cloning of the enriched pool and activity assay of the individual 
clones 
Since the majority of the pool was proven active in cis and trans, the pool was cloned using 
TOPO-TA system and was submitted to Sanger sequencing. The transformed bacteria were 
plated and subjected to blue-white screening. A stop-codon cassette was included in the 
forward primer to decrease the number of false-negative colonies. To confirm that the clones 
were harboring the pool insert, we performed colony PCR on 40 randomly picked colonies 
(35 white, 5 blue). All tested colonies, including the blue ones, proved positive. To test 
whether the obtained clones contained active sequences, transcripts were generated from the 
colony PCR samples. Briefly, a portion from each colony PCR product was amplified in a 
larger PCR reaction. The reaction was then precipitated, and the resulting dsDNA was 
transcribed in vitro. Streptavidin gel-shift assay was performed to test the individual variants 
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for activity. The results of this experiment confirmed that all colonies were active. However, 
they were not equally efficient (Figure 3-7). 
 
3.2.4 Sanger sequencing results 
After the activity assay, the plasmids extracted from 22 of the colonies were submitted for 
Sanger sequencing. Twenty one out of 22 clones were successfully sequenced. Analysis of 
these sequencing results revealed three major sequence groups denoted as FH14, FH20, and 
FH31. The sequence groups identified through Sanger sequencing are listed in (Table 3-2). 
The sequences belonging to FH14 and FH20 groups shared remarkable similarity (Figure 
3-8 A) and both groups proved more efficient in streptavidin gel-shift assay. The FH31 group 
shared little similarity to the other two groups except for a 5'-GAYA-3' motif shared across 
all variants. 
The FH31 sequence group demonstrated the lowest efficiency of the three groups, despite 
having the highest frequency (12 out of 21 sequences) (Figure 3-7). A closer inspection of 
the FH31 group revealed the presence of a point mutation in the left binding arm. This 
mutation may have been the reason behind the lower efficiency of the FH31 sequence group. 
The left binding arm was the only part of the constant region not being included in any 
primer. Thus, this arm of the pool could mutate during the PCR reactions. 
 
Figure 3-7 Streptavidin gel-shift assay of ten exemplary, individual clones indicate varying levels 
of efficiency. Clone numbers 14 and 28 (highlighted in red) belong to the sequence group FH14 and 
the clones 20, 24, and 4B (highlighted in green) belong to the sequence group FH20. Clones 12, 22, 
31, and 34 (highlighted in blue) which belong to the sequence group FH31 show drastically lower 





Table 3-2 Sequence groups identified from Sanger sequencing of the isolated clones 
Group 5'- Sequence-3' Times repeated 
FH14 CACGCTGAGTAGACATACTTGCAAACGCTGCAAACATAGA* 3 
CACGCTGAGTAGACATACTTGCAAAACGCTGCAAACATAGA 1 
FH20 CTCGCTGCGTAGACATACCTGGCTCCCTCCCAGCCATAGA* 5 




* Denotes: Sequences subjected to kinetic experiments 
 
3.2.5 Kinetic comparison of the evolved species 
DNA templates for FH14, FH20 and FH31 were ordered in which the loop and the 3'-
extension was removed, and a 5'-GG was added to the right arm to ensure transcribability. 
The mutation in the FH31 binding arm was also restored in these templates. Single turnover 
kinetic experiments were then performed in triplicates using 3'-fluorescein-labeled selection 
substrate sequence (Parent sequence). The tests were performed to compare the reaction rate 
and efficiency of the FH variants. The ratio between the substrate sequence and the ribozyme 
was adjusted at 1:10. The reaction conditions were identical to the selection process. The 
pseudo-first order kinetic curves derived from these experiments determined kobs values of 
~1.8 x10-2, ~0.14 x 10-2, and ~ 0.78 x 10-2 min-1 for FH14, FH20 and FH31, respectively 
(Figure 3-8 B & C) (Table 3-3). These values indicate that FH14 is the fastest reacting and 
the most efficient variant followed by FH31. FH20 however, falls far behind. Ribozymes 
FH14 and FH31 were therefore characterized, while FH14 was studied more thoroughly. 
Despite remarkable sequence similarity between FH14 and FH20, and high activity of FH20 
in cis-, the results of kinetic experiments in trans were quite unexpected. On the other hand, 
FH31, which performed poorly in the streptavidin gel shift assay, demonstrated significantly 
higher efficiency and reaction yield compared to FH20. The discrepancy between the cis- 
and trans-activity test results of the FH31 could be attributed to the presence of the mutation 
in the right binding arm, which was restored for the trans-activity kinetic experiments.  
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Figure 3-8 Sequence alignment and kinetic comparison of the evolved variants. (A) Partial alignment 
of the FH14, FH20, and FH31 catalytic core sequences. Red: identity, Green: similarity, Black: 
difference. GAYA motif shared among variants is underlined. (B) Fluorescent gel image of the 
single-turnover kinetic assay performed on the evolved variants. Reaction conditions: 3'-fluorescein 
parent substrate sequence (1 µM), ribozyme transcript (10 µM), 1x selection buffer, including 40 
mM MgCl2 and 200 µM N6-biotin-ATP. Incubation at 37°C. time-points taken at 0, 15, 30, 60, 120 
and 240 minutes, resolved on a 20% analytical denaturing PAGE. (C) The bands were quantified and 
plotted using Kaleidagraph software. Curve-fitting was performed using pseudo-first order kinetic 
function (Y=Ymax(1-ekobst)). 
 
3.2.6 Secondary structure prediction of the evolved variants 
Possible secondary structures of the evolved variants were predicted using the Vienna 
RNAfold server (Hofacker, 2003). FH14 and FH20 showed similar predicted secondary 
structures, while FH31 was largely unstructured. The predicted secondary structures and the 
base-pair probability dot plots of the three variants can be seen in (Figure 3-9) 
 
Figure 3-9 Secondary structure prediction of the three variants. Structures and the dot plot of the 





3.2.7 Characterization of the reaction product 
3.2.7.1 Probing of the modification-site 
The trans-activity assays confirmed the modification site to be located in the substrate 
sequence. The exact modified position, however, could not be determined from those 
experiments. 
To pinpoint the modification site, a synthetic 21-nucleotide analog of the substrate sequence 
(R660) was synthesized with a hexynyl modification at the 5'-end. This sequence was labeled 
using 5-FAM-azide and CuAAC reaction resulting in 5'-5-FAM-R660. The labeled 
oligonucleotide was then modified on a preparative scale, with an N6-biotinylated-adenylyl 
branch using the ribozymes FH14 and FH31. The reaction mixture was resolved after 
overnight incubation on a 20% denaturing PAGE and subjected to fluorescence imaging. 
The conversion efficiency based on fluorescence imaging was estimated to be around 75 to 
80% in each case. The modified band was then PAGE purified with an isolated yield of 
roughly 50% (Figure 3-10 A). 
RNase T1 digestion and alkaline hydrolysis was performed on the ribozyme modified and 
unmodified 5'-FAM-R660: 
 In case of the T1 lanes, the bands resulting from cleavage after G1 and G9 lack mobility 
shift in the modified lanes relative to the unmodified lane (Figure 3-10 A & B). The bands 
pertaining to the cleavage after G11 and the full-length oligonucleotide in the lanes with the 
modified sample however are shifted compared to their counterparts in the unmodified lane 
(Figure 3-10 B).  
In the alkaline hydrolysis lanes of the modified sample, a clear shift is visible in case of the 
bands corresponding to cleavage after A10. This shift is lost in the bands resulting from 
cleavage before A10. A further observation, which can be made from this experiment, is that 
the band corresponding to the cleavage immediately 3'- to A10 is missing from the lanes 
containing the modified sample (Figure 3-10 B). Since the cleavage reaction in alkaline 
hydrolysis relies on deprotonation of the 2'-OH, lack of the A10 cleavage band indicated that 
the 2'-position of this nucleotide is blocked. 
These results confirm that our selection process has guided the modification to the bulged A 
nucleotide without the need for exerting additional selection pressure. 
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Figure 3-10 Probing of the modification site. (A) Preparative scale modification of the 3'-5FAM- 
R660. (5FAM-R660 (1 nmol), ribozyme (1.3 nmol) mixed in 25 µL of the selection buffer including 
40 mM MgCl2 and 400 µM N6-biotin-ATP. Incubated overnight at 37°C and isolated on a 20% 
analytical denaturing PAGE. (B) Gel image of the alkaline hydrolysis and RNase T1 probing of the 
modification site. The RNase T1 digestion (T1) performed using 5FAM-R660 modified or 
unmodified (1 µM),50 mM Tris buffer pH= 7.5, and 0.2 U/µL of RNase T1, 37°C for 30 seconds. 
The alkaline hydrolysis was performed using 5-FAM-R660 modified or unmodified (1 µM) in 10 µL 
of 10, 25, or 50 mM NaOH. Samples were incubated at 95°C. Timepoint samples were taken at 1, 
2.5, and 5 minutes. Based on the results of this experiment, both FH14 and FH31 appear to modify 
the predetermined A. 
 
3.2.7.2 ESI-Mass spectrometry of the reaction product 
The desired activity in the FH selection was 2'-5' adenylyl transferase reaction that leads to 
the addition of a single adenylyl branch to the modification site. This branch was expected 
to be connected via a 2'-5' phosphodiester bond. However, ribozymes forming other types of 
linkages might also arise from our selection. It was therefore important to confirm the mass 
of the product to gain further proof of its identity. A short synthetic analog of the original 
substrate sequence was used for this purpose. The synthetic oligonucleotide was shorter than 
the original substrate sequence by two nucleotides from the 5'-end. The removed nucleotides 
were the 3'-GG that was necessary for in vitro transcription. The synthetic oligonucleotide 
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also contained a 3'-aminohexyl modification, which added the potential for further 
derivatization. This oligonucleotide was called R594. 
R594 was modified, using FH14 ribozyme, in a semi-preparative manner under the selection 
conditions including 400 µM N6-aminohexyl-ATP and 40 mM MgCl2. PAGE purification 
of the modified shifted band resulted in approximately 50% isolated product yield. The 
product was submitted to ESI-mass spectrometry. The expected mass was calculated to be 
5959.9909 Da, based on the monoisotopic mass of the N6-aminohexyl-adenylylated R594. 
The observed mass was found to be 5959.07598 Da, which confirms the formation of the 
desired product (Figure 3-11). 
 
Figure 3-11 ESI-mass analysis of the FH14 modification product. Sequence of the R594 and the 
modification product of FH14. Calculated mass vs observed mass confirms the identity of the 
product. (Full spectrum shown in (Figure 8-1) of the appendix). 
 
3.2.8 Characterization of the FH14 and FH31 ribozymes 
3.2.8.1 Target sequence scope of the evolved variants 
3.2.8.1.1 Substrate sequence specificity of FH14 and FH31 
After it was discovered that the modification has been successfully directed to the desired 
position, the sequence generalizability of the evolved variants was tested. For this purpose, 
a set of target sequences were designed in which particular sets of mutations were made to 
the parent substrate sequence. In our initial tests, we decided to leave the GAG modification 
context intact while heavily mutating the other positions. Since the 5'-GG dinucleotide was 
required for efficient in vitro transcription, this dinucleotide was also left unchanged. All the 
other positions were either transition mutated (TM substrate sequence) or subjected to two 
types of transversion mutations. In case of the TV1 substrate sequence, all the positions were 
mutated into their complementary nucleotides. For the TV2 substrate sequence, the 
transversions were made to the non-complementary counterparts. FH14 and FH31 
ribozymes were also designed with their binding arms co-varied corresponding to each of 
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the designed substrate sequences (Figure 3-12 A). The target sequences were transcribed in 
vitro and 3'-fluorescein-labeled using periodate oxidation method. Single-turnover kinetic 
experiments were performed using these substrate sequences and their corresponding 
ribozymes in the selection conditions. The results revealed a high degree of flexibility 
regarding the positions outside the GAG context for both FH14 and FH31 ribozymes (Figure 
3-12 B-E). A rather surprising observation, in the case of the FH14 ribozyme is that all the 
mutated substrate sequence variants show remarkably higher modification rate and 
efficiency compared to the parent sequence (Figure 3-12 D). All three sequences 
demonstrated a yield of over 75% within 1 hour. The kobs values for the mutant substrate 
sequence/ribozyme pairs however could not be derived from these experiments for the FH14 
ribozyme, due to fast reaction kinetics. Kinetic experiments with more data points between 
0-30 minutes are needed for to determine the kobs values for these mutants. A stretch of 8-
nucleotides within the catalytic core of the FH14 has an identical sequence to the parent 
substrate. A possible explanation for the lower efficiency of the parent sequence might, 





Figure 3-12 Target sequence variability of FH14 and FH31. (A) Positions outside the GAG context 
on the substrate sequence were subjected to three sets of mutations. Modification-site is signified in 
Red. Blue signifies positions unchanged from the parent sequence. Yellow boxes indicate co-varied 
positions on the substrate sequence and the ribozyme arm. Green shows positions unchanged in 
ribozyme arms. Gel image of the kinetic assays of the ribozyme: substrate sequence pairs for FH14 
(B) and FH31 (C). Reaction conditions: 3'-substrate fluorescein-substrate (1 µM) sequence and 
corresponding ribozyme (10 µM) in standard selection conditions. Time points: 0, 15, 30, 60, 120 
and 240 minutes for FH14 and 0, 10, 20, 30, 60, 120 and 300 minutes for FH31. (D) And (E) Pseudo-
first order kinetic curve fits of the FH14 and FH31 respectively. 
 
 
Figure 3-13 Folded and misfolded states of the FH14 ribozyme paired with the parent substrate 
sequence. An 8-nucleotide segment in the catalytic core is identical to a part of the substrate sequence 
(green). This segment might pair to the ribozyme’s left-arm (purple) and prevent the formation of 
the active complex. 
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3.2.8.1.2 Modification site sequence-context requirements of FH14 and FH31 
To determine the essentiality of the GAG modification context, substrate sequences were 
designed in which the two G-nucleotides flanking A were mutated. Mutations were made to 
one G-nucleotide at a time, to the three other possible substitutions (Figure 3-14 A). These 
transcripts were based on the TM substrate sequence since it proved to be the most efficiently 
modified by their corresponding FH14 ribozymes (Figure 3-12 B & D). Kinetic assays were 
performed using these substrate sequence variants and their corresponding ribozymes. The 
results proved that FH14 ribozyme tolerates all the mutations to either of the G-nucleotides. 
FH31 ribozyme, however, demonstrates a strong preference towards the G nucleotide 
located 3' to the modification site A, while the mutations to the G located at the 5' are better 
tolerated (Figure 3-14 B). Analysis of the combined effects of these mutations to the 
modification context sequence is yet to be performed. 
An analog of the parent substrate sequence containing an A to G mutation (Figure 3-14 C) 
at the modification site was not modified by either of the ribozymes (Figure 3-14 D). The 
modification site A has therefore been determined as essential for the ribozyme activity. The 
modification site sequence context required for the FH14 ribozyme is therefore determined 







Figure 3-14 Modification-site sequence context requirement of the FH14 and FH31. (A) The TM 
substrate was used for this purpose with mutations in the 5'-GAG-3' context, ribozyme arms were 
co-varied to maintain base pairing. (B) Gel-image of the single-turnover kinetic experiments on 
FH14 and FH31 using TM-GAG mutant: ribozyme pairs. All mutations appeared to be well tolerated 
by FH14 ribozyme, whereas FH31 strongly prefers the presence of a G nucleotide 3' to the 
modification site A (red). (C) Mutation of the modification site A to G. (D) Fluorescent gel-image 
of the single-turnover kinetic experiments on FH14 and FH31 using the substrate with A to G 
mutation in the modification site. 
 
3.2.8.2 NTP substrate scope of the evolved variants 
3.2.8.2.1 NTP analog specificity range of FH14 
The NTP analog used in this selection was ATP, biotinylated at N6 via an aminohexyl linker. 
Thus, it was important to determine whether biotin and/or the aminohexyl linker are essential 
substrate requirements of the ribozymes. Single turnover kinetic assays were performed 
using N6-aminohexyl-ATP, which is highly similar to the selection substrate except that it 
lacks the biotin (Figure 3-15). Unmodified ATP was also used to examine the necessity of 
the aminohexyl linker. The results of these tests determined that biotin is not an essential 
substrate sequence requirement of FH14. The N6-aminohexyl-ATP demonstrated similar 
ligation rates and overall efficiency as the biotinylated ATP (Figure 3-16 A & C) (Table 
3-3). On the other hand, a dramatic drop, in reaction rate and efficiency, was observed when 
unmodified ATP was used as the modification substrate. These results indicate that the 
presence of the linker at the N6- position is preferred for efficient labeling (Figure 3-16 A 
& C) (Table 3-3). 
The ligation efficiency of FH14 was also examined with ATP analogs in which biotin in the 
selection substrate was replaced by a fluorophore. For this purpose, N6-aminohexyl-ATP 
58 
conjugated to 5-FAM, ATTO550, or sulfoCy3 (Figure 3-15) were used as modification 
substrate in single turnover-kinetic experiments. All three fluorophore conjugates were 
efficiently ligated to the target RNA (Figure 3-16 B & C). The reaction yield for ATTO550 
and 5FAM conjugated ATP was 75% in 5 hours. SulfoCy3 however, resulted in a yield of 
roughly 50% in the same duration of time (Table 3-3). The reduced efficiency of the 
sulfoCy3-conjugated ATP might be attributed to the presence of the negatively charged 
sulfonate groups. These groups may be electrostatically repelled by the similarly charged 
phosphate backbone of the ribozyme. Nevertheless, the results of these kinetic assays 
established the FH14 ribozyme as a potent tool for RNA labeling using fluorescent dyes or 
biotin. 
 
Figure 3-15 List of the ATP analogs used in this thesis project. 
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Figure 3-16 NTP analog specificity of FH14 ribozyme. (A) Kinetic gel of FH14 ribozyme tested 
using N6-biotin and N6-aminohexyl-ATP and unmodified ATP. Reaction conditions (5FAM-R660 
(1 µM), FH14 (10 µM) in 1x selection buffer including 40 mM MgCl2 and 200 µM of the ATP 
analog. 37°C, time points: 0, 30, 60, 120, 240, 360 and 480 minutes) (B) Kinetic gel of FH14 
ribozyme tested with fluorophore-conjugated ATP. Reaction conditions: (Cy5-R660 (1 µM) and 
FH14 (10 µM) in 1x selection buffer including 40 mM MgCl2 and 200 µM ATP analog.) Time points 
taken at 0, 15, 30, 60, 120and 300 minutes. (C) Pseudo-first order kinetic curve fits of the quantified 
bands from (A) and (B). 
 
Necessity of the 2'-OH of the ATP analog was also tested using N6-aminohexyl-dATP as 
modification substrate. The effect of removal of the 2'-OH on reaction yield was negligible. 
In another experiment, 8-aminohexyl-aminoATP was used in which the position of the linker 
is moved from N6 to C8. No reactivity was observed in case of this substrate. These results 
may imply that the C8 modified substrate may not be recognized by the ribozyme possibly 
due to the steric hindrance caused by modification at this position (Figure 3-17 A). 
Further investigation was performed into the NTP substrate scope of FH14 using various N6-
modified ATP analogs (Figure 3-15). For example, the effect of reducing the length of the 
aminohexyl linker was examined by using N6-aminobutyl-ATP as substrate. The substrate 
resulted in an 8-hour yield of ~48% compared to ~80% for the substrate for aminohexyl 
linker. Despite this drop in the reaction efficiency, the yield remained significantly higher 
than unmodified ATP (~23% after 8 hours of incubation). The results indicate a strong 
preference for N6-modified analogs (Figure 3-17 B). 
Since it was established that FH14 strongly prefers N6-modified ATP substrates, other types 
of modifications at this position were also tested. The prospect of FH14 ribozyme was 
examined for indirect RNA labeling via means such as CuAAC or SPAAC. For this purpose, 
kinetic experiments were performed using N6-azidohexyl-ATP and N6-propargyl-ATP 
(Figure 3-15). Despite similarity between the N6-aminohexyl and N6-azidohexyl ATP 
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analogs, replacement of the amino group with an azide functionality drastically reduced 
ribozyme reactivity. The 8-hour yield of this reaction was ~17%, which is lower than that of 
the unmodified ATP. The N6-propargyl analog also performed poorly with only ~12% 
conversion after 8-hours (Figure 3-17 C). The results from the azido and propargyl 
functionalized analogs, therefore, indicate that these substrates are not suitable for FH14 
mediated indirect RNA labeling. 
N6-benzyl-ATP was also tested as an analog with a bulky modification at N6. This substrate 
demonstrated surprisingly high reactivity towards FH14 ribozyme. Despite being radically 
different from the N6-aminohexyl analog, N6-benzyl-ATP resulted in 61% yield in 8-hours 
(Figure 3-17 D). The reason behind this high yield might be formation of stacking 
interactions with nucleotides positioned in the ribozyme’s substrate-binding pocket. 
No product was formed in kinetic experiments using GTP (Figure 3-15) as modification 
substrate, within the time course of 4 hours (Figure 3-17 E). 2-amino-ATP and 2F-ATP 
(Figure 3-15) however were accepted albeit weakly by the ribozyme (Figure 3-17 D E). 
The results indicate the significance of the 6-amino group of adenine for FH14 mediated 
recognition. 
 
Figure 3-17 Further investigation of the NTP analog scope of FH14 ribozyme. Reported yields are 
from 8-hour time-point samples Single-turnover kinetic experiments using 5-FAM-R660 and FH14 




3.2.8.2.2 NTP substrate specificity range of FH31 
Although generally less efficient than FH14, FH31 demonstrated a similar pattern of 
reactivity towards the analogs tested. FH31 showed no dependence on biotin and proved to 
be specific for ATP and its N6-modified analogs (Figure 3-18). Carolin Scheitl, as a practical 
course student, performed these sets of kinetic experiments. 
 
Figure 3-18 ATP analog scope of FH31 ribozyme. FH31 demonstrates a similar reactivity pattern 
towards tested NTP analogs as FH14. 
 
Table 3-3 kobs values of FH ribozymes, and FH14 with different substrates 
Ribozyme Substrate RNA N6-modified ATP kobs x 10-2 (min-1) Yield (%) * 
FH14 Parent-Flu Biotin-ATP 1.8 ± 0.2 68 ± 1 
FH20 Parent-Flu Biotin-ATP 0.14 ± 0.01 26 ± 1 
FH31 Parent-Flu Biotin ATP 0.78 ± 0.06 55 ± 1 
FH14 5FAM-R660 Biotin-ATP 1.75 ± 0.03 75 ± 1 
FH14 5FAM-R660 Aminohexyl-ATP 1.14 ± 0.1 67 ± 3 
FH14 5FAM-R660 ATP 0.04 ± 0.005 19 ± 4 
FH14 Cy5-R660 ATTO550-ATP 2.5 ± 0.1 84 ± 1 
FH14 Cy5-R660 5-FAM-ATP 1.16 ± 0.06 74 ± 2 
FH14 Cy5-R660 Cy3-ATP 0.53 ± 0.03 48 ± 3 
* For ATTO550, Cy3 and 5-FAM modified substrates the reported yield is after 5 h while other values 
pertain to 4 h reaction time. 
 
3.2.8.3 MgCl2 dependency and NTP substrate concentration range 
The selection process and the kinetic assays have so far all been performed under 200 µM 
concentration of the N6-aminohexyl-biotin and in the presence of 40 mM MgCl2. We decided 
to examine the dependency of FH14 ribozyme on Mg2+ and to determine the range of ATP 
analog concentrations under which FH14 can efficiently modify its target sequence. Two 
sets of kinetic experiments were prepared. In one group of experiments, the N6-aminohexyl-
ATP-biotin concentration was kept constant (200 µM) while the MgCl2 concentration was 
varied (20, 10, 5, and 1 mM). At ATP analog concentration of 200 µM, reducing MgCl2 by 
half did not affect the final yield of the reaction after 8 hours compared to the reaction 
performed previously at 40 mM MgCl2. The reaction kinetics however turned significantly 
slower as the kobs value was reduced by roughly 50%. Further reduction of the MgCl2 
concentration to 10 mM and 5 mM, had a more severe effect on kobs value and the final yield 
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of the reaction. At MgCl2 concentration of 1 mM no product was formed during the time 
course of the reaction (Figure 3-19 B & D). 
Another group of reactions were performed at constant MgCl2 concentration (40 mM) and 
different concentrations of the N6-biotinylated ATP analog (100, 50, 20, and 10 µM). The 
reduction of the ATP analog concentration from 200 µM to 100 µM, at 40 mM concentration 
of MgCl2, had no effect whatsoever on the final reaction yield. However, the kobs value of 
the reaction was reduced by ~34%. Further reduction of the ATP analog concentration led 
to a more dramatic reduction in reaction yield and rate constant. These effects however, were 
not as severe as observed in the case of the lowered MgCl2 concentration experiments 
(Figure 3-19 A & C). Combined effect reducing ATP analog and MgCl2 concentration, 
simultaneously, has not yet been examined. All the kobs values and the reaction yields under 
different MgCl2 and ATP analog concentrations are listed in (Table 3-4) 
 
Figure 3-19 MgCl2 dependency and the ATP analog concentration range of FH14. (A) Effect of 
reducing ATP analog concentration on FH14 efficiency and reaction rate. (B) Effect of reducing 
MgCl2 concentration on FH14 reaction rate and efficiency (C) Pseudo-first order curve fit of FH14 
reaction kinetics under varying ATP analog concentrations. (D) Pseudo-first order curve fit of FH14 
reaction kinetics under varying MgCl2 concentrations. 
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Table 3-4 kobs values of FH14 ribozyme-catalyzed labeling of 5FAM-R660 with N6-biotin-ATP, with 
varying Mg2+ and ATP concentrations. 
MgCl2 Conc. (mM) ATP Conc. (µM) kobs x10-2 (min-1) Yield (%) 4h Yield (%) 8h 
40 200 1.75 ± 0.03 75 ± 1 79 ± 0.3 
20 200 0.89 ± 0.07 67 ± 1 76 ± 0.5 
10 200 0.2 ± 0.02 32 ± 3 48 ± 1 
5 200 0.02 ± 0.006 5 ± 1 8 ± 0.4 
40 100 1.16 ± 0.06 70 ± 3 76 ± 2 
40 50 0.67 ± 0.07 53 ± 0.6 64 ± 2 
40 20 0.4 ± 0.03 30 ± 0.3 41 ± 0.6 
40 10 0.05 ± 0.02 13 ± 5 21 ± 7 
 
3.2.8.4 Effect of TbCl3 on FH14 reaction kinetics 
It was previously shown that the presence of TbCl3 remarkably augments the reaction 
efficiency and the rate constant of 10DM24. The effect is largely dependent on the NTP 
substrate concentration and can reach a rate enhancement up to four orders of magnitude 
(Büttner et al., 2014). We were interested to examine whether a similar effect can be 
observed in the case of the ribozyme FH14. Single turnover kinetic experiments were then 
performed on FH14 ribozyme in the presence of 0, 10, and 100 µM concentrations of TbCl3. 
MgCl2 and N6-biotin-ATP concentrations were identical to selection conditions. TbCl3 at 
100 µM, did indeed dramatically enhance the reaction rate of FH14, causing it to behave in 
a bi-exponential manner. The rate constant of the fast component of this reaction was 
improved by roughly 8 times corresponding to the originally determined kobs value in the 
absence of TbCl3. At 10 µM concentration however, TbCl3 showed no effect on the reaction 
efficiency or rate constant (Figure 3-20). These results of these experiments suggest a 
possible similarity between the catalytic mechanism of FH14 and 10DM24. TbCl3, however, 
is known to induce RNA degradation, which may affect the quality of the labeled sample. 
For this reason, TbCl3 was not included in any of the labeling experiments. 
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Figure 3-20 Effect of Tb3+ on FH14 reaction kinetics. (A) Single turnover kinetics of FH14 ribozyme 
under 0, 10, and 100 µM concentration of TbCl3. Reaction conditions: 5-FAM-R660: FH14 ratio of 
1:10. 40 mM MgCl2 and 200 µM N6-biotin-ATP. (*) indicates that the value is the fast component 
of a biexponential kinetic curve fitting. (B) Kinetic plot of the FH14 reaction under varying TbCl3 
concentrations. Curve fitting for 100 µM TbCl3 condition was done using biexponential function. 
The other two conditions showed pseudo-first order behavior. 
 
3.2.9 FH14-mediated labeling of RNA from cellular origin 
Up to this point, all the kinetic experiments using various target sequences or ATP analogs 
were performed using short (17 to 21 nucleotides) synthetic or in vitro transcribed RNA. 
These model RNA substrates were used to simplify kinetic analysis using PAGE and 
fluorescence imaging. The results obtained using these sequences, however, may not directly 
be translatable to large RNA targets. Larger RNA molecules tend to be more heavily 
structured compared to short model substrates. Their modification target sites may, 
therefore, not be readily accessible to the ribozyme. Thus, we decided to test the efficacy of 
the FH14 ribozyme for labeling of cellular RNA. 5S rRNA (Noller, 1984) and RyhB (Massé 
and Gottesman, 2002) small RNA from E. coli were chosen for this purpose. These 
transcripts were significantly larger than the model RNA substrates that had been tested. At 
the same time, they were in a size range that could be easily analyzed using established 
techniques in our laboratory such as PAGE and fluorescent imaging. The other reason behind 
this choice was the structured nature of these RNA molecules especially in case of 5S rRNA, 
which is heavily structured. Moreover, due to its role in ribosomal structure and function, 
5S rRNA is one of the most abundantly found RNA molecules in cells, including E. coli. 
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Various potential modification sites were chosen in these RNA molecules to be labeled by 
FH14 ribozyme. 
 
3.2.9.1 FH14-mediated labeling of 5S rRNA 
3.2.9.1.1 Labeling of the pure transcript generated in vitro 
Three adenine nucleotides were chosen in E. coli 5S rRNA (Figure 3-21 A). One of the 
selected positions, A49, resides in a context within a loop region, presumably accessible to 
the FH14 binding arms. The second position, A66, lies in a single nucleotide bulge in a 
region where its neighboring nucleotides are mainly paired. The last position, A99, is located 
in a bubble, where its flanking nucleotides, except for a few, are engaged in base pairing. 
FH14 variants were designed with binding arms complementary to 8-10 nucleotides flanking 
these positions from each side. We also produced in vitro transcribed 5S rRNA and labeled 
it at 3'-end using fluorescein thiosemicarbazide. We first attempted to label each of the 
chosen positions individually, using their corresponding FH14 ribozyme and N6-ATTO550-
ATP. Time points were taken from each reaction at 0, 2, and 4 hours and resolved on a 10% 
analytical denaturing PAGE. Multichannel fluorescent imaging of the gel revealed 
successful labeling of all three positions, within 2 to 4 hours. The ATTO550 emission 
intensity of the 2-hour and 4-hour time-points were roughly similar meaning the labeling 
reaction reached a plateau in under 2 hours (Figure 3-21 B). The efficiency of this reaction 
however could not be estimated, due to the poor resolution of PAGE, for differentiating the 
labeled from unlabeled RNA, as a result of the large size of the transcript. 
We also tested whether the three chosen positions can be labeled simultaneously. We, 
therefore, set up reactions with only one ribozyme (FH14_5S-A45 or two ribozymes 
(FH14_5S-A45 and FH14_5S-A66) or all three ribozymes. Non-labeled in vitro transcribed 
5S rRNA was used in this case and the ATTO550 conjugate ATP was added as the labeling 
substrate. The reactions were quenched after 4 hours and aliquots taken from them were 
resolved on 10% denaturing analytical PAGE next to the 3'-fluorescein-labeled 5S rRNA as 
size marker. As expected, the signal intensity consistently increased from the single-labeled 
lane to the double-labeled and the triple labeled one (Figure 3-21 C). 
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3.2.9.1.2 Labeling 5S rRNA in the context of total cellular RNA 
To test whether the FH14 ribozyme can specifically recognize its cognate substrate when 
there is a large number of nonspecific sequences present, we attempted to label 5S rRNA in 
the context of total cellular RNA. Hence, three reactions were set up using each of the 5S 
rRNA targeting FH14 variants along with total cellular RNA extracted from TOP 10 E. coli 
cells. N6-ATTO550-ATP was used as the labeling substrate. The reaction mixture was 
precipitated after 4 hours to remove the excess unreacted ATTO550 conjugated ATP. The 
pellets were then resolved on a 10% denaturing analytical PAGE along with 3'-fluorescein-
labeled in vitro transcribed 5S rRNA as a size marker. Multichannel fluorescent imaging of 
the gel revealed the presence of a strong sharp ATTO550 labeled band, with similar 
electrophoretic mobility to the 5S rRNA size marker in all three ribozyme lanes (Figure 
3-21 D). We, therefore, concluded that the designed FH14 variants successfully recognized 
and labeled 5S rRNA from a large bulk of nonspecific cellular RNA. The gel was then 








Figure 3-21 FH14 mediated labeling of E. coli 5S rRNA. (A) Sequence and secondary structure of 
the E. coli 5S rRNA (Noller, 1984). Positions targeted for modification are highlighted in red. 
Nucleotides marked in green, represent the ribozyme binding regions. (B) Multichannel fluorescent 
gel image of FH14 mediated ATTO550 labeling of in vitro transcribed 3'-fluorescein-labeled 5S 
rRNA at three different positions. Reaction conditions: (5S rRNA-Flu (2 µM), corresponding 
ribozyme (20 µM), 1x selection buffer including 40 mM MgCl2 and 200 µM N6-ATTO550-ATP, 
37°C. Time points taken at 0, 1h and 2h.) (C) Multichannel gel-image of the simultaneous FH14-
catalyzed labeling of 5S rRNA at multiple positions, using ATTO550. Reaction conditions: (5S 
rRNA transcript (1 µM), one (1), two (2) or all three (3) FH14 ribozymes (10 µM) in 1x selection 
buffer including 200 µM N6-ATTO550 and 40 mM MgCl2, 37°C) 3'-fluorescein-labeled 5S rRNA 
used as size marker (SM). (D) Left: multichannel gel image of FH14 mediated 5S rRNA labeling in 
total cellular RNA context. (50 ng E. coli total cellular RNA, 50 pmol of the respective ribozyme in 
5 µL of the 1x selection buffer including 200 µM N6-ATTO550 and 40 mM MgCl2, 4 hours at 37°C. 
3'-fluorescein-labeled 5S rRNA as size marker. Right: SYBR Gold staining of the same gel to reveal 
the rest of the cellular RNA. 
 
3.2.9.2 FH14-mediated labeling of RyhB small RNA 
RyhB is an HfQ binding small RNA found in E. coli (Massé and Gottesman, 2002). Its main 
role is to regulate the translation efficiency and stability of the mRNA of proteins involved 
in RNA metabolism. In iron-rich media, it inhibits translation of its cognate mRNA via 
recruitment of RNase E (Massé et al., 2005). However, RNase E also cleaves RyhB ensuring 
coregulation of the level of RyhB with its target mRNA (Massé et al., 2005). In iron-poor 
media where the target mRNA levels are low RyhB can accumulate at higher levels. We 
chose two sites (A23 and A62) within this RNA and designed two FH14 variants to target 
these positions (Figure 3-22 A). The experiments were performed as done for 5S rRNA in 
the way that RyhB was labeled both as pure transcript and within total cellular RNA. 
Labeling of the pure transcript was done using 3'-fluorescein-labeled in vitro transcribed 
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RyhB with ATTO550 conjugated ATP as labeling substrate. Both positions were 
successfully labeled based on these results within 2 to 4 hours (Figure 3-22 B). 
For the cellular RNA experiments, TOP10 cells were grown in the presence or absence of 
the iron chelator 2-2'-Bipyridine (BiP). Iron depletion using BiP is known to stabilize RyhB 
(Massé et al., 2005) (Figure 3-22 C). RNA extracted from each of these cultures were 
incubated with either of the RyhB targeting FH14 variants. ATTO550 conjugated ATP was 
used as the labeling substrate and 3'-fluorescein-labeled RyhB in vitro transcript as size 
marker. No band of the correct size was observed when the labeling reaction was performed 
on RNA extracted from cells grown in the absence of BiP. A strong truncated band, however, 
was visible only when the A62 was targeted for labeling. In the case of RNA extracted from 
BiP treated cells, faint bands of the correct size were visible for both labeled positions. The 
truncated band however was still visible in the lane pertaining to the A62 labeling product 
(Figure 3-22 D). 
The signal intensity in case of the FH14 mediated RyhB labeling experiments was 
dramatically lower compared to the experiments performed on 5S rRNA. The reason might 
be that the optimal conditions, in the growth medium, for maximum stability and level of 
RyhB had not been achieved. The nature of the truncated band appearing only when A62 is 
labeled is not clear. This position is situated in the HfQ binding site of the RyhB (Tjaden et 
al., 2006) and therefore one explanation for the appearance of this band is that, this segment 
of the RNA is protected from further nuclease degradation after cleavage by RNase E. 
 
Figure 3-22 FH14-catalyzed labeling of RyhB RNA. (A) Sequence and secondary structure of E. 
coli RyhB RNA. Targeted positions shown in red. Ribozyme binding arms designed complementary 
to the positions shown in green. (B) Multichannel fluorescent gel-image of the FH14 catalyzed 
labeling of the 3'-fluorescein-labeled RyhB in vitro transcript, at two different positions using 
ATTO550. Reaction conditions: RyhB-Flu (2 µM), corresponding FH14 (20 µM), in 1x selection 
buffer, 40 mM MgCl2 and 200 µM N6-ATTO550-ATP, 37°C. timepoints: 0, 2, and 4 hours. (C) 2-
2'-bipyridine (BiP)-iron complex. BiP was added to deplete the culture medium from iron (D) 
Multichannel fluorescent gel image of FH14-catalyzed labeling of RyhB in total cellular RNA. RNA 
extracted from E. coli cells in the presence (+ BiP) or absence (- BiP) of 250 mM 2-2'-bipyridine, 
was subjected to labeling using FH14 targeted to A23 or A62 or RyhB. 3'-fluorescein-labeled RyhB 
in vitro transcript was used as size marker (SM). Reaction conditions: 50 ng cellular RNA, 50 pmol 
of the respective ribozyme, 5 µL of the selection buffer, 40 mM MgCl2, 200 µM N6-ATTO550-ATP. 
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3.3 Tenofovir transferase ribozymes 
 
Figure 3-23 Tenofovir transferase ribozyme selection substrate and desired reaction. N6-Biotin-
Tenofovir-diphosphate (N6-Biotin-TenDP) was used for this selection, the desired reaction was a 
nucleophilic attack by the 2'-OH of the predetermined modification site A onto the phosphonate 
center pushing out pyrophosphate. The product is, therefore, formation of a phosphonomonoester 
bridge between the target RNA and tenofovir. 
 
3.3.1 Selection progress 
The selection of the tenofovir transferase ribozymes was performed analogous to that of 
adenylyltransferase ribozymes. The first round started with similar complexity (~2.7 x 1014 
unique variants at an average copy number of 7). The incubation step of each round was 
performed using ~50 µM concentration of the RNA pool (including the 3'-LY labeled 
fraction) in selection buffer including 40 mM MgCl2 and 300 µM of N6- Biotin-Tenofovir-
diphosphate (synthesized by a postdoctoral fellow of the group, Dr. Surjendu Dey) (Figure 
3-23) at 37°C. The first sign of enrichment became apparent at the end of the 4th selection 
round were ~ 0.44% of the pool was retained. A rise in the activity level to ~1.42 % in the 
next round further confirmed the success of the enrichment process. The incubation time 
was reduced from overnight to 4 hours at round 8 and was further decreased to 1 hour by the 
12th round (Figure 3-24 A). Details of the selection rounds are listed in (Table 3-5). 
 
3.3.2 Cis- and trans- activity of the enriched pool 
Similar to the adenylyltransferase ribozyme selection, the enriched pool from the 12th round 
was subjected to cis- and trans-activity assays. The cis-activity assay was performed using 
streptavidin gel-shift assay on 3'-lucifer yellow labeled RNA pool. Trans-activity assay was 
performed using roughly 2:1 ratio of the 3'-lucifer yellow-labeled substrate sequence over 
the trans-acting pool transcript generated by PCR and in vitro transcription as shown in 
(Figure 3-6 C). Both reactions were performed under identical conditions as the selection 
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experiment. According to the results of the cis-activity assay, over 80% of the pool was 
biotinylated after overnight incubation under selection conditions (Figure 3-24 B). Trans-
activity assay also confirmed that the pool was compatible for intermolecular target sequence 
modification (Figure 3-24 C). 
 
Figure 3-24 Selection progress and cis- and trans-activity of the enriched pool. (A) The enrichment 
level at each selection round was estimated by fluorescence measurement of the eluted RNA. 
Incubation time was reduced after significant enrichment was observed to allow the selection of 
faster-reacting ribozymes. (B) Streptavidin gel-shift assay of the round 12 pool. reaction 
conditions:15 µM Round 12 RNA Pool labeled with LY-CH in selection buffer including, 300 µM 
N6-biotin-TenDP and 40 mM MgCl2. Time points taken at 0, 1, 6 hours, and overnight were subjected 
to streptavidin gel-shift on 10% PAGE. (C) Trans-activity assay of the enriched pool. LY-CH labeled 
substrate sequence (24 µM) and the trans-active round 13 pool (12 µM) were dissolved in the 
selection buffer containing 300 µM of the N6-biotin-TenDP and 40 mM of MgCl2. Time points were 
taken at 0, 1, 2, and 4 hours and overnight. 
 
Table 3-5 Details of the selection rounds of tenofovir transferase ribozymes. 
Selection round 1 2 3 4 5 6 7 8 9 10 11 12 
Pool concentration (µM) ~ 50 
Incubation time (h) Overnight 4 3.5 2.5 2 1 
Eluted % - - - 0.4 1.4 3.2 4.5 4.7 4.5 10 3.4 2.8 
 
3.3.3 Sequence identification of the evolved variants 
3.3.3.1 Sanger sequence 
The outcome of the 12th selection round was subjected to cloning and the resulting colonies 
was confirmed using colony PCR. 10 colonies were randomly chosen for submission to 
Sanger sequencing. The sequencing results revealed the presence of only two variants in 10 
colonies that were denoted as FJ1 with eight copies and FJ8 with two copies. The sequence 
groups identified through Sanger sequencing are listed in Table 3-6) 
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Table 3-6 Sequence groups identified from the Sanger sequencing of isolated clones 
Group 5'-Sequence-3' Number repeated 
FJ1 CCACCCTCATAAAACTGAAGATCCTTTGGCAAGGGTCTA 8 
FJ8 ACGGTGTTACAAAACGAAACCTTAGGACATTACCTTCCCC 2 
 
3.3.3.2 Next-generation-sequencing of the enriched pool 
To study the selection pool more deeply and investigate the enrichment patterns of different 
variants, we performed Illumina sequencing. The samples from round 7 and round 12 were 
chosen for submission to NGS analysis. Round 7 was picked since it was the last low-
stringency round and presumably had higher complexity than the round 12 samples. 
Comparison of the change in frequency of each variant from round 7 to round 12 also 
provided a measure of enrichment or de-enrichment of the variants through the selection 
rounds. After quality control and trimming of the adapters, the sequencing data were 
analyzed using fastaptamer tools (Alam et al., 2015). Ten major sequence clusters were 
identified through these analyses (Figure 3-25) (Details of the read numbers in (Table 8-6) 
of the appendix). Surprisingly, the clusters to which FJ1 and FJ8 belonged, were not the 
most abundant groups. These ribozymes belonged to cluster 4 and cluster 2 respectively. 
These two sequences however, had the highest log2 values (8.67 for FJ1 and 9.74 for FJ8) 
(Table 3-7) based on the comparison of their read per million (RRM) values between round 
7 and round 12. These values are calculated using log2(RPMround7/RPMround12) and indicate 
that these ribozymes were highly enriched between round 7 to round twelve possibly due to 
their superior reaction kinetics. The next highest enrichment level belonged to the first 
sequence of cluster 9 (FJC9) with a log2 value of 4.32 (Table 3-7) (full details in Table 8-7 
of the appendix). The first sequence of cluster 1 (FJC1), demonstrated the next highest log2 
value of 1.95. Log2 values between 0 and 2 indicate no meaningful enrichment or de-
enrichment. Other clusters mostly showed negative log2 values, which indicates that they 
were gradually lost from round 7 to round 12. FJC9 and FJC1 were, therefore, chosen for 
further investigation along with FJ1 and FJ8. From the de-enriched clusters, FJC3 from 
cluster 3 (log2= -0.35) was also chosen for comparison. A partial alignment of the core 
sequence of these ribozymes can be seen in (Figure 3-26 A). FJ1 and FJ8 are remarkably 




Figure 3-25 Abundance of individual sequences in reads per million (RPM) compared in round 7 
and round 12. Sequence clusters identified in round 12 are shown in the same color. The dots 
representing the chosen sequences are marked with an arrow. 
 
Table 3-7 The chosen sequences from NGS data analysis with their respective log2 values 
Variant 5'-Sequence-3' Cluster# log2(X/Y)* 
FJ8 ACGGTGTTACAAAACGAAACCTTAGGACATTACCTTCCCC 2 9.74 
FJ1 CCACCCTCATAAAACTGAAGATCCTTTGGCAAGGGTCTA 4 8.67 
FJC9 ACGAGATATGTTGCACTACACTTTAGCGAATTGGGCATCC 9 4.32 
FJC1 GAAACGTGTCACATAAGAAAACGGTAAACTAGCAAGTTCC 1 1.95 
FJC3 CGAATGCCACCGAACCGTATAATTGCCGCCTCCAATTTC 3 -0.35 
 
3.3.4 Kinetic comparison of the evolved variants 
The DNA templates coding for the selected variants, with loop and 3'-extension removed, 
were ordered and transcribed. These transcripts were subjected to single-turnover kinetic 
experiments, using 10:1 ratio of the ribozyme over 3'- fluorescein-labeled parent substrate 
sequence. Buffer and reagent concentrations were identical to the selection reaction. Based 
on the results of these experiments, FJ1 was clearly determined as the fastest reacting variant 
(kobs = 0.27 h-1). FJ8 and FJC9 showed similar reaction kinetics with kobs value of 0.09 and 
0.1 h-1 respectively. The overall efficiency of all three variants were roughly the same (over 
70 % after 22 hours). FJC1 showed significantly slower reaction kinetics compared to FJC9 
however, the final yield of FJC1 was similar to that of FJC9. As expected, FJC3 was the 
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least efficient variant, demonstrating almost linear kinetics and a final yield of ~ 39% 
(Figure 3-26 B & C). The details of the reaction yields and kobs values of the tested variants 
are listed in (Table 3-8). These results are correlated to the log2 values calculated for each 
variant from round 7 to round 12. 
 
Figure 3-26 Partial alignment and kinetic comparison of the variants identified from Sanger and 
next-generation sequencing. (A) Partial alignment of the catalytic core sequences of the chosen 
variants. Red: identity, Green: similarity, Black: difference. (B) Gel image of the single turnover 
kinetic assay performed on the chosen FJ variants. 3'-fluorescein-labeled parent sequence: ribozyme 
at 1:10 ratio in selection buffer including 40 mM MgCl2, 300 µM N6-Biotin-TenDP, 37°C. Time 
points: 0, 0.25, 0.5, 1, 2, 4, 6, 8 and 22 hours. (C) Pseudo-first order kinetic curve fitting of the 
quantified bands. 
 
Table 3-8 Kinetic parameters of the FJ variants 
Ribozyme Substrate sequence kobs (h-1) Final yield (%) 
FJ1 3'-fluorescein-Parent 0.27 ± 0.04 86 ± 2 
FJ8 3'-fluorescein-Parent 0.09 ± 0.01 81 ± 7 
FJC1 3'-fluorescein-Parent 0.04 ± 0.004 71 ± 3 
FJC3 3'-fluorescein-Parent 0.02 ± 0.002 39 ± 4 
FJC9 3'-fluorescein-Parent 0.10 ± 0.005 70 ± 2 
 
3.3.5 Secondary structure prediction of FJ1, FJ8 and FJC9 
Secondary structure prediction was performed on the three most efficient variants, using the 
Vienna RNAfold server. The predicted structures of the FJ1 and FJ8 ribozymes are very 
different despite the high degree of similarity in their sequence. Schematic representation of 
74 
the predicted structures and the corresponding base pair probability dot plots are depicted in 
(Figure 3-27). 
 
Figure 3-27 Predicted secondary structures and base pair probability dot plots of the selected FJ 
ribozymes, generated by the Vienna RNAfold server. 
 
3.3.6 Characterization of the reaction product 
3.3.6.1 Probing of the modification site 
Trans-activity assay of the enriched pool and the kinetic experiments confirmed that the FJ 
ribozymes are active in trans. As in the case of adenylyltransferase ribozymes, these 
experiments offer no information regarding the exact positions of modification. RNase T1 
and alkaline hydrolysis experiments were then performed to identify the modification site of 
two ribozymes, FJ1 and FJC9. We, therefore, set-up semi-preparative reactions using either 
of these ribozymes, to modify the 5FAM-R660 and isolated the modified product (Figure 
3-28 A). 
RNase T1 and alkaline hydrolysis experiments on the oligonucleotide modified using FJ1, 
revealed a similar pattern of bands as in the case of FH14 and FH31 ribozymes (Figure 3-28 
B).This means that FJ1 modifies the desired position. The results from the FJC9 ribozyme 
however were different. The bands corresponding to cleavage at G9 were missing in all 
RNase T1 digestion and alkaline hydrolysis lanes from the modified RNA. The A10 
cleavage band, in this case, was present, however, it was shifted compared the unmodified 
samples. The shifted pattern of bands was lost when the cleavage happened before G9. These 
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results, therefore, determine 2'-OH of the G9 rather than A10, as the modification target of 
the FJC9 ribozyme (Figure 3-28 B). 
 
 
Figure 3-28 Probing of the FJ1 and FJC9 modification site. (A) Preparative scale modification of 
5FAM-R660 using FJ1 and N6-Biotin-TenofovirDP. (B) Alkaline hydrolysis and RNase T1 probing 
gel image of the 5FAM-R660 modified using FJ1 and FJC9. The results indicate the modification 
site for FJ1 as A10, whereas FJC9 modification site is revealed as G9. 
 
3.3.6.2 ESI-mass analysis of the reaction product 
The desired reaction in this selection experiment was the formation of a phosphono-
monoester bond between 2'-OH of the modification site and tenofovir. To confirm this 
linkage type we semi-preparatively modified the R594 using FJ1 and N6-biotin-TenDP used 
in selection. The reaction product was isolated at a yield of roughly 50%. The product was 
then submitted to ESI-mass spectrometry. The observed mass was found to be 6125.14 Da 
vs the calculated mass of 6125.08371 Da (Figure 3-29) (Full mass spectrum is shown in 
Figure 8-2 of the appendix). 
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Figure 3-29 Mass analysis of FJ1 ribozyme product. Sequence of R594 and the structure of the 
product of the FJ1-catalyzed reaction. Calculated mass of the product was 6125.08371 Da vs the 
observed mass of 61205.1406 Da. 
 
3.3.6.3 Dbr1 resistance of the phosphonyl branch 
One of the reasons behind choosing tenofovir-diphosphate analogs as selection substrate was 
formation of the phosphonomonoester linkage. We assumed this type of linkage to be more 
enzymatically stable than the phosphodiester branch, formed by the adenylyltransferase. 
Debranching enzymes in particular are responsible for efficient hydrolysis of 2'-5' 
phosphodiester linkages in cell (Chapman and Boeke, 1991). We decided to compare the 
stability of the phosphonomonoester and phosphodiester linkages against yeast debranching 
enzyme (Dbr1). Debranching assay experiments with recombinant Dbr1 (kindly provided 
by A. Hoskins, U of Wisconsin) were therefore set up on 5FAM-R550 substrate sequence 
carrying either N6-biotinylated tenofovir or N6-biotinylated adenylyl branch structures. 
These modifications were introduced using FJ1 and FH14 ribozymes respectively (Figure 
3-30). At 1 µM MnCl2 concentrations, the phosphonomonoester branch strongly resisted the 
debranching by Dbr1 with only ~17% of the RNA, debranched after 1-hour incubation. The 
phosphodiester counterpart, however, was quantitatively debranched under the same 
conditions, within the same duration of time. At 1 µM MnCl2, between 15 to 30 minutes 
time points the fraction of the debranched RNA rises from ~30% to ~65% in the case of the 
phosphodiester branch. The half-life (t1/2) of the phosphodiester bond under these conditions, 
therefore, can be estimated to be roughly 25 minutes. On the other hand, the t1/2 of the 
phosphonomonoester bond, introduced by FJ1, can be estimated to be over 200 minutes 
under the same conditions. At 5 µM MnCl2 concentrations, the FJ1 modification product is 
still significantly more resistant to debranching than the FH14 modified RNA. The half-lives 
of these two products are estimated to be ~20 minutes for the FJ1 product and less than 5 
minutes for the FH14 modified RNA. At 10 and 100 µM MnCl2 however, both branch 
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structures are rapidly degraded. These conditions clearly demonstrate higher stability of the 
phosphonomonoester bond against debranching compared to the phosphodiester branch. The 
FJ1 labeling product, however, was not completely resistant to debranching. Moreover, the 
conditions tested in these debranching assays, do not reflect the debranching rate of these 
products under cellular conditions. 
 
Figure 3-30 Resistance of FJ1 vs FH14 modified RNA to debranching. Gel images of the Dbr1 
catalyzed debranching of the (A) FJ1- and (B) FH14- modified 5FAM-R660. Debranching was done 
using the modified RNA (1 µM), 50 ng/µL of Dbr1 in 50 mM Tris pH = 7.4, 25 mM NaCl, 2.5 mM 
DTT, 0.01% (V/V) Tween-20, 0.15% (V/V) glycerol, 1, 5, 10 and 100 µM MnCl2 at 37°C. Time 
points taken at 0, 15, 30, and 60 minutes. 
 
3.3.7 Characterization of the chosen variants 
3.3.7.1 Target sequence requirements 
3.3.7.1.1 Modification-site context requirements of FJ1 and FJ8 
Substrate sequence generalizability of FJ ribozymes was investigated in the same manner as 
it was done for FH ribozymes. The same transcripts with transition and transversion 
mutations (Figure 3-12 A) outside the GAG context were utilized for FJ1 ribozymes with 
co-varied binding arms. FJ1 was unable to modify any of the three extensively mutated 
variants. Even after 22 hours of incubation, no product was formed (Figure 3-31 A). TV1 
mutant of the parent substrate sequence was also tested with the corresponding FJ8 
ribozyme. No modification was observed when testing this ribozyme: substrate sequence 
pair either (Figure 3-31 E). 
Since FJ1 and FJ8 ribozymes were unable to modify the mutated substrate sequence variants, 
new mutants were designed to further investigate their modification context requirement 
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(Figure 3-31 B). In one variant, the constant GAG window from the parent substrate 
sequence was extended by one nucleotide from each side and the rest of the sequence was 
transition mutated. The result of these mutations was called TM-UGAGC. The 5'-UGAGC-
3' context in this transcript is identical to the parent substrate sequence. Another sequence 
was also designed in which the segment 5' to the GAG was transversion mutated while the 
3'-segment was kept unchanged resulting in 5'TV1-3'Parent substrate sequence. Both the 
TM-UGAGC and 5'TV1-3'Parent substrates were successfully modified by their 
corresponding FJ1 ribozyme. The reaction rate and efficiency for both these substrate 
sequences were nearly identical to the parent sequence (Figure 3-31 C & D) (Table 3-9). 
The common feature in these sequences was that the GAG context was followed by a C 
nucleotide. At this point, the modification context sequence of the FJ1 was determined to be 
5'-GAGC-3'. Based on this information, a new mutant was designed in which 5'-GAGC-3' 
context was left intact. The rest of the sequence was transversion mutated to complementary 
nucleotides with respect to the parent sequence. This mutant, denoted as TV1-GAGC, was 
indeed modified by its respective FJ1 variant, however, the reaction efficiency was 
extremely poor (Figure 3-31 C & D) (Table 3-9). We, therefore, concluded that for efficient 
FJ1 mediated labeling to occur, it is best if the 5'-GAGC-3' context is followed by at least 
one pyrimidine nucleotide. 
We tested whether mutations to the GAG context are tolerated by mutating each G on either 
side of modification site A of the parent substrate sequence. The rest of the sequence was 
kept the same as the parent. Mutational tests within the GAG context revealed the mutations 
to the G situated 5' the bulged A are tolerated however, when pyrimidines are substituted in 
this position, reaction rate and efficiency fall drastically. Replacing this G with an A 
however, has no effect on either of those parameters (Figure 3-31 C & D) (Table 3-9). 
Mutating the 3'-G to an A on the other hand, completely abolishes the reactivity. Mutating 
the modification site A to a G, reduced the efficiency severely, however, it did not 
completely abolish the reactivity (Figure 3-31 C). 
Considering all the data from substrate sequence specificity tests, it can be concluded that 
5'-AGC-3' is the minimal essential required context for FJ1 modification. For optimal 
labeling efficiency, however, 5'-RAGCY-3' is preferred. 
FJ8 ribozyme could also modify the parent substrate sequence with AAG modification 
context as well as the 5'TV1-3'Parent sequence. The original substrate sequence with 
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modification site A mutated to G was not modified by this ribozyme. Other mutated target 
sequence variants were not examined for this ribozyme (Figure 3-31 E). 
 
Figure 3-31 Target sequence variability of FJ1 and FJ8 ribozymes. (A) Gel image of the single 
turnover kinetic experiments using parent, TM, TV1 and TV2 substrate sequences. (B) Additional 
substrate sequence variants designed for investigation of the modification context sequence 
requirement of FJ1 and FJ8. Ribozyme arms were also co-varied. Blue: same as parent, Orange: TM 
mutation, Green: TV1 mutation, Yellow: TV2 mutation. Red: modification site A, Italic: mutation 
of the modification site. Two asterisks signify similar efficiency to parent, and on asterisk indicate 
severely reduced efficiency. No asterisk: no modification. Common features of the reactive 
sequences shown in bold. (C) gel image and (D) kinetic plot of the kinetic experiments performed 
using sequence variants in (B) and their corresponding FJ1 ribozyme. (E) Gel image of the kinetic 
experiments performed using substrate sequence variants shown in (B) and their corresponding FJ8 
ribozyme. Reaction conditions in all cases: 3'-Fluorescein labeled substrate sequence and 
corresponding ribozyme at 1:10 ratio. Selection buffer, 40 mM MgCl2, 300 µM N6-Biotin-TenDP, 
37°C. time points: 0, 0.25, 0.5, 1, 2, 4, 6, 8 and 22h. 
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Table 3-9 Kinetic Details of the investigation of the FJ1 modification context. 
Substrate sequence Modification context* kobs (h-1) Final yield (%) 
Parent 5’-GAGCC-3’ 0.27 ± 0.04 86 ± 2 
TM-UGAGC 5’-GAGCU-3’ 0.23 ± 0.01 92 ± 1 
5'TV1-3'Parent 5’-GAGCC-3’ 0.23 ± 0.02 92 ± 1 
TV1-GAGC 5’-GAGCG-3’ 0.011 ± 0.001 25 ± 0.1 
Parent-AAG 5’-AAGCC-3’ 0.27 ± 0.06 89 ± 1 
Parent-UAG 5’-UAGCC-3’ 0.031 ± 0.001 60 ± 9 
Parent-CAG 5’-CAGCC-3’ 0.012 ± 0.002 25 ± 3 
* Modification site is shown in bold. 
3.3.7.1.2 Target sequence generality of FJC9 
FJC9 ribozyme demonstrated a greater level of flexibility than FJ1 and FJ8, regarding target 
sequence generalizability. This ribozyme was able to modify all three mutated target 
sequences (TM, TV1, TV2), albeit at varying efficiencies. The most efficiently modified 
target sequence, by FJC9, was the parent sequence. The other substrate sequences were 
significantly slower; however, the final reaction yield was over 60 %, except for TV2 mutant 
(Figure 3-32 A). 
Mutating the G nucleotide, which happens to be the modification site for this particular 
ribozyme, significantly reduces the reaction rate (Figure 3-32 B-D). When this position is 
mutated to A the final reaction yield is roughly the same as in the case of G. The kobs value, 
on the other hand, is reduced by roughly an order of magnitude. Mutations of the 
modification site G to U or C, have much more drastic effects on yield and reaction rate 
(Table 3-10). 
Mutating the G at the 3' of the GAG context enhances the reaction rate with the best results 
achieved by mutation to C. This mutation increases the kobs value by 20% and the final yield 
is increased. Mutations of this G to A or U do not change the rate constant significantly, 
however, the final yields are slightly increased (Figure 3-32 B-D)(Table 3-10). When A in 
the GAG context is mutated to G, no product formation can be observed even after overnight 
incubation (Figure 3-32 B & C). The best modification context tested for the FJC9 is 
determined to be 5'-GAC-3'. The combined effect of mutating both Gs at the same time, 
however, has not been studied. The surprising observation in the case of this ribozyme is 
that the bulged A seems to be even more essential than the modification site G. The reason 




Figure 3-32 Substrate sequence flexibility of FJC9. (A) Gel image of kinetic experiments performed 
using four main substrate sequence mutants and their corresponding FJC9 ribozyme. (B) Mutations 
into the GAG modification context of the parent substrate sequence. Red: modification site, Orange: 
bulging nucleotide. Positions placed in yellow boxes were co-varied in the ribozyme and the substrate 
sequence. (C) gel image and (D) kinetic plot of the single turnover kinetic experiments performed 
using GAG context mutated substrate sequence variants and their corresponding FJC9 ribozymes. 
Reaction conditions in all cases: 3'-Fluorescein labeled substrate sequence and corresponding 
ribozyme at 1:10 ratio. Selection buffer, 40 mM MgCl2, 300 µM N6-Biotin-TenDP, 37°C. time 









Table 3-10 Kinetic details of the investigation of the FJC9 modification context. 
Substrate sequence Modification context kobs (h-1) Final yield (%) 
Parent 5’-GAG-3’ 0.10 ± 0.005 70 ± 2 
Parent-GAA 5’-GAA-3’ 0.1 ± 0.02 84 ± 3 
Parent-GAU 5’-GAU-3’ 0.09 ± 0.01 80 ± 1 
Parent-GAC 5’-GAC-3’ 0.12 ± 0.01 91 ± 1 
Parent-AAG 5’-AAG-3’ 0.031 ± 0.001 70 ± 2 
Parent-UAG 5’-UAG-3’ 0.022 ± 0.001 50 ± 1 
Parent-CAG 5’-CAG-3’ 0.020 ± 0.003 45 ± 7 
 
3.3.7.1.3 Effect of mismatch on FJ1 and FJC9 labeling efficiency 
We examined the effect of introducing mismatch on either side of the bulging A-nucleotides. 
Substrates Parent-AAG and Parent-GAA were tested for modification with FJ1 and FJC9 
specific for Parent sequence (GAG). Parent-AAG and Parent-GAA substrates combined 
with original ribozymes result in A-C mismatches 5' or 3' to the bulging A, respectively 
(Figure 3-33 A). For FJC9 ribozyme, introduction of the A-C mismatch at 5' side of the A, 
resulted in an almost complete loss of activity. The same mutations at 3', resulted in slightly 
more efficient labeling with a final yield of 19% after 22 hours of incubation (Figure 3-33 
B). This number is still drastically lower than the matched combination, which yields in 70% 
modification in the same amount of time. For FJ1, A-C mutation at 5' reduced the labeling 
yield after 22 hours to 17% from 86% observed with the matched combination. Mismatch at 
the 3' resulted in complete loss of activity (Figure 3-33 B). 
 
Figure 3-33 Effect of mismatch on FJ ribozyme labeling efficiency. (A) Mismatched substrate: 
ribozyme combinations tested. Red: Mismatched positions. Green: unchanged with regards to the 
GAG-context. (B) Kinetic gel of the mismatched substrate: ribozyme pairs. Reaction conditions: 3'-
Fluorescein labeled substrate sequence and corresponding ribozyme at 1:10 ratio. Selection buffer, 
40 mM MgCl2, 300 µM N6-Biotin-TenDP, 37°C. time points: 0, 2, 4, 8 and 22h). 
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3.3.7.2 Tenofovir analog scope of the ribozymes 
The ribozymes were selected using a TenDP conjugated to biotin via an N6-aminohexyl 
linker. Thus, a risk exists that the evolving variants during selection may develop a 
dependency on biotin or the aminohexyl linker. To test whether the linker or biotin are 
essential, we performed single-turnover kinetic experiments using commercially available 
unmodified tenofovir-diphosphate as substrate (Figure 3-34). All three ribozymes accepted 
the unmodified TenDP, showing no dependency whatsoever on biotin or the aminohexyl 
linker. Surprisingly, FJ1 and FJ8 ribozymes demonstrated significantly higher labeling rates 
and efficiencies in the presence of unmodified tenofovir than the selection substrate, 
although the yields were difficult to quantify due to the poor resolution (Figure 3-35 A & 
C). 
 
Figure 3-34 list of Tenofovir-diphosphate analogs used in this study. R-TenDP is the only 







In the next step, we replaced biotinamidohexyl moiety in the selection substrate, with 
hexynyl or azidohexyl chains (Figure 3-34). These two substrates were also accepted, at an 
even higher rate and efficiency than N6-biotin-TenVP by all three ribozymes (Figure 3-35 
A & C). This observation establishes these ribozymes as valuable tools for indirect labeling 
of RNA using CuAAC or SPAAC techniques. 
We also tested the potential of FJ1 and FJC9 for direct coupling of fluorophore-conjugated 
tenofovir to target RNA. We synthesized 5-FAM and sulfoCy5 conjugated tenofovir-
diphosphate analogs (Figure 3-34), through CuAAC reaction, using the azido functionalized 
dyes and N6-hexynyl-TenDP. These substrates however, showed poor reactivity towards 
either of the ribozymes. The reaction rates were extremely slow but the final yields after 22 
hours were between 40%-60% depending on the ribozyme and dye-conjugated substrate 
(Figure 3-35 B & C). 
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Figure 3-35 Tenofovir-diphosphate analog specificity of FJ ribozymes. (A) Gel images of the kinetic 
experiments performed on FJ ribozymes using TenDP analogs with and without N6-modification. 
(B) Gel images of the kinetic experiments on FJ1 and FJC9, using N6- Cy5 and FAM conjugated 
TenDP. (C) Reaction yields of the ribozymes with different TenDP analogs after 8 hours (blue) and 
22 hours (grey). Reaction conditions in all cases: 3'-Fluorescein labeled substrate sequence and 
ribozyme at 1:10 ratio. Selection buffer, 40 mM MgCl2, 300 µM TenDP analog, 37°C. time points: 
0, 0.25, 0.5, 1, 2, 4, 6, 8 and 22h. 
 
The selection substrate and all the modified variants were synthesized as racemic mixtures 
while the commercially provided TenDP was the pure R-enantiomer. Therefore, we 
speculated that higher reactivity of the FJ1 and FJ8 towards unmodified TenDP could be due 
to the stereospecificity of the ribozyme. To test this hypothesis, unmodified TenDP was also 
synthesized as a racemic mixture and tested along with the R-TenDP (Figure 3-36 A). Both 
reactions showed similar rate and efficiency (Figure 3-36 B), thus excluding the preference 
for one of the enantiomers. 
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Figure 3-36 Racemic TenDP vs R-TenDP and their reactivity towards FJ1. (A) Asterisk indicates 
the steric center. (B) Both substrates show a similar rate and efficiency. 
 
3.3.7.3 Orthogonality test of FH and FJ ribozymes 
To test the possibility of cross-reaction between the FH and FJ ribozymes, their ability for 
utilizing one another’s substrates were put to test. The FH ribozymes were tested for the 
tenofovir transferase activity. Using N6-biotin-TenDP. FH14 showed no reactivity towards 
this substrate even at 800 µM concentration. FH31, on the other hand revealed residual 
ligating activity towards N6-TenDP (Figure 3-37 A). When FJ1 and FJC9 were tested for 
reactivity towards N6-biotin-ATP, no product formation could be detected even after 
overnight incubation (Figure 3-37 B). The FJ ribozymes and the FH14 ribozyme can thus 
be considered as orthogonal. 
 
Figure 3-37 Orthogonality test of FH and FJ ribozymes. (A) Reactivity of FH ribozymes towards 
N6-TenDP. (B) Orthogonality of FJ1 and FJC9 towards N6-modified ATP analogs. 
 
3.3.7.4 Dependency of FJ1 on Mg2+ 
To determine the range of Mg2+ concentration required for efficient FJ1-mediated labeling, 
we set up single-turnover kinetic experiments under different MgCl2 concentrations. 
Experiments were set up using 3'-fluorescein-parent substrate sequence and N6-Biotin-
TenDP. Timepoint samples were taken after 8, 24 and 36 hours of incubation at 37°C. PAGE 
resolution followed by fluorescent imaging of the gel revealed the FJ1 shows no activity at 
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1 mM MgCl2 concentration and severely reduced activity at 5 mM concentration of this salt. 
The reaction yield was slightly reduced at 20 mM MgCl2 compared to 40 mM. The reaction 
yield at 10 mM was drastically reduced, however, nearly half of the parent substrate 
sequence was modified within 24 hours (Figure 3-38). 
 
Figure 3-38 Mg2+ dependency of FJ1. Reaction conditions: 1 µM 3'-fluorescein-parent substrate 
sequence, 10 µM ribozyme, 300 µM N6-TenDP-biotin. 37°C. timepoints: 8, 24 and 36 hours. 
 
3.3.8 Selection of tenofovir transferase ribozymes using an N25-pool 
Another selection experiment was performed using a pool with similar design as the N40-
pool, but with a 25-nucleotide random region. The details of this selection are summarized 
in (Table 3-11). 
Table 3-11 Details of the selection rounds of the N25 tenofovir transferase ribozyme selection. 
Selection round 1 2 3 4 5 6 7 8 9 10 
Pool concentration (µm) ~50 
Incubation time (h) Overnight 4 3 2 
Eluted % - - - - 0.3 1.6 1.4 1.5 1.7 0.72 
 
3.3.8.1 Sanger sequencing of the selection outcome 
After 10 rounds of selection, the pool was subjected to cloning and sequencing (Figure 3-39 
A). The 10 clones that were submitted to sequencing all harbored the same insert. A single 
variant was identified from this selection experiment. This ribozyme was denoted as FK22 
(Figure 3-39 B). 
 
3.3.8.2 Substrate sequence variability and tenofovir substrate scope of FK22 
To test the target sequence generalizability of the FK22 ribozyme, we tested the TV1 
substrate sequence for modification by the corresponding version of the ribozyme. The 
ribozyme successfully modified this target sequence albeit at a lower rate and efficiency 
compared to the original selection substrate (Figure 3-39 C & D). Further investigation into 
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this ribozyme was not performed. The exact modification-site of this ribozyme has also not 
been probed. 
The FK22 ribozyme shows greater dependency on biotin and the aminohexyl linker as it 
does not accept unmodified TenDP as a substrate. TenDP analogs harboring azidohexyl and 
hexynyl at N6 of the nucleobase, also acted as poor substrates (Figure 3-39 E). These 
substrates demonstrated extremely slow reaction kinetics however, 22h yields of over 50% 
was achieved. 
The fact that this ribozyme has such a strong dependency on biotinyl-moiety is quite 
unexpected. We assumed that a ribozyme with a smaller catalytic core might provide fewer 
contact points with the substrate. The dependency of FK22 on the selection tag, however, 
proves that this assumption may not be necessarily true. 
 
Figure 3-39 Selecting a tenofovir transferase ribozyme using an N25 pool. (A) Selection progress 
monitored using fluorescence measurement of the eluted RNA after each round. (B) Sequence of the 
catalytic core of the single variant identified in the selection of the N25 tenofovir transferase 
ribozyme. (C) Gel image and (D) Kinetic plot of the single turnover kinetic assay performed using 
parent and TV1 substrate sequences and their corresponding FK22 ribozyme. (E) Gel image of the 
single turnover kinetic experiments performed on FK22 using TenDP analogs with and without N6-
modification. Reaction conditions in all cases: 3'-Fluorescein labeled substrate sequence and 
ribozyme at 1:10 ratio. Selection buffer, 40 mM MgCl2, 300 µM TenDP analog, 37°C. Time points: 
0, 0.25, 0.5, 1, 2, 4, 6, 8 and 22h. 
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3.3.9 Application of the tenofovir transferase ribozymes 
3.3.9.1 FJC9 mediated labeling of 5S rRNA 
Position G98, in 5S rRNA was targeted for labeling (Figure 3-40 A), using FJC9 and 5FAM-
TenDP. The reactions were performed analogously to 5S rRNA labeling using the FH14 
ribozyme. 5S rRNA was effectively recognized and labeled by FJC9 in total cellular RNA 
(Figure 3-40 B). While the reaction rate of this ribozyme with 5FAM-TenDP was shown to 
be slow (Figure 3-35 B & C), a 5-hour incubation time was enough for 5S rRNA to be 
labeled and visualized on PAGE. 3'-fluorescein-labeled 5S rRNA in vitro transcript was used 
as size marker. 
To provide additional proof for the specificity of this ribozyme for the modified position, we 
performed reverse transcriptase-based primer extension assay. These experiments are based 
on the fact that certain modified positions stall reverse transcriptase during cDNA synthesis, 
resulting in abortive products. These products can be detected using end-labeled primers for 
reverse transcription followed by resolution of the product on denaturing analytical PAGE. 
A 5'-32P-labeled primer was synthesized complementary to the last 14 nucleotides of the 5S 
rRNA. This primer was annealed to the 5S rRNA in vitro transcript, modified either using 
FH14 at each individual FH14 target site or FJC9 and subjected to primer extension using 
superscript III reverse transcriptase. Unmodified 5S rRNA was used as control. Abortive 
bands were observed in the case of the modified 5S rRNA lanes when the primer extension 
product was resolved on 15% analytical PAGE and subjected to phosphorus imaging. To 
determine the exact positions at which the reverse transcriptase is stalled, RNA sequencing 
reactions were performed based on dideoxynucleotide chain-termination. Since the sequence 
of 5S rRNA was known, we only performed sequencing using ddCTP and ddTTP to 
determine the G and A positions, respectively. The product of the sequencing reaction was 
also resolved next to the samples from the primer extension performed on the modified and 
non-modified 5S rRNA. The abortive bands appeared for positions modified by FH14 at 
exactly one nucleotide 3' to the modification site, which indicates the presence of a steric 
block, at the modified positions. Since FJC9 modified G98 rather than A99, the abortive 
band therefore appears at A99 (Figure 3-40 C).  
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Figure 3-40 FJC9 mediated labeling of the E. coli 5S rRNA. (A) Sequence and secondary structure 
of the E. coli 5S rRNA. The position highlighted in red indicates the modification site (G98), the 
bulging A is shown in orange. The green positions including G98 were paired with ribozyme arms. 
(B) Left: gel image of the labeling of 5S rRNA in total cellular RNA using FJC9 and N6-FAM-
TenDP. Conditions: 50 ng cellular RNA, 100 pmol of the corresponding FJC9 in selection buffer 
including 40 mM MgCl2 and 200 µM N6-FAM-TenDP. 37°C, 6 hours. Right: SYBR Gold staining 
of the same gel. (C) Reverse transcriptase primer extension experiments on in vitro transcribed 5S 
rRNA modified using FJC9 and FH14 ribozymes. Biotinylated TenDP and ATP were used for FJC9 
and FH14-mediated 5S rRNA modification, respectively. 32P-labeled primer was used for this 
reaction. The reaction was performed on non-modified and modified 5S rRNA using each ribozyme. 
A and G sequence ladders were made using primer extension in the presence of ddTTP and ddCTP, 
respectively. 
 
3.3.9.2 Dual-color orthogonal labeling of synthetic and cellular RNA 
3.3.9.2.1 Mutually orthogonal double labeling of an in vitro transcribed model 
substrate 
Ribozymes FH14 and FJ1 were established as perfectly orthogonal with no cross-reactivity 
to one another’s substrates (Figure 3-37).These ribozymes, therefore, hold the potential for 
simultaneous dual-color, mutually exclusive labeling of a single RNA molecule at different 
targeted positions. To put this potential to test, we designed a synthetic transcript of 41 
nucleotides with two potential sites for FJ1 and FH14 mediated labeling. The transcript was 
the result of the fusion of the parent substrate sequence via a 4-nucleotide linker to an 18-
nucleotide sequence containing a GAG modification context. The segment corresponding to 
the parent sequence was targeted using FJ1 ribozyme while the other segment was targeted 
91 
using an FH14 ribozyme with appropriate binding arms (Figure 3-41 A). Three reactions 
were set up using this transcript with both ribozymes present in the reaction. The reaction 
mixtures were incubated in the presence of either Cy5-TenDP or 5FAM-ATP individually, 
or both at the same time (Figure 3-41 A). Aliquots were taken from time-points 0, 5h, and 
after overnight incubations. The samples were analyzed using a 15% analytical denaturing 
PAGE and multichannel fluorescent imaging. As expected, only one labeled band was 
observed in time points 5h and overnight, the reaction in which only one labeled NTP analog 
was included. The emitted signal corresponded to the dye that was conjugated to the NTP 
analog in each reaction. Cy5-tenofovir branched and 5FAM-AMP branched RNA 
demonstrated shifted electrophoretic mobility due to the difference in mass and charge of 
the added moieties. Three labeled bands were visible in the lanes pertaining to the 5h and 
overnight samples of the reaction, in which both analogs were included. The lightest band 
emitted FAM signal, the slightly heavier band emitted Cy5 signal, and for the heaviest band 
both signals overlapped. These results demonstrate that the synthetic transcript was 
successfully labeled with both dyes using both ribozymes (Figure 3-41 C). 
To confirm the positional specificity of the labeling reaction, we utilized the RNA cleaving 
8-17NG deoxyribozyme (Schlosser et al., 2008). The deoxyribozyme was designed to cleave 
the model substrate between the nucleotides 24 and 25. The uneven cleavage results in two 
fragments with the larger fragment (24 nt) harboring the FJ1 modification site and the 
smaller fragment (17nt) containing the FH14 modification site (Figure 3-41 B). Cleaving 
the singly and doubly labeled model substrate with this 8-17NG and PAGE analysis of the 
cleavage products, confirmed the mutually orthogonal nature of the labeling reaction. The 
larger fragments from the reactions in which Cy5-TenDP had been included, always emitted 
with Cy5 signal and the smaller fragments from the reactions, in which only 5FAM-ATP 
had been included, always emitted with FAM signal (Figure 3-41 C). 
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Figure 3-41 Mutually orthogonal double labeling of a synthetic transcript. (A) Double labeling of 
the synthetic transcript using FJ1 and FH14 ribozymes. Segment recognized and modified by FJ1 is 
highlighted in green and the segment targeted by FH14 is shown in blue. Modified As are shown in 
red. (B) Asymmetric 8-17NG deoxyribozyme cleavage of the double-labeled target sequence. (C) 
Multichannel fluorescent gel image of the double and single labeling reactions and the cleavage of 
the labeled products. Labeling reaction conditions: target sequence (4 µM), corresponding FJ1 and 
FH14  ribozymes (10 µM each) were dissolved in selection buffer including 200 µM of N6-Cy5-
TenDP or N6-FAM-ATP or both, and incubated at 37°C. Time-points taken at 0, 5 hours, and after 
overnight incubation. Cleavage conditions: 20 µM 8-17NG deoxyribozyme, 50 mM HEPES (pH= 
7.5), 400 mM KCl, 100 mM NaCl, 10 mM MnCl2,10 mM MgCl2 at 37°C. Time points taken at 0, 
0.5, and 1 hour. 
 
3.3.9.2.2 Dual-color simultaneous labeling of large cellular RNA 
We established the high specificity and efficiency of FH14 ribozyme in labeling highly 
structured long RNA such as E. coli 5S rRNA. Thus, we attempted  to test labeling potential 
of the FH14 and FJ1 ribozymes for labeling even larger cellular RNAs such as 16S and 23S 
rRNA (Montpetit et al., 1998; Petrov et al., 2013) (Figure 3-42). Ultimately, we sought to 
address both ribosomal RNAs, simultaneously, using different fluorescent dyes and both 
ribozymes. 
These two ribosomal RNAs were chosen due to their size, structural complexity, and 
abundance in E. coli cells. In fact, these RNAs are so abundant that they can be visualized 
as two distinct bands using standard staining methods, during agarose gel electrophoresis of 
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total cellular RNA (Smith et al., 1988). Two potential target sites in 16S rRNA (A325 and 
A412), and one in 23S rRNA (A637) were targeted using FH14 alone. Three sites within 5'-
RAGCY-3' context were chosen to be addressed by FJ1. Positions A272 and A1572 also 
situated in 5'-RAGCY-3' context, where targeted by both ribozymes (Figure 3-42). 
ATTO550-ATP or 5FAM-ATP were used as labeling substrates for FH14 ribozyme and 
Cy5-TenDP for FJ1 ribozyme. 
These two rRNAs were targeted by FH14 and FJ1 at chosen positions individually or 
simultaneously within the context of total cellular RNA. Due to the large size of these RNAs, 
agarose gel electrophoresis followed by multichannel fluorescent imaging was used for the 
analysis of the labeled products. All targeted positions were successfully labeled by each 
individual ribozyme using corresponding dye-conjugated substrate analog. In one of the 
samples, we tried simultaneous targeting of A649 from 16S rRNA and A272 from 23S 
rRNA, using FJ1 and FH14 ribozymes, respectively. As a result, 16S rRNA was labeled with 
Cy5 and the 23S rRNA was labeled by ATTO550, as revealed by agarose gel electrophoresis 
and multichannel fluorescent imaging (Figure 3-43 A). 
The size difference between the two ribosomal rRNAs was enough to confirm the specificity 
of each ribozyme for its corresponding target sequence and cognate NTP analog. 
Nevertheless, an additional confirmatory test was performed. We chose to target A1572 of 
23S rRNA with FJ1 for Cy5 labeling and A412 of the 16S rRNA with FH14 for 5FAM 
labeling. Five reactions were prepared all containing total cellular RNA. Two of the reactions 
contained FJ1 ribozyme alone, with either Cy5-TenDP or 5FAM-ATP. Two other reactions 
were set up similarly using only the FH14 ribozyme. The 5th reaction contained both 
ribozymes and both substrates. This experiment further approved the strong specificity of 
the ribozymes for their corresponding target sequence and their orthogonality relative to one 
another (Figure 3-43 B). Either 23S or 16S rRNA were labeled by their corresponding 
ribozymes when the correct ribozyme: dye-conjugated substrate combination was present. 
In the 5th reaction where both ribozymes and substrates were present, both ribosomal RNA 




Figure 3-42 Targeted positions on E. coli 16S and 23 rRNAs. Positions shaded in blue were targeted 
to be labeled using FJ1. Positions shaded in pink were targeted for labeling using FH14. Positions 
shaded in purple were targeted by both ribozymes individually. Positions marked in red, correspond 
to the modification site. Positions marked in green were paired to ribozyme arms. 16S and 23S rRNA 
secondary structures were generated by “rnacentral.org” using PDB IDs 3J9Z for16S rRNA and 
4V56 for 23S rRNA. 
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Figure 3-43 FJ1 and FH14 mediated labeling of 16S and 23S rRNA at targeted positions. (A) Lanes 
2-4: FJ1 mediated labeling of 16S rRNA at three different positions using N6-Cy5-TenDP. Lanes 5-
8: FH14 mediated labeling of 23S rRNA at different positions using N6-ATTO550-ATP. Lane 8: 
corresponds to the simultaneous labeling of 16S and 23S rRNA using FJ1 and FH14 respectively. 
N6-Cy5-TenDP was used as the labeling substrate for FJ1, whereas N6-ATTO550-ATP was used for 
FH14. Lanes 9-12: FJ1 mediated labeling of 23SrRNA at three different positions using N6-Cy5-
TenDP. Lanes 12 and 13: FH14-catalyzed labeling of 16S rRNA at 2 different positions using N6-
FAM-ATP as substrate. Lane 1 included unmodified RNA as control. The top three images were 
acquired using single- and multichannel fluorescent imaging of the agarose gel while the bottom gel 
image was acquired after SYBR Gold staining. (B) Orthogonality test of FJ1 and FH14. Four first 
lanes from the left include cellular RNA with either FJ1 or FH14 with cognate or orthogonal 
substrates. The last lane includes both ribozymes and both substrates. Successful labeling was only 
observed when matching ribozyme and substrate were present in the reaction. N6-Cy5-TenDP and 
N6-FAM-ATP were used as labeling substrates. The top three images were taken using multichannel 
fluorescent imaging while the bottom image was acquired after SYBR gold staining of the same gel. 
 
Primer extension test using Superscript III reverse transcriptase and appropriate 5'-32P-
labeled primers were performed for some of the targeted sites in 16S or 23S rRNA, as was 
done in the case of 5S rRNA modified by FH14 and FJC9 ribozymes. For 16S and 23S rRNA 
however, total cellular RNA was used for modification reactions and primer extension 
assays. These tests confirmed the site-specificity of the FJ1 and FH14 labeling reaction for 




Figure 3-44 Reverse transcriptase primer extension assay on FJ1 or FH14 modified, 16S, and 23S 
rRNA. The 16S and 23S rRNA subjected to FJ1 and FH14-mediated modification in the context of 
total cellular RNA. N6-Biotin-TenDP and N6-biotin-ATP were used as modification substrates for 
FJ1 and FH14, respectively. 5'-32P labeled primers, binding up to 40 nucleotides downstream of the 
modification site were used for the extension assay. A and G sequencing ladders were also included 
to determine the exact position of the modification site. The abortive bands appeared in every case 
at exactly one nucleotide 5'-to the modified position confirming site-specificity of FJ1 and FH14 




4.1 Selection of trans-acting ribozymes for site-specific RNA 
modification 
4.1.1 Analogies with deoxyribozyme selection methods 
Our partially structured pool and selection strategy enabled the selection of efficient 
ribozymes for site-specific modification of target RNA in trans. The modification occurs in 
most cases at a predetermined position. The pool was designed to include a hypothetical 
substrate sequence, which was paired to left and right recognition arms, leaving one bulged 
nucleotide as the desired modification site. The hypothetical substrate sequence was 
physically connected to the pool via a 14-nucleotide connecting loop. The ribozymes were 
therefore selected essentially as “self-biotinylating” catalysts. Removal of the connecting 
loop, however, was enough to convert these ribozymes into efficient trans-acting tools. 
The design of our selection library was a simplified variation of the 10DM24 deoxyribozyme 
selection pool. The design of the 10DM24 selection library was rather complex with four 
binding arms, recognizing two RNA substrates. Pairing of the arms to the substrate 
sequences led to formation of a three-helix-junction (Zelin et al., 2006). The deoxyribozyme 
was selected for 2'-5' ligation of two RNA oligonucleotides and was further engineered for 
2'-5' branching of an RNA target using a single nucleotide (Höbartner and Silverman, 2007). 
The engineering process was done by removing the 5'-triphophorylated guanine nucleotide 
from the 5'-end of the right hand oligonucleotide substrate and supplying it as a free GTP. 
The deoxyribozyme recognizes the GTP analog thorough Watson-Crick base-pairing to a 
cytosine in one of its binding arms (Höbartner and Silverman, 2007). By mutating the 
cytosine in this position, the specificity of 10DM24 can be switched towards other 
complementary NTPs (Höbartner and Silverman, 2007). 
Our selection was performed directly for the single nucleotide branching activity using 
natural and non-natural ATP analogs. Hence, a “preorganized three-helix junction” setting 
was not necessary. The number of binding arms was therefore reduced to two recognizing a 
single substrate RNA. Through this selection strategy, ribozymes have been evolved that 
could be easily engineered for targeting various RNA sequences. The mode of NTP analog 
recognition of these ribozymes, however, may be more complex than 10DM24. In-depth 
investigation should thus be performed to elucidate the mechanism behind substrate 
specificity of these ribozymes, in order to engineer NTP analog specificity. 
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Analogies can also be made between our selection strategy and other deoxyribozyme 
selection methods. The constant regions of the deoxyribozyme selection pools are in most 
cases designed as binding arms complementary to the substrate sequence(s). 
Deoxyribozymes acting on non-oligonucleotide substrates have also been selected following 
similar design principles. In these instances of DNA catalysts, oligonucleotides 
complementary to the constant regions of the pool are conjugated to the reaction substrates. 
This pairing facilitates the localization of reactants in the vicinity of the random region, 
improving the likelihood of the isolation of the desired catalyst. The oligonucleotide 
(tethered) substrate is required to be ligated to the single-stranded DNA pool, before each 
selection round, as it is lost during the PCR amplification cycles. The evolved variants are 
also generally compatible with activity in trans when the target oligonucleotide or the 
oligonucleotide tethered substrate is not covalently attached to the catalyst (Silverman, 
2009).  
For selection of RNA catalysts acting on unmodified RNA substrates the physical linkage 
between the substrate sequence and the pool was made transcriptionally. The extra ligation 
step, necessary in case of 10DM24 deoxyribozyme was therefore not needed.  
 
4.1.2 Basis of the modification site selectivity of the evolved ribozymes 
Out of four ribozymes probed for modification site determination, three modified the 
predetermined adenosine. The other ribozyme labeled the target sequence at one nucleotide 
5' to the bulged A. This proves that our selection strategy facilitates rapid evolution of 
ribozymes with the ability to modify this particular position. Two reasons may contribute to 
the site-selectivity of our selection process: 
First, adenine nucleotides in a bulged structural context have been shown to have higher 
tendency to participate in branching reactions compared to other nucleotides. This 
conclusion was made by Silverman et al based on their experience of selecting 2'-5' ligase 
deoxyribozymes. The 7S11 deoxyribozyme developed by this group is the earliest example 
of 2'-5' RNA ligase deoxyribozymes (Coppins and Silverman, 2004a). The selection process 
of 7S11 was initially aimed at development of a linear 3'-5' ligase deoxyribozyme. 7S11, 
however, evolved in a way that it formed a triple-helix junction surrounding a bulged adenine 
nucleotide that served as the branch-site (Coppins and Silverman, 2005). This structural 
context was the inspiration for the selection of the 10DM24 ribozyme. The deoxyribozyme 
was initially selected for branching a bulged uridine, however, replacement of the uridine 
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with an adenine remarkably improved the ligation rate. These findings along with strong 
prevalence of bulged A-nucleotides at branch-sites of class II and spliceosomal introns, led 
to the conclusion that the bulged adenines are “inherently favored” for 2'-5' branching 
reactions. This conclusion was the basis of our choice for the modification-site adenine 
nucleotide (Zelin et al., 2006). Furthermore, Büttner et al discovered that the 5'-GAG-3' is 
the optimal modification context for 10DM24 (Büttner et al., 2014). For that reason, the 
bulged A for our ribozyme selection was also placed within a GAG context. 
Additionally, the desired reactions for which the ribozymes were selected, involve the 
introduction of bulky groups to the ribose backbone of the RNA. These types of 
modifications are known to stall reverse transcriptase. Thus, the variants that self-modify at 
positions outside the priming range (i.e., in the random region) are eliminated from the pool 
due to failure in full-length cDNA synthesis. 
 
4.1.3 Comparison with other trans-acting RNA modifying ribozymes 
To our knowledge, no 2'-5' nucleotidyltransferase ribozymes had been developed prior to 
our work. However, several other artificial RNA-modifying ribozymes exist that possess 
trans-activity (Jadhav and Yarus, 2002; Kang and Suga, 2007; Lorsch and Szostak, 1995; 
Poudyal et al., 2017; Saran et al., 2005). These ribozymes were mostly selected using 
unstructured RNA libraries. Except for some 5'- or 3'- modifying ribozymes, no 
predetermined modification site was considered during the selection process of most of these 
ribozymes. The modification sites were, therefore, randomly evolved. To turn these 
ribozymes into trans-acting variants, an in-depth investigation had to be performed to probe 
the modified position and predict or determine the secondary structure of the ribozyme. 
Mutational studies are then often performed to minimize the ribozyme and determine the 
critical positions often resulting in loss of efficiency. The ribozyme is then split into the 
substrate segment and the catalyst segments. In some cases, the substrate and the catalyst 
segment interact via partially complementary regions. The complementary parts can 
sometimes be covaried to allow flexibility regarding the target sequence, however, in many 
cases these ribozymes have a narrow range of substrate sequences they can modify. The 
required modification context in those instances is complex and with a low probability of 
appearing in any given RNA sequence. For example, the kinase ribozyme 2PTmin3.2 is a 
trans-acting ribozyme that recognizes its target sequence via partial complementarity. This 
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ribozyme phosphorylates the 2'-OH of the first purine nucleotide within a 5'-RAAAANCG-
3' context (Saran et al., 2005). 
Our selection strategy using a partially structured pool allows the selection of ribozymes that 
can readily be adopted for trans-activity simply by removing the connecting loop and varying 
the binding arms based on the desired target. These changes do not cause any loss of 
efficiency. Moreover, the variants selected mostly demonstrated remarkable target sequence 
variability. 
 
4.2 Properties of FH ribozymes 
The adenylyl transferase ribozymes identified in this thesis project were denoted as FH 
ribozymes. These ribozymes were selected for site-specific RNA labeling and as RNA 
analogs of 10DM24 deoxyribozyme. The selection process involved N6-Biotin-ATP as the 
selection substrate and led to the identification of three major sequence groups. These groups 
were named based on their representative clone number as FH14, FH20, and FH31. 
 
4.2.1 Sequence analysis and kinetic comparison of FH ribozymes 
Upon sequence alignment, a remarkable degree of similarity was observed between FH14 
and FH20. FH31 however had very few sequence signatures with similarity to FH14 and 
FH20, particularly in 5'-GAYA-3' motif that was shared among all variants. The functional 
significance of this motif is still unknown and may become apparent through in-depth 
mutational and structural studies. 
Single-turnover kinetic experiments of the trans-acting versions of these variants revealed 
the FH14 as the most efficient of the three, followed by FH31. FH20, on the other hand, was 
the least efficient variant in these experiments, despite its high activity level in cis and the 
strong sequence resemblance to FH14. The reasons behind this disparity is not yet 
understood. Structural and mutational comparison of FH14 and FH20 may facilitate 
minimization of FH14 through the identification of the critical and non-critical positions. 
Furthermore, the data acquired from these studies may provide further insight into the factors 
and structural features that contribute to the efficient trans-activity of the ribozyme. 
Additionally, modern techniques based on high-throughput sequence analysis allow 
simultaneous testing of a large number of mutants. Nokumura and Yokobayashi, have 
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recently utilized these techniques to determine critical positions in R3C ligase (Nomura and 
Yokobayashi, 2019). Their work led to minimization of the catalytic core of this ribozyme 
to only 18 nucleotides. Such techniques can also be utilized to minimize ribozymes evolved 
during this thesis project. 
 
4.2.2 Potential of the FH ribozymes as RNA labeling tools 
Tools that are applied for site-specific post-transcriptional labeling of RNA at internal 
positions should possess two main features: 
First, the tool should be modular and easily targeted towards various RNA sequences. In 
other words, it should possess the capability to be engineered for targeting RNA sequences 
of interest through simple means. While the tool can be flexibly designed for various targets, 
it should maintain high specificity towards targeted sequences. Secondly, the tool should 
provide the possibility for attachment of a wide range of chemical probes, and bioorthogonal 
functionalities, to the target RNA. 
The FH14 and FH31 ribozymes demonstrate these features to a large extent. We first 
established that these ribozymes are trans-active and modify the hypothetical substrate 
sequence at the expected position. We then proceeded by derivatizing the binding arms of 
these ribozymes to target extensively mutated variants of the substrate sequence used in 
selection. All the sequences were efficiently modified by these ribozymes. The FH14 
ribozyme even revealed enhanced modification rate and efficiency for these mutated target 
sequences, compared to the selection substrate it was evolved to modify. FH14 was able to 
modify all three mutated substrate sequences (TM, TV1, and TV2) with over 70% yield, in 
less than 15 minutes. 
Investigation into the modification context of FH14 and FH31 ribozymes, revealed their 
modification-site sequence context as a single A nucleotide for FH14 ribozyme and 5'-AG-
3' for FH31. Assuming a random distribution of nucleotides in an RNA of interest, the 
probability of finding a potential modification-site is on average 1 in every 4 nucleotides for 
FH14, and 1 in every 16 nucleotides for FH31 ribozyme. In reality however, targeting the 
potential labeling positions may not be so simple. The desired position for example, can be 
situated in a stable secondary or tertiary structure or bound by proteins. In those cases, the 
modification sites may not be accessible to the ribozyme and therefore not efficiently 
labeled. Both FH14 and FH31 ribozymes require simple modification contexts. A large 
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number of potential FH14/31 labeling positions can therefore be found in most RNAs of 
interest. Thus, it may not be particularly challenging to find easily accessible labeling 
positions for these ribozymes.  
The FH ribozymes, and specially FH14, demonstrated remarkable flexibility regarding the 
diversity of ATP analogs they could accept. Our initial concern regarding the use of 
biotinylated ATP substrate was the selection of variants with biotin as an essential substrate 
requirement. Reports of artificially developed biotin-binding functional nucleic acids exist 
in literature. Biotin binding aptamer and the self-alkylating biotin-ligase ribozymes are two 
examples of such sequences (Starikov and Nilsson, 2002; Wilson and Szostak, 1995). 
Fluorogenic Mango aptamer, selected using TO1-biotin, also showed dependency on biotin 
for optimal binding and fluorescence activation (Dolgosheina et al., 2014). These studies 
provide evidence that RNA can be evolved to recognize biotin. It was therefore likely that 
some of our selected variants might bind to the selection substrate, via the biotinyl moiety. 
Fortuitously, this was not the case for the FH ribozymes. ATP analogs of the selection 
substrate, in which biotin was removed or replaced with fluorophores were efficiently ligated 
to the substrate sequence by FH14 ribozyme. 
Further investigation into ATP analog specificity of the FH14 ribozyme revealed that the 
presence of the N6-substituent of the ATP analog is essential for ribozyme binding. This 
conclusion was reached when we observed that the GTP is not accepted by the ribozyme, 
while ATP, 2F-ATP or 2-aminoATP can still be ligated. The reaction rate and efficiency 
with these ATP analogs, however, were severely reduced compared to some ATP analogs 
modified at N6. Analogs derivatized at N6 with linear aminoalkyl chains of 4-6 carbons, were 
ligated efficiently with final yields of 50-80%. Azidohexyl or propargyl group substitution 
at this position however, reduced the reaction rate and efficiency drastically. Nevertheless, 
other forms of azido or alkynyl groups, such as the types conjugated via an amide bond to 
the aminohexyl-ATP analog, may be ligated more efficiently (Figure 4-1 A). 
Another interesting observation was the relatively high yield of FH14 ribozyme mediated 
labeling when N6-benzyl-ATP was used. Thus, the ribozyme may also be able to accept 
bioorthogonal functionalities similar to the benzyl group, such as styrene or tetrazine (Figure 
4-1 B). Both types of modifications can act as bioorthogonal handles for IEDDA reactions. 
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Figure 4-1 Potential FH14 mediated labeling substrates with bioorthogonal handles. (A) Azido and 
alkyne containing analogs (B) Bioorthogonal functionalities with similarity to benzyl substitution. 
 
4.2.3 FH14-mediated labeling of long heavily structured RNA 
Reliance of the ribozymes on Watson-Crick base-pairing for target recognition may be a 
disadvantage when it comes to labeling of heavily structured RNA. This could be due to the 
competition between the ribozyme arms and the internal sequences of the substrate RNA for 
pairing to the target site. The potential of FH14 ribozyme for labeling large and heavily 
structured RNAs was tested by targeting three target sites in E. coli 5S rRNA. 5S rRNA is 
significantly larger than the synthetic model substrate sequences. The second reason was the 
strongly structured nature of this RNA. The 5S rRNA targeting FH14 variants successfully 
labeled all three target positions individually and simultaneously on in vitro transcribed pure 
5S rRNA. While it was impossible to determine the yield of the labeling reaction, the 
intensity of the labeled band signal after 4 hours of reaction was roughly similar across all 
labeled positions. FH14 also successfully labeled all three positions of 5S rRNA within the 
context of cellular RNA. 
The results were reproducible when another class of cellular RNA was labeled in 2 different 
positions using the FH14 ribozyme. RyhB was a second RNA of cellular origin that was 
successfully labeled using FH14 as a pure transcript. Labeling within the total RNA cellular 
context of RyhB resulted in significantly lower intensity bands compared to 5S rRNA. The 
reason behind this difference could be attributed to the instability of the RyhB RNA in cell 
under the growth conditions used. 
FH14 was also successfully applied to the labeling of even larger cellular RNA such as E. 
coli 16S and 23S rRNA, at multiple positions. The site-specificity was confirmed by both 
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fluorescent imaging of the agarose gel and using reverse transcriptase primer extension 
assay. 
 
4.2.4 FH ribozymes and perspective for RNA labeling in live cells 
FH14 ribozyme demonstrated immense potential for RNA labeling in vitro. The ribozyme 
shows excellent substrate sequence variability and a broad range of specificity towards ATP 
analogs. Various synthetic and cellular RNAs could be efficiently labeled using this 
ribozyme, even the positions we considered difficult to access. Successful labeling of 5S, 
16S and 23S rRNAs and the RyhB sRNA in total cell RNA confirms the potential of this 
ribozyme for application in live cell. Nonetheless, some limitations make the cellular 
application of this ribozyme impossible, at least in its current form. 
First and foremost, the nature of the substrate utilized for RNA labeling is not entirely 
orthogonal to the cellular RNA synthesis machinery. The N6-modified ATP analogs are 
expected to be incorporated into actively transcribed RNA sequences through the action of 
the cellular RNA polymerases (Grammel et al., 2012). Poly-A polymerase is another cellular 
enzyme that can use N6-modified ATP analogs for extending the poly-A tail of the 
polyadenylated cellular RNA (Grammel et al., 2012). Both these events would result in 
strong non-specific background emission, making the signal emitted from the desired target 
indistinguishable. 
Another inherent limitation of the labeling reaction is the formation of a 2'-5'-phosphodiester 
branch. Such structures are recognized by cellular debranching enzymes and rapidly 
removed, leading to loss of label (Chapman and Boeke, 1991). This has been demonstrated 
in case of the 10DM24 labeling products in yeast cell lysate (Carrocci et al., 2017). 
A third limitation may be the cellular entry of the N6-modified ATP analogs. The 
triphosphate forms of these analogs are not cell-permeable, due to the high density of 
negative charges. One way to solve this problem is to express NTP transporters in the cell. 
These transporters have been reported to facilitate entry of unnatural bioorthogonal NTP 
analogs into bacterial cells (Feldman et al., 2018). Examples of NTPs attached to bulky 
fluorophores, however, have not been reported. An alternative way is introducing these 
NTPs in the nucleoside form in the culture media. Treatment of mammalian cells with N6-
propargyl-adenosine, for example, facilitated RNA polymerase and poly-A polymerase 
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mediated RNA labeling (Grammel et al., 2012). Bulkier modifications on the N6, however, 
may reduce cell permeability even in the form of a nucleoside. 
Another major issue of the FH14 ribozyme is its dependence on high concentrations of free 
Mg2+ ions. Our Mg2+ dependency test revealed that the ribozyme’s efficiency drops severely 
at Mg2+ concentrations below 10 mM. At 1 mM, which is the closest condition tested to the 
free Mg2+ level in living cell (Murphy, 2000; Romani, 2011), the ribozyme shows no activity. 
Molecular crowding effect in the cell has been shown to allow natural ribozymes to operate 
under significantly lower salt concentrations in vivo than required in vitro (Paudel et al., 
2018). Despite this fact however, artificial nucleic acids with lower Mg2+-dependency are 
known to act more efficiently in living cells (Filonov et al., 2014; Huang et al., 2019). It is 
conceivable that FH14 can be reselected for reduced Mg2+ dependency or evolved towards 
usage of new bioorthogonal ATP analogs. In this thesis, we followed another route, namely 
the selection with bioorthogonal nucleotide analogs. 
 
4.3 Tenofovir transferase ribozymes 
4.3.1 Antiviral nucleotide analogs as substrate for ribozyme catalyzed 
RNA labeling 
Due to the lack of bioorthogonality of the N6-labeled ATP substrates, we decided to explore 
unnatural ATP analogs as potential substrates for ribozyme catalyzed RNA labeling. 
Antiviral ATP analogs were chosen as potential substrates that may solve the orthogonality 
issue of the analogs based on natural ATP. Nucleotide analogs that act as inhibitors of the 
viral polymerases while demonstrating low reactivity towards cellular polymerases were 
considered as suitable choices. Many different classes of antiviral nucleotides exist with 
these properties (Poudyal et al., 2017). While studying various options as potential substrate 
choices, we decided that acyclic nucleotide phosphonates might present an attractive option. 
Acyclic nucleotide phosphonate analogs are an unusual class of bioactive molecules that can 
be considered as analogs to natural nucleotide monophosphates. Tenofovir (Figure 4-2) is 
an analog of AMP that belongs to this group of analogs. It has been approved by FDA as an 
anti-HIV and anti-HBV drug (De Clercq and Holý, 2005). The most striking feature of 
tenofovir, and acyclic nucleotide phosphonates in general, is the presence of a phosphonate 
group instead of the α-phosphate. Due to this negatively charged phosphonate group, 
tenofovir in its free form, cannot permeate the cellular membrane. It is therefore 
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administered in more cell-permeable, lipophilic prodrug forms in which the phosphonate 
group has been masked. Tenofovir disoproxil (Gallant and Deresinski, 2003) and tenofovir 
alafenamide (Ray et al., 2016) are the two most commonly used forms of the drug wherein 
the phosphonate group is masked by isopropyl methyl carbonate esters or in the form of a 
phosphonamidate respectively. Upon cellular entry, natural cellular enzymes remove the 
protective groups. The free phosphonate group is then phosphorylated by cellular nucleotide 
kinases that convert the drug to its active diphosphate form (Figure 4-2). Tenofovir-
diphosphate in turn, acts as an ATP analog and is incorporated by viral HIV reverse 
transcriptase or HBV DNA polymerase into the nascent DNA chain. Upon incorporation, 
tenofovir acts as an obligatory chain terminator blocking replication or reverse transcription 
of the viral genome (Naesens et al., 1998; van Hemert et al., 2014). Owing to its extremely 
low reactivity towards mammalian cellular DNA polymerases, tenofovir is essentially non-
toxic to mammalian cells (Cihlar et al., 2002). The incorporation rate of tenofovir-
diphosphate, into RNA via cellular RNA polymerases has not been measured. Nevertheless, 
due to the lack of a functional group analogous to the ribose 2'-OH, it is safe to assume that 
the incorporation rate is extremely low (Wang et al., 2006). Moreover, upon incorporation 
of tenofovir an abortive transcript is formed, which may be degraded rapidly through the 
RNA quality control mechanism in the cell (Kilchert and Vasiljeva, 2013). 
Features such as cellular activation and orthogonality made tenofovir an attractive candidate 
as a substrate for ribozyme catalyzed RNA labeling in situ. Furthermore, polymerase-
mediated incorporation of tenofovir into DNA results in formation of a phosphonomonoester 
linkage. Ribozyme-catalyzed branching of a target sequence using tenofovir diphosphate, 
results in a phosphonomonoester branch. We speculated that this branch type would be more 
resistant to debranching compared to the 2'-5'- phosphodiester linkage. 
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Figure 4-2 Tenofovir, an acyclic nucleotide phosphonate analog of ATP. Prodrug forms of tenofovir 
and their cellular activation pathway. 
 
To develop tenofovir transferase ribozymes, a selection experiment was initiated using N6-
Biotin-TenDP as the selection substrate. This analog of tenofovir is not commercially 
available and was therefore synthesized in our lab. Selection using this substrate led to the 
successful identification of two closely related variants through traditional Sanger 
sequencing, denoted as FJ1 and FJ8. 
Several other species were later identified through Illumina next-generation sequencing from 
which FJC1, FJC3, and FJC9 were chosen for further investigation. The variants were tested 
in single turnover kinetic experiments. Through these tests, FJ1 was determined as the most 
efficient catalyst of the group. FJ8 and FJC9 demonstrated similar reaction rates while the 
final yield of FJ8 was higher. FJC1 and FJC3 were the least efficient variants. These two 
variants had the lowest log2 values from the comparison of the sequence reads obtained from 
NGS analysis of the round 7 and round 12 pool samples. Log2 offers a measure for the 
enrichment of ribozymes throughout the selection process (Alam et al., 2015). Log2 values 
of above 2, mean a positive enrichment from an earlier round to a later selection round. 
Values between 0-2 mean that sequence was neither enriched nor actively eliminated during 
the selection rounds. The log2 value of FJC1 was 1.95 meaning that the effect of increasing 
selection pressure was neutral on this variant. The log2 value of FJC3 was -0.35 meaning a 
slight de-enrichment from round 7 to round 12. The low log2 values of these ribozymes are 
directly translated into their lower catalytic efficiency. The other three ribozymes had log2 
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values significantly higher than 2. They, therefore, benefited from the increasing selection 
stringency due to their faster reaction kinetics. 
 
4.3.2 Target sequence generality of tenofovir transferase ribozymes 
The ribozymes FJ1, FJ8, and FJC9 were chosen for further characterization due to their 
higher efficiency. The modification site of FJ1 was determined to be the bulged A nucleotide 
in the substrate sequence. We then tested whether FJ1 can be flexibly engineered for 
targeting other substrate sequences. This ribozyme was unable to modify the extensively 
mutated substrates (TM, TV1, and TV2), tested for the FH ribozymes. Therefore, we 
wondered whether this inability is due to the more complex sequence requirement of FJ1 
compared to FH14 or FH31. Further experiments proved that the modification contexts of 
FJ1 and FJ8 were indeed more complicated than that of FH ribozymes. The minimal 
modification site sequence requirement of FJ1 was found to be 5'-AGC-3' with 5'-RAGCY-
3' as the optimal context. Thus, the probability of finding an optimal labeling site for FJ1 in 
any given target RNA can be calculated as one in every 256 nucleotides. Thus, it is more 
challenging to find FJ1 modification sites in desired positions in an RNA of interest 
compared to FH14. A rather surprising observation regarding FJ1 was that the mutation of 
the modification site A to G, did not result in complete loss of activity although the reaction 
efficiency was severely diminished. Mutations of the GC dinucleotide following the A led 
to complete loss of labeling. It was concluded from these results that the 5'-GC-3' in the 5'-
AGC-3' context, may have a more critical role than the modification site A-nucleotide. The 
reason behind the indispensability of these nucleotides is not yet understood.  
FJC9, on the other hand, proved far less restrictive compared to FJ1, regarding its target 
sequences. All three mutated substrate sequences (TM, TV1, and TV2) were successfully 
modified using this ribozyme. Mutations to the G nucleotides flanking the presumptive 
modification site A, were also tolerated. Mutating 5'-G however especially to a pyrimidine 
did result in significant loss of activity whereas mutations of the 3'-G enhanced the reaction 
rate and efficiency. The labeling activity was fully lost when A in the context was mutated 
to G. These findings initially led us to believe that FJC9, shares the same modification site 
as other ribozymes probed in this thesis. Nevertheless, probing of the labeling products of 
this ribozyme using primer extension, RNase T1 digestion, and alkaline hydrolysis disclosed 
the modification site as 5'-G within the 5'-GAG-3' context. Hence, the identity of the 
modified nucleotide in the case of this ribozyme proved less essential than the unpaired A 
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that follows it. The modification site sequence context of this ribozyme was thus determined 
as 5'-NA-3' with a strong preference for 5'-RA-3'. 
 
4.3.3 Tenofovir diphosphate specificity range of FJ ribozymes 
All the tested FJ ribozymes demonstrated a broad range of TenDP analog specificity. No 
dependency on biotin or the aminohexyl linker was observed in case of FJ1 and FJ8 
ribozymes. These ribozymes ligated the unmodified TenDP to the substrate sequence, at an 
even enhanced rate compared to N6-Biotin-TenDP. Similar results were observed when N6-
azidohexyl and hexynyl TenDP analogs were used for all three FJ ribozymes. These 
ribozymes, therefore, demonstrate great potential for indirect RNA labeling using CuAAC 
and SPAAC chemistries. 
Fluorophore-conjugated TenDP analogs were ligated to the target RNA at reduced rates and 
efficiencies by FJ1 and FJC9. The conjugates were prepared by conjugating the azido-
functionalized fluorophore to the N6-Hexynyl-TenDP by CuAAC. As a result, the aliphatic 
linker length between the dye and TenDP is reduced to four nucleotides and a bulkier and 
more rigid triazole linkage is formed (Figure 4-3 A). The combination of the short, rigid 
linker along with the inherent bulkiness of the fluorophore may have contributed to the lower 
reaction efficiency due to steric hindrance. Perhaps fluorophore-TenDP conjugates prepared 
via different chemistries can be ligated more efficiently. For example, NHS-ester 
functionalized dyes can be conjugated to the N6-aminohexyl-TenDP (Figure 4-3 B). The 
formed product in this instance, will share greater similarity to the selection substrate as well 
as being more akin to the fluorophore-ATP conjugates used for FH14. 
 
Figure 4-3 Alternative fluorophore-TenDP conjugate. (A) Conjugates tested in this thesis project. 
(B) Conjugates that may be ligated more efficiently by FJ ribozymes. 
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4.3.4 Orthogonality of FH and FJ ribozymes: potential for simultaneous 
dual-color RNA labeling 
The ribozymes FJ1 and FJC9 demonstrated no reactivity with the FH14 ribozyme substrate 
N6-Biotin-ATP. FH14 and FH31 ribozymes were also tested for reactivity with N6-Biotin-
TenDP. FH14 showed no activity with the TenDP analog whereas FH31 managed to ligate 
this substrate to the target sequence, albeit at low efficiency. Thus, FJ1 and FJC9 can be 
considered as perfectly orthogonal to the FH14 ribozyme but not to FH31. The orthogonality 
of the ribozymes allowed labeling of a synthetic RNA transcript at two different positions 
simultaneously, using FJ1 and FH14. Cy5-TenDP and FAM-ATP were used as labeling 
substrates for FJ1 and FH14, respectively. Dual-color labeling of target RNA at two different 
positions is significant, as it allows the installation of FRET pairs in strategic positions. 
Subsequently, the conformational dynamics of labeled RNA can be studied using the FRET 
signal. The main problem with large RNA molecules, in this case, is the lack of suitable 
techniques for separation of the doubly labeled RNA from the unlabeled or singly labeled 
products.  
We have also managed to label large cellular RNA such as E. coli 16S or 23S rRNA, using 
FJ1 and FH14 ribozymes, both individually and at the same time. The results of these 
reactions once again asserted the orthogonality of these ribozymes as well as their high 
degree of specificity. Our method involved labeling of the target sequence RNA in total 
cellular RNA. The treated cellular RNA was then resolved on a gel and visualized via 
fluorescent imaging. This strategy can be compared to blotting techniques such as northern 
blotting. Our strategy, however, requires fewer steps, as in northern blotting the RNA is 
typically transferred and fixed onto a nylon membrane. Synthetic probes that are labeled 
either radioactively or fluorescently are then annealed to the target RNA followed by 
visualization on the membrane after washing off the unbound probe. In our strategy, RNA 
is visualized directly in the gel, without the need for additional labeled probes. For this 
strategy to replace northern blotting however, it is important to investigate the sensitivity of 
our technique. The lowest range of RNA that can be detected using this strategy needs to be 
determined. The smallest amount of RNA detected in northern blotting using near infra-red 
fluorescent dyes was determined to be around 0.05 fmol (Köhn et al., 2010; Miller et al., 
2018). These systems however use multiple dyes per probe. The sensitivity of our system 
may also be improved by targeting the same RNA at several positions and attaching multiple 
labels, as demonstrated for 5S rRNA that was labeled at three sites. 
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4.3.5 FJ ribozymes and the path to RNA labeling in situ 
The tenofovir-diphosphate analog used for selection of FJ ribozymes solves the 
orthogonality issue of the ATP based substrates used by FH ribozymes. The background 
signal produced as a result of FJ ribozyme labeling in live cell, may be lower as cellular 
polymerases do not incorporate tenofovir. 
We have also tested resistance to debranching of the RNA samples branched using FJ1 or 
FH14. As expected, the phosphonomonoester linkage introduced by FJ1 was more resistant 
towards debranching by highly active recombinant Dbr1 compared to their phosphodiester 
counterparts. Although less enzymatically labile, the phosphonomonoester branch was not 
fully resistant towards debranching. The debranching rate of this product at Mn2+ 
concentrations above 10 µM was similar to the phosphodiester linkage. The results obtained 
in our debranching experiments by no means reflect the complex cellular conditions. 
Debranching assay in environments such as cellular extracts should still be performed to 
provide us with a more realistic view. 
There may be a way to make phosphonomonoester linkages even more resistant to 
debranching. Carrocci et al discovered that using Sp diastereomer of GTP-αS, in 10DM24 
catalyzed branching reaction results in the formation of the Rp-thiophosphodiester (Figure 
4-4 A). This branch type showed exceptional resistance to debranching even in 4 mM Mn2+ 
concentration (Carrocci et al., 2017). Similarly, thiophosphonate analogs can be synthesized 
and tested for FJ ribozyme mediated ligation (Figure 4-4 B). Ultimately, the 
thiophosphonate-branched RNA substrate can be examined for debranching resistance. 
There is a likelihood that FJ ribozymes may not accept the thiophophonate analog as 
substrate. In that case it may be necessary to evolve new variants that utilize such tenofovir 
analogs. Rescue using thiophilic metal ions such as Cd2+ may also be another option (Basu 
and Strobel, 1999), however such ions are highly toxic for cells. 
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Figure 4-4 Debranching resistant NTPs analogs. (A) GTPαS analog used by Carocci et al (B) 
Potentially debranching resistant substrate for FJ1 labeling. 
 
Apart from substrate orthogonality and stability of the introduced label, FJ ribozymes share 
one major limitation with FH ribozymes. The dependency on high Mg2+ concentration is still 
a major issue that needs to be resolved prior to any cellular experiments. Folding in live cell 
and sensitivity to nuclease degradation is also an issue facing artificially developed 
functional nucleic acids (Filonov et al., 2015). This problem may be resolved by placing the 
FJ ribozymes within the context of stably folded RNA scaffold (Filonov et al., 2015) as 
mentioned in 1.4.1.3, for the case of fluorogenic aptamers. 
Another limitation of both FH and FJ ribozymes, like most other covalent labeling methods, 
is the lack of fluorogenicity. It is important to design a fluorogenic substrate that only 
becomes fluorescent after it is attached to RNA. Otherwise, the background emission from 
the unligated substrate will interfere with the analysis. Absence of fluorogenicity limits the 
application of these ribozymes to fixed cells where the excess of unbound substrate can be 
washed out of the cell (Muthmann et al., 2020). The problem may be solved by using 
internally quenched nucleotide analogs, in which a fluorophore is conjugated to the 
nucleobase and a quencher to the γ-phosphate (Hacker et al., 2015). These analogs, however, 
are not naturally produced in the cell. The cellular entry of these types of substrates will also 
be challenging.  
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5 Conclusion and Perspective 
During this thesis project, a selection method was established, which consistently resulted 
in the isolation of trans-acting RNA-modifying ribozymes using two different types of 
selection substrates. Our selection process leads to evolution of variants that mostly modify 
a predetermined position within the substrate sequence. Moreover, the identified variants 
demonstrate a great deal of sequence versatility and flexibility regarding their target 
sequence and cognate nucleotide analogs. They have been easily designed to target small 
and large RNA molecules at various potential labeling sites. All the targeted sites have 
successfully been labeled using various fluorophore-conjugated forms of labeling substrates. 
The FH14 and the FJ ribozymes are perfectly orthogonal regarding their labeling substrates, 
which made possible simultaneous mutually exclusive dual-color labeling of RNA. 
Furthermore, due to orthogonality of the labeling substrate and resistance to enzymatic 
cleavage, FJ ribozymes have great potential for cellular application. Although the current 
ribozymes have not been tested for cellular applications, due to the limitations discussed, 
they may be further optimized for that purpose.  
 
5.1 Possible strategies for FJ ribozyme optimization for cellular 
application 
5.1.1 Reducing Mg2+-dependency by reselection in vitro 
One commonly used strategy for improving existing activities or evolving new ones, is 
partial randomization and reselection. The FJ ribozyme catalytic core can be randomized 
partially either through error-prone PCR or by doping during chemical synthesis of the 
template. The selection process can then be re-initiated at reduced MgCl2 concentrations. 
After signs of enrichment become apparent, the MgCl2 concentration can be further reduced 
until substantial activity at concentrations below 1 mM is achieved. Since cellular free Mg2+ 
concentrations are typically between 0.25 to 1 mM, a ribozyme that functions efficiently 
within this range, might be more suitable for RNA labeling in situ. 
 
5.1.2 Possibility of selection in vivo 
Functional nucleic acids evolved in vivo are known to function more efficiently under 
cellular conditions. Fluorogen-activating Broccoli and Corn aptamers for example, 
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demonstrate significantly lower MgCl2 dependency compared to the in vitro selected HBI-
analog binding aptamers. They have also been shown to demonstrate significantly improved 
folding and enzymatic stability in cell, as they do not necessarily require a stable RNA 
scaffold (Filonov et al., 2014; Song et al., 2017). 
More recently an in vivo selection system was applied to improve the trans-activity of the 
Hammerhead ribozyme in vivo by reducing its dependence on Mg2+ (Huang et al., 2019). 
Analogously, FJ ribozymes may be further reselected in vivo for improved activity under 
cellular conditions. It is, therefore, necessary to define conditions under which the survival 
of cells harboring various mutant forms of FJ ribozymes (FJ1 or FJC9) can be linked to the 
labeling activity of these ribozymes. 
A bacterial three-hybrid system can be imagined, through which cell survival and FJ1 
mediated activity can be linked under certain growth conditions. Bacterial three hybrid 
systems are designed for the study of RNA-protein interactions (Berry and Hochschild, 
2018). In these systems, a DNA-binding protein such as λCI is fused to an RNA-binding 
protein such as MCP. The binding site of the λCI protein (λ operator) is inserted upstream 
of a weak promoter with an extremely low basal transcription level. The promoter drives the 
transcription of a reporter gene. From a second plasmid, a hybrid RNA is transcribed 
containing the MBS stem-loop fused to an RNA library that may contain sequences with 
binding affinity for a particular RNA-binding protein. The RNA-binding protein of interest 
is fused to the α-subunit of bacterial RNA polymerase, replacing the natural α-subunit of the 
C-terminal domain (αCTD). λCI-MCP fusion binds to the λ operator upstream of the reporter 
gene. MCP, in turn, binds to the MBS stem-loop of the chimeric RNA. In case the RNA 
segment fused to MBS harbors the binding motif of the RNA binding protein of interest, the 
bacterial RNA polymerase is recruited to the promoter, dramatically enhancing reporter gene 
expression (Berry and Hochschild, 2018). 
Similarly, three-hybrid systems can be designed for selecting FJ ribozymes in cis- or trans- 
reacting settings (Figure 5-1): 
For the Cis-reactive version, FJ1 or FJC9 with a partially randomized core, along with a 
substrate sequence, inserted into a stably folded RNA scaffold are fused to the MBS stem-
loop. A DHFR-fused α-subunit is then expressed from another plasmid. N6-Trimethoprim 
conjugated tenofovir is supplied in the culture medium in disoproxil or alafenamide form. 
Trimethoprim is a DHFR inhibitor with strong binding affinity and has been shown to bind 
to this protein even when conjugated to other tags (Carrocci and Hoskins, 2014; Gallagher 
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et al., 2007). The tenofovir analog enters the cell and is activated by cellular machinery. The 
FJ ribozyme mutants that can function under cellular conditions will be conjugated to 
trimethoprim allowing the chimeric RNA to bind to the DFHR conjugated α-subunit, 
recruiting the E. coli RNA polymerase to the promoter and activating expression of an 
antibiotic resistance gene (Figure 5-1 A). The medium is also supplied with the 
corresponding antibiotic, allowing only cells that harbor highly active FJ ribozyme 
constructs to survive. Alternatively, the gene coding for a fluorescent protein can be placed 
instead of the antibiotic resistance gene, and the cells with desirable levels of FJ ribozyme 
activity can be sorted using FACS. 
The selection for FJ ribozymes under the trans-settings can be performed following the same 
principles. In this system, only the substrate sequence is fused to MBS stem-loop. The FJ 
ribozyme in its trans-acting form, with a partially randomized core, is inserted in an RNA 
scaffold. Modification of the substrate sequence in trans- using trimethoprim-TenDP 
conjugate, allows for the activation of a reporter gene (Figure 5-1 B). The design for 
inserting a trans-acting FJ ribozyme in a stable scaffold was inspired by the work of Huang 
et al, in which trans-acting hammerhead ribozyme was transcribed intracellularly within the 
context of a tRNA scaffold (Huang et al., 2019). 
 
5.2 Potential future selection projects 
The selection process established during the work on this project offers endless possibilities 
for ribozyme-based RNA labeling tools. The focus in this thesis was the development of 
ribozymes utilizing NTP analogs based on ATP. The selection, however, can be performed 
using other types of biotinylated natural and unnatural NTPs. Those selection experiments 
can result in the development of more ribozyme variants with specificities towards various 
NTP-based substrates. This will allow us to expand our labeling potential beyond dual-color 
imaging of RNA. 
By changing the bulged nucleotide adenosine to other nucleotides, it might be possible to 
evolve ribozyme with specificities towards other internal nucleotides. Ultimately, 
randomizing this position may provide the possibility of selecting ribozymes that can modify 
any type of nucleotide. Such ribozymes can be targeted to virtually any accessible position 
within the RNA of interest. 
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Moreover, non-nucleotide-based selection substrates can be applied in the selection process 
to develop other classes of RNA-modifying ribozymes. Other possibilities include the 
development of ribozymes such as RNA alkyltranferases or acyltransferases. The 
modification sites in those cases may not be limited to the 2'-OH of the ribose backbone but 
the nucleobases may also be involved. Non-nucleotide based, uncharged, fluorogenic 
substrates can be used in the selection to evolve RNA labeling ribozyme with fluorescent 
turn-on potential. The uncharged nature of the substrates would also resolve the issue of cell 
permeability. 
Countless other selection scenarios can be imagined or realized using the selection system 
established and optimized during the work of this thesis project. Thus, the search for ideal 
RNA labeling ribozymes goes on. 
 
Figure 5-1 Possible three-hybrid system for reselection of FJ ribozymes in vivo. (A) Reselection 




6 Material and methods 
6.1 Instruments 
Table 6-1 List of instruments used in this thesis project 
Instrument Model Company 










Gel dryer Model 583 gel dryer Biorad 
HPLC ÄKTApurifier 10 with autosampler 
ÄKTAmicro 
GE Healthcare 
Mass spectrometer micrOTOF-Q III Bruker 
Nanophotometer 
UV/Vis 





ÄKTA start GE Healthcare 
PCR T100 Thermal cycler Biorad 
Phosphorimager Amersham Typhoon Amersham Bioscience 
Speed Vac Savant Speedvac Concentrator Thermo Scientific 
Synthesizer LKB Gene Assembler Plus Pharmacia 









6.2.1 Chemicals and reagents 
All common chemicals and reagents were purchased from ROTH, Applichem, Sigma 
Aldrich, and Roth with no further purification.  
All the ATP analogs used in this study, including the N6-Biotin-ATP and the N6-fluorophore-
conjugated analogs were purchased from Jena bioscience. 
Fluorescein-NHS ester was purchased from ThermoFisher Scientific, fluorescein-
thiosemicarbacide and lucifer yellow carbohydrazide were purchased from Sigma. 6-FAM-
PEG3-azide was purchased from Jena Bioscience. 
Enzymes were purchased from ThermoFisher Scientific. T7 RNA polymerase was a lab 
prepared stock. Yeast Dbr1 was kind gift from A. Hoskins (Dept. of Biochemistry, U. 
Madison-Wisconsin). 
MicroSpin G-25 Columns and Ready-To-Go RT-PCR Beads were purchased from GE 
Healthcare. QIAquick® Gel Extraction Kit and QIAprep® Spin Miniprep Kit were purchased 
from Qiagen. TOPO® TA Cloning® Kit for Sequencing with One Shot® TOP10 Chemically 
Competent E. coli was purchased from New England Biolab. 
γ-32P-ATP was purchased from Hartmann Analytic GmbH. 
Transcription templates and primers were purchased from Microsynth and purified on 
denaturing PAGE prior to use. 
Water used for all experiments was purified with a Milli-Q-unit of Sartorius. 
 
6.2.2 Buffers and solutions 
TBE buffer (10x): 890 mM Tris, 890 mM boric acid, 200 mM EDTA (pH= 8.3) 
Acrylamide-gel stock solution (10%): 10% acrylamide, 7 M urea, 89 mM Tris, 89 mM 
boric acid, 20 mM EDTA (pH= 8.3) 
Acrylamide-gel stock solution (15%): 15% acrylamide, 7 M urea, 89 mM Tris, 89 mM 
boric acid, 20 mM EDTA (pH= 8) 
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Acrylamide-gel stock solution (20%): 20% acrylamide, 7 M urea, 89 mM Tris, 89 mM 
boric acid, 20 mM EDTA (pH= 8) 
High dye solution: 80% formamide (99%), 89 mM Tris (pH = 8), 89 mM boric acid, 70 
mM EDTA (pH = 8), 0.25 mg mL-1 bromophenol blue, 0.25 mg mL-1 xylene cyanol 
STOP solution: 80% formamide (99%), 89 mM Tris (pH = 8), 89 mM boric acid, 50 mM 
EDTA (pH = 8) 
TEN buffer: 100 mM Tris (pH = 8), 1 mM EDTA, 300 mM NaCl 
Transcription annealing buffer (10x): 100 mM Tris (pH = 8), 50 mM NaCl, 0.1 mM 
EDTA 
Selection buffer (5x): 250 mM HEPES (pH = 7.5), 600 mM KCl, 25 mM NaCl 
Binding-Washing (BW) buffer (2x): 2 M NaCl, 10 mM Tris (pH = 7.5), 1 mM EDTA (pH 
= 8) 
Denaturing washing buffer: 8 M urea, 10 mM Tris (pH = 7.5), 1 mM EDTA (pH = 8), 
0.01% tween-20 
Formamide elution buffer: 95% formamide, 1 mM EDTA (pH = 8) 
TBS buffer (5x): 250 mM Tris (pH = 7.5), 750 mM NaCl 
X-gal solution:  40 mg/ml X-gal in DMSO 
8-17NG cleavage buffer (5x): 250 mM HEPES (pH = 7.5), 2 M KCl, 500 mM NaCl 
Dbr1 reaction buffer (5x): 250 mM Tris pH = 7.4, 125 mM NaCl, 12.5 mM DTT, 0.05% 
(V/V) Tween-20, 0.75% (V/V) glycerol) 
RNA extraction solution: 95% formamide, 18 mM EDTA (pH = 8), 0.025% SDS, 1% 2-
mercaptoethanol. 
Detritylation solution: 3% Dichloroacetic acid in 1,2-dichloroethane 
Activation solution: 0.25 M ethylthiotetrazole in acetonitrile 
Oxidation solution: 10 mM Iodine in acetonitrile/ sym-collidine/ H2O: 10/1/5 
Capping A solution: 0.5 M 4-(Dimethylamino)pyridine in acetonitrile. 
Capping B solution: Aceticanhydride/ sym-collidine/ acetonitrile: 2/3/5 
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6.3 Methods 
6.3.1 General procedures 
6.3.1.1 PAGE purification 
To ensure maximum purity of the oligonucleotides used in the experiments, purchased 
samples were purified using denaturing polyacrylamide gel electrophoresis (PAGE) prior to 
use. Depending on the size of the oligonucleotides, they were resolved on 10%, 15% or 20% 
acrylamide gel with a thickness of 0.75 mm. For gel preparation, 50 mL acrylamide gel stock 
solution of the corresponding percentage was mixed with 45 µL of N,N,N’,N’-
tetramethylethylene-1,2-diamine (TEMED) and 150 µL of ammonium peroxodisulfate 
(APS, 25% (w/v) in water). The polymerized gel was put into a gel electrophoresis apparatus 
filled with 1x TBE buffer and pre-equilibrated at a constant power of 35 W for 30 minutes. 
The dissolved samples were mixed with an equal amount of high dye solution and loaded on 
the pre-equilibrated gel. After application of the samples, it was run for another two hours 
using the same voltage and current conditions as before. The gel was then transferred 
between cling film and imaged using UV light (265 nm). The bands corresponding to the 
desired oligonucleotides were cut out, chopped up, and transferred into 1.5 mL microtubes. 
TEN buffer was added until the gel pieces were completely covered (usually 300 - 450 µL). 
The mixture was then incubated at 37 °C for 1.5 - 3 hours or overnight at 4 °C. The gel 
extract was aspirated and transferred into a fresh microtube. A second fraction of TEN buffer 
was added to the gel pieces and treated as the previous fraction. The gel extracts were EtOH 
precipitated, and the pellets were dissolved in water. 
 
6.3.1.2 Ethanol precipitation 
Absolute ethanol with a temperature of -20 °C was added to the solution containing 
oligonucleotides at a ratio of 3:1. The minimum volume of oligonucleotide solution was 100 
µL including a final concentration of 300 mM NaCl as precipitant. After freezing the mixture 
in liquid nitrogen for 3-5 minutes, it was centrifuged in a refrigerated tabletop centrifuge at 
maximum speed, at 4 °C for 30 minutes. The supernatant was aspirated, and the pellet was 
desalted by adding 75 µL of ice-cold 70% EtOH. The sample was spun down at top speed 
and 4 °C for another 10 minutes. Afterwards, the supernatant was discarded, the pellet was 
dried in vacuum and dissolved in milliQ water. 
121 
6.3.1.3 In vitro transcription 
The annealing mixture was prepared by dissolving 100 pmol of the oligonucleotide D008 
(T7 promoter) (Milligan et al., 1987) and 100 pmol of the single-stranded DNA template in 
50 µL of 1x annealing buffer. Annealing was performed by incubating the reaction mixture 
for 5 minutes at 95 °C followed by incubation at room temperature for 10 minutes. 
Afterwards, 4 μL of 1M Tris buffer (pH= 8), 4 μL of 250 mM DTT, 4 μL of each NTP (100 
mM stock concentrations), 3 μL of 1 M MgCl2, 2 μL of 100 mM spermidine was added to 
the annealed mixture and the total volume was brought to 96 μL using deionized water. After 
mixing properly, 4 μL of T7 RNA polymerase (4 mg/mL) was added to the reaction and the 
sample was incubated at 37°C for 3-6 hours. The final concentration of each reagent was 
therefore 40 mM Tris, 10 mM DTT, 4 mM of each NTP, 30 mM MgCl2, 2 mM spermidine. 
After the incubation, the reaction was then stopped by adding 20 μL of 0.5M EDTA and 50 
μL of high dye gel loading buffer. The final transcript was then purified from the mixture 
using PAGE purification. 
 
6.3.1.4 Solid-phase oligonucleotide synthesis 
RNA oligonucleotides were synthesized on amino-ON controlled pore glass (CPG) with a 
pore size of 500 Å and a loading of 30-40 µmol g-1. The synthesis scale was 0.85 μmol (25 
mg of CPG), with a final detritylation step to remove the 4,4‘-dimethoxytrityl group. For 
each coupling step, 75 µL of a 100 mM phosphoramidite solution (in MeCN) was used, 
which was dried over activated 3 Å molecular sieves prior to synthesis. The same MeCN 
was also used for the rinsing procedure and preparation of other solutions for the solid-phase 
synthesis. The detritylation was performed using dichloroacetic acid (3% in DCE). ETT 
(0.25 M in MeCN) was used for the activation of the phosphoramidite building blocks. The 
coupling time for unmodified RNA phosphoramidites was 4 minutes and 12 minutes for 
modified phosphoramidites. For the capping of unreacted nucleosides, a 1:1 mixture of 
Capping A and Capping B solution was used. Oxidation was performed by treatment with 
an iodine solution (10 mM in sym-collidine/H2O/MeCN 1:5:11) for 1 minute. After the 
synthesis, the CPG support with the bound oligonucleotide was dried under vacuum and 
subsequently subjected to deprotection. 
Cleavage of the oligonucleotides from the solid support and deprotection of the nucleobases 
and phosphate groups was achieved by incubating the CPG with 0.5 mL of MeNH2 (40% in 
water) and 0.5 mL of NH3 at 65 °C for 3 hours. The reaction mixture was centrifuged, the 
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supernatant was collected, and the CPG was washed with 0.5 mL of water. Both solutions 
were combined, and the solvent was evaporated. For 2'-deprotection, the RNA was re-
dissolved in 0.5 mL of a 1 M TBAF solution (in THF). The reaction was performed overnight 
at 37 °C while shaking (ca. 200 rpm). The reaction was quenched by adding 0.5 mL of 1 M 
TRIS-HCl solution (pH = 8.0) and THF was removed under reduced pressure. Subsequently, 
the oligonucleotides were desalted by size exclusion chromatography using HiTrap desalting 
columns (3 x 5 mL) and water as eluent. After desalting, the solvent was removed under 
reduced pressure and the RNA was re-dissolved in 0.5 mL of water. The crude RNA samples 
obtained were purified on denaturing PAGE. 
 
6.3.1.5 Oligonucleotide labeling 
6.3.1.5.1 3'-end labeling using periodate glycol-oxidation 
For the in vitro transcribed substrate sequences, 3-5 nmol of RNA was dissolved to a final 
concentration of 100 µM in 50 mM sodium phosphate buffer pH=7.4, NaIO4 was added to 
a final concentration of 20 mM and the reaction was incubated at 37°C for 10 minutes. The 
excess of unreacted periodate was quenched by addition of Na2SO3 to a final concentration 
of approximately 100 mM and the reaction was incubated for an additional 5 minutes at 
37°C. Fluorescein-thiosemicarbazide was added to a final concentration of approximately 
10 mM and the reaction was incubated in the dark for 1 hour. Stop solution was then added 
to the reaction at an amount equal to the final reaction volume and the sample was resolved 
on a 0.75 mm, 20% denaturing PAGE under constant power of 35 W for 2 hours. 
For longer transcripts (i.e. the selection pool and in vitro transcribed E. coli 5S rRNA and 
RyhB RNA) a slightly modified protocol was used. The RNA was dissolved in the reaction 
mixture to a final concentration 30-60 µM in 50 mM sodium phosphate buffer pH= 7.4, 
NaIO4 was added to a final concentration of 20 mM and the reaction was incubated at 37°C 
for 10 min followed by quenching at 37°C for 5 min using a final concentration of ~100 mM 
Na2SO3. Lucifer yellow-carbohydrazide or fluorescein-thiosemicarbazide was then added to 
the sample (~10 mM final concentration) and the reaction was incubated at 37°C for 1 hour. 
Instead of gel purification, Illustra G-25 spin columns (GE-healthcare) were used to remove 
the salts and the excess of the unreacted dye from the samples. 
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6.3.1.5.2 CuAAC labeling of the synthetic 5'-hexynylated RNA 
5 nmol of the synthetic 5'-hexynyl-RNA was dissolved in 10 µL of H2O: DMSO: tBuOH 
(4:3:1) containing 5 mM 5-FAM-azide or sulfocyanine 5-Azide, 5 mM CuBr and 10 mM 
TBTA. The reaction mixture was incubated at 37°C for 3 hours and then quenched by adding 
10 µL of high dye gel-loading buffer. The sample was resolved on a 20% denaturing gel. 
The band corresponding to the labeled RNA was then cut out and subjected to gel extraction 
and ethanol precipitation. 
 
6.3.1.5.3 5'-32P labeling of DNA primers 
100 pmol of the DNA primer was dissolved in 10 μL of PNK buffer A including 5 μCi of γ-
32P-ATP, and 5 units of PNK. The reaction was incubated at 37°C for 1 h, followed by two 
rounds of ethanol precipitation. The pellet was dissolved in 10 μL of milliQ water, resulting 
in a sample with 2000-3500 IPS. 
 
6.3.1.6 Total cellular RNA extraction 
Total RNA from E.coli was obtained by RNA extraction using a modified RNA snap 
protocol (Stead et al., 2012). Briefly, TOP10 cells (NEB) were grown in LB medium to an 
OD600 of 0.4-0.8. 1 mL of this culture was then spun down, and the supernatant was 
discarded. The pellet was then resuspended in 100 µL of RNA extraction solution and the 
sample was placed at 95°C for 7 minutes. The sample was then immediately centrifuged at 
16000g for 5 minutes. The supernatant containing total cellular RNA was then carefully 
removed and brought to 400 µL by adding milliQ water. The sample was then subjected to 
P/CI extraction and ethanol precipitation. This procedure usually yielded in isolation of 0.7-
1.5 µg of total cellular RNA. 
 
6.3.2 Ribozyme selection 
6.3.2.1 Preparation of the selection pool 
The DNA template of the pool was prepared by mixing 600 pmol of each of the forward and 
reverse pool primers in a total volume of 100 µL of milliQ water. The sample was annealed 
by placing at 95°C for 5 minutes and slow cooling to room temperature for 10 minutes. The 
rest of the reagents were then added to this mixture, resulting in a 200 µL final volume of 1x 
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Klenow buffer, 200 µM of each dNTP, and 0.2 Unit/µL of Klenow exo-. The reaction was 
then incubated at 37°C for 1 hour. The sample was then subjected to P/CI extraction and 
ethanol precipitation to obtain 600 pmol of the double-stranded full-length DNA template. 
Approximately 450 pmol of the double-stranded pool template was dissolved in 400 µL of 
standard in vitro transcription mix (See 6.3.1.3). The sample was incubated at 37°C for a 
minimum of 6 hours. The reaction was then stopped by adding 80 µL of 0.5 M EDTA pH = 
8 and 320 µL of stop solution. The pool transcript was then subjected to PAGE purification. 
 
6.3.2.2 Selection process 
6.3.2.3 Incubation step 
Each incubation step of the FJ selection, and until round 7 of the FH selection, was performed 
with ~50 µM of the pool RNA. This approximation is made by taking into consideration the 
~150-300 pmol of the 3'-lucifer yellow labeled pool. The 1st selection round in each selection 
experiment was performed using ~3.3 nmol of the RNA pool (including the lucifer yellow 
labeled fraction) in 60 µL of the selection reaction. For the subsequent rounds, the amount 
of RNA pool used in the reaction was adjusted based on the transcription yield of the 
previous round. The volume of the selection reaction was kept at a minimum of 12 µL. 
During the FH selection, the RNA concentration was reduced to half after the 7th round. 
After the 11th round of the FH selection only the labeled fraction was added. 
For FH selection the concentration of the selection substrate, N6-biotin-ATP was 200 µM 
throughout the selection rounds. The concentration of the selection substrate N6-TenDP in 
FJ selection was maintained at 300 µM in all selection rounds. Both selections were 
performed in 1x selection buffer and the presence of 40 mM MgCl2. At every selection 
round, an annealing step was performed prior to the addition of the selection substrate and 
MgCl2. To do so the samples were placed at 95°C for 3 minutes followed by 10 minutes 
incubation at room temperature. The incubation temperature for each round was 37°C for 
both selections. The incubation period was overnight in the initial rounds of both selection 
reactions which was gradually reduced after significant enrichment was observed. The 
details of FH and FJ selection rounds are listed in (Table 6-2) and (Table 6-3), respectively. 
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6.3.2.4 Capture, wash and elution 
To separate the active (biotinylated) species from the large bulk of inactive pool, streptavidin 
or neutravidin coated magnetic beads were used. To avoid selecting for 
neutravidin/streptavidin binders, the affinity matrix was alternated between neutravidin and 
streptavidin every 2 rounds. For the first selection round of all selection experiments, a 
volume from the bead suspension corresponding to 1 mg of magnetic beads was transferred 
into a 1.5 mL microcentrifuge tube. The beads were equilibrated by washing three times, 
each time using 1 mL of 1x BW buffer. The beads were then resuspended to a final 
concentration of 2.5 mg/mL in 1X BW buffer containing 5 mg/mL E. coli tRNA (Sigma-
Aldrich) and incubated at room temperature for 20 minutes while shaking. The supernatant 
was then removed after placing the beads on the magnetic stand for 1 min. The beads were 
washed once with 1mL of 1x BWT buffer (1x BW + 0.1% Tween-20) and twice, each time 
with 0.5 mL of 1X BW buffer. The binding of the biotinylated species was performed, after 
tRNA treatment, by resuspending the beads in 2x BW buffer. The biotinylated pool RNA, 
dissolved in an equal volume of milliQ water, was then added to the suspension. The sample 
was then shaken at RT for 1 hour. 
At this point the beads were placed on the magnetic stand and the supernatant containing the 
unbound pool RNA was removed. The beads were then washed 5 times, each time with 1 
mL of denaturing wash buffer and twice, each time 1 mL of milliQ water. The elution was 
done by resuspending the beads in 100 µL of the elution buffer and placing the sample at 
95°C for 10 minutes. The sample was placed on a magnetic stand and the supernatant was 
transferred to a fresh microcentrifuge tube. The beads were further washed twice with a total 
volume of 590 µL of TEN buffer and the supernatants from these washing steps were pooled 
in the same tube as the initial eluent. 10 µL of 3M NaCl was then added to the sample and 
the eluted RNA was then precipitated by addition of ice-cold ethanol (2 mL). The pellet was 
dissolved in 50 µL H2O and the enrichment was quantified by fluorescence measurement ( 
See 6.3.2.5). 
In the subsequent selection rounds 0.1 mg of beads were used for each 100 pmol of the pool 
RNA. The minimum amount of beads used was 0.6 mg. The details of bead equilibration, 
tRNA treatment, binding, washing, and elution were the same as for the first round. See 
(Table 6-2) and (Table 6-3). 
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6.3.2.5 Monitoring of the selection progress 
A portion of the selection pool, entering each selection round was labeled at 3'-end using 
LY-CH. After each incubation step the sample was subjected to ethanol precipitation and 
the resulting pellet was dissolved in an amount of milliQ water corresponding to twice the 
volume of the bead slurry taken for the capture step (or equal to the volume of the 2x BW 
buffer used for resuspending the beads after equilibration and blocking). 10 μL of this sample 
was taken and diluted to a total volume of 50 μL. This sample was then subjected to 
fluorescent measurement using Jasco fluorescent spectrophotometer. The following 
parameters were used during fluorescence measurement: Excitation wavelength 428 nm, 
Emission range 440-700 nm, emission excitation bandwidth 5nm, scanning speed 100 
nm/min. The resulting pellet from the elution step was also dissolved in 50 μL of milliQ 
water and subjected to fluorescent measurement using the same parameters. The estimation 




𝐴𝐴𝐴𝐴(2 ∗ 𝐵𝐵𝐸𝐸𝐵𝐵𝐸𝐸 𝑣𝑣𝑣𝑣𝐸𝐸𝐸𝐸𝑣𝑣𝐸𝐸10 )
∗ 100 
(Ae = integrated peak area of the fluorescent emission of the eluted sample, Ai = integrated 
peak area of the fraction taken from the sample prior to addition of the bead slurry) 
Table 6-2 Details of each FH selection round. 
Selection round 1 2 3 4 5 6 7 8 9 10 11 12 13 
Amount of RNA(nmol) 3 1 1 0.6 0.6 0.6 0.6 0.3 0.3 0.3 0.3 0.15 0.15 
Reaction volume (µL) 60 20 20 12 12 12 12 12 12 12 12 12 12 
Bead type N N S S N N S S N N S S N 
Amount of beads (mg) 1 1 1 0.6 0.6 0.6 0.6 0.6 0.6 0.6 0.6 0.6 0.6 
 
Table 6-3 Details of each FJ selection round. 
Selection round 1 2 3 4 5 6 7 8 9 10 11 12 
Amount of RNA*(nmol) 3 1 0.8 0.6 0.6 0.6 0.6 0.6 0.6 0.6 0.6 0.6 
Reaction volume (µ 60 20 16 12 12 12 12 12 12 12 12 12 
Bead type** N N S S N N S S N N S S 
Amount of beads (mg) 1 1 0.8 0.6 0.6 0.6 0.6 0.6 0.6 0.6 0.6 0.6 
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6.3.2.6 Amplification step 
The capture step was followed by a two-step amplification protocol. The first step involved 
a one-pot RT-PCR reaction during which the recovered RNA at the end of each round was 
reverse transcribed to cDNA, followed by 10 cycles of PCR to result in the back-up sample 
of the selection. A portion of this sample was then used in a standard PCR reaction to 
generate a sufficient amount of DNA template required for transcription of the enriched 
RNA pool entering, next selection round (Figure 3-3). The rest of the sample was stored as 
a back-up of the selection round. 
The RT-PCR amplification scheme is depicted in (Figure 3-3). Two separate forward 
primers were designed to ensure the amplification of ribozymes that modify the substrate 
sequence, while ribozymes that modify internal nucleotides in the core would not be 
amplified efficiently. The forward primer used in the RT-PCR step covers the connecting 
loop while only partially covering the substrate sequence (Starting at two nucleotides 3' to 
the predetermined modification site). The forward pool primer was then used in the second 
PCR reaction to restore the substrate sequence to its full-length. This primer also carried the 
T7 promoter sequence at its 5' end. The reverse primer was the same in both amplification 
steps (Figure 3-3).  
RT- (1st) PCR 
Following fluorescent measurement, 30 pmol of the forward and 50 pmol of the reverse 
primers were added to the 50 µL eluted RNA sample. The resulting solution was transferred 
into a 0.2 µL microcentrifuge tube containing one Illustra Ready-to-Go RT-PCR bead and 
the sample was placed in a thermal cycler. Cycling parameters are listed in Table 6-4. 
Table 6-4 Cycling parameters of the one-pot, RT-PCR reaction 
Reaction step Temperature (°C) Incubation time Number of cycles 
Reverse transcription 45 30 min 1 
Initial melting 95 4 min 1 
Melting 95 30 sec  
10-2* Annealing 65 30 sec 
Extension 72 25 sec 
Final extension 72 4 min 1 
Infinite 4°C hold 
* For the initial selection rounds the number of cycles was maintained at 10. After the enrichment 
was observed the cycle number was reduced due to the increasing amount of template. 
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2nd PCR 
A portion of the initial RT-PCR sample was used as a template in a subsequent PCR reaction 
for making sufficient transcription template. The rest of the sample was stored as a back-up 
of the selection round. In general, 10 µl of the first PCR reaction was used with 100 pmol of 
forward and 150 pmol of reverse primer in 200 µl of the 1x DreamTaq buffer, including 200 
µM of each dNTP, 10 % DMSO and 1 unit of the DreamTaq DNA polymerase. The cycling 
parameters are listed in Table 6-5. 
Table 6-5 Cycling parameters of the PCR reaction 
Reaction step Temperature (°C) Incubation time Number of cycles 
Initial melting 95 4 min 1 
Melting 95 30 sec  
32-15* Annealing 65 30 sec 
Extension 72 25 sec 
Final extension 72 4 min 1 
Infinite 4°C hold 
* In the initial rounds 32 cycles were used, after the enrichment level increased the number of 
required cycles was also reduced. 
 
6.3.2.7 Activity assay on the enriched pool 
6.3.2.7.1 Cis-activity assay 
Prior to cloning and sequencing, the enriched pool from round 12 of FH and FJ selection 
experiments were examined for activity using streptavidin gel-shift assay. 150 pmol of each 
pool was labeled at 3'-end using lucifer yellow. The labeled samples were then incubated 
with their cognate biotinylated substrate under selection condition in a total reaction volume 
of 10 µL. An annealing step, in this case, was also performed prior to addition of the 
biotinylated substrate and MgCl2. Aliquots (2 µL) were taken at certain time-points and were 
quenched by adding to 98 µL of TEN buffer. The samples were then subjected to ethanol 
precipitation to remove the excess of the unreacted biotinylated substrate. The pellet was 
subsequently dissolved in 5µL 1x TBS buffer including 2 µg of streptavidin. The samples 
were then incubated at room temperature for 5 minutes and mixed with 1 µL of the 6x 
glycerol loading dye. The samples were then resolved on a 10% PAGE (minigel 10 x 8 x 0.1 
cm) without urea for 45 min at 200 V. The gel was then subjected to fluorescent imaging 
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using the biorad chemidoc gel documentation device. The shifted bands were quantified 
using image-lab software. 
 
6.3.2.7.2 Trans-activity assay 
The trans-acting ribozymes were generated according to the scheme depicted in (Figure 3-6 
C). The PCR reactions were performed in 100 µL of the 1x DreamTaq buffer including 200 
µM of each dNTP, 0.5 unit of the DreamTaq DNA polymerase,100 pmol of the selection 
reverse primer and the alternative forward primer. The forward primer was designed to 
remove the substrate sequence and add the T7 promoter and transcription start site directly 
to the connecting loop. For the sample pertaining to FH selection, 2 µL of the backup sample 
from round 13 was used as template. In the case of the FJ selection 2 µL of the backup 
sample from round 12 was added to the reaction as template. Cycling parameters in case 
both reactions were as listed in Table 6-5, however, the annealing temperature was reduced 
to 62°C. The reaction was then ethanol precipitated and the dsDNA template was transcribed 
in vitro under standard conditions. 
About 120 pmol of the RNA transcribed from the generated templates were then mixed with 
240 pmol of the in vitro transcribed, 3'-LY labeled substrate sequence in 10 µL of a reaction 
with the same conditions as the selection rounds. 1µL aliquots were taken from the reaction 
at certain time-points and quenched by transferring into 4 µL of stop solution. 2.5 µL of this 
sample was then resolved on a 20% denaturing PAGE under 35 W for 1 hour. The gel was 
then subjected to fluorescent imaging. 
 
6.3.3 Sanger sequencing 
6.3.3.1 Cloning and of the enriched pool 
In the case of FH selection, 2 pmol of the transcript generated after the round 13 was 
subjected to RT followed by 15 cycles of PCR, using the pool forward primer and the 
selection reverse primer. Parameters were set as described in Table 6-4. 2 µL of this reaction 
mixture was then transferred into a 200 µL PCR reaction using the forward cloning primer 
and the selection reverse primer (Reaction conditions: 1x DreamTaq buffer including, 200 
µM of each dNTP, 10% DMSO, 1 unit DreamTaq DNA polymerase and 1µM of each 
primer. cycling conditions in Table 6-5). The product was then cleaned up using PCR clean-
up kit (Qiagen). The insert was then used in a TOPO-TA cloning reaction according to the 
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manufacturer’s protocol. Briefly, 16 ng of the insert was mixed with 1 ng of the vector in a 
total volume of the 1x salt solution provided by the manufacturer. The reaction was 
incubated at room temperature for 30 minutes before transformation. 
For FJ selection 2 µL of the back-up RT-PCR sample was first PCR amplified using the pool 
forward primer and the selection reverse primer. 2 µL of this sample was then used as 
template in a 200 µL PCR reaction in which the cloning forward primer and the selection 
reverse primer were included (Reaction conditions: 1x DreamTaq buffer including, 200 µM 
of each dNTP, 10% DMSO, 1 unit DreamTaq DNA polymerase and 1µM of each primer. 
cycling conditions in Table 6-5). The Product was cleaned-up using Qiagen kit and 30 ng 
of this product was used in TOPO-TA cloning reaction. 
 
6.3.3.2 Heat shock transformation 
2 µL of the ligation mixture were added into a vial of OneShot chemically competent E. coli 
cells (NEB). The sample was mixed by gentle tapping on the tube and placed on ice for 30 
minutes. The mixture was then subjected to heat shock by placing at 45°C for 30 seconds 
and back on ice immediately. Afterwards 250 µL of room temperature S.O.C.-medium was 
added to the mixture. The tubes were capped tightly and shaken horizontally (ca. 200 rpm) 
for 1 hour at 37°C. 10 µL and 50 µL fraction from each suspension were then plated onto 
LB agar containing 150 µg/mL Ampicillin. The surface of the solid culture medium was 
coated evenly with 40 µL of X-gal solution prior to plating of the cells. The X-gal coating 
was done for blue-white screening. 
 
6.3.3.3 Colony PCR 
To confirm the success of the cloning process forty PCR reaction mixtures were prepared. 
Each mixture contained 25 pmol of the cloning forward primer and 25 pmol of the selection 
reverse primer dissolved in 20 µL of 1x Taq buffer including 200 µM of each dNTP, 0.3 
units of the enzyme and 5% DMSO. The randomly chosen colonies were picked using 
sterilized wooden toothpicks and spotted onto a fresh LB agar containing 150 µg/mL 
ampicillin as the backup of the chosen colonies. After spotting onto the backup plates the 
toothpicks were dipped inside the individual PCR reactions a few times. The toothpicks were 
discarded, and the reactions were sealed. The tubes were cycled using the same parameters 
as in Table 6-5. 5 µL of each PCR reaction was mixed with 1 µL of the glycerol loading dye 
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and resolved on 10% native PAGE (minigel) under 200 V for 45 minutes. The gel was then 
subjected to SYBR green staining and fluorescent imaging. 
 
6.3.3.4 Activity assay of the individual clones 
The clones that harbored the insert were subjected to streptavidin gel-shift based activity 
assay. To generate transcripts from the individual clones for the activity assay, 2 µL of the 
colony PCR reaction products were added into PCR reactions with total volumes of 25 µL. 
reaction conditions and cycling parameters were identical to the colony PCR reactions. The 
reaction products of these PCR reactions were ethanol precipitated and the dried pellets were 
dissolved in 30 µL of standard in vitro transcription mix (Tris 50 mM pH= 8, 10 mM DTT, 
4 mM each NTP, 30 mM MgCl2, 2 mM spermidine, 4 µg/mL T7 RNA polymerase). The 
samples were then incubated at 37°C overnight. Afterwards the reactions were quenched by 
adding 30 µL of high-dye loading buffer and the crude transcripts were purified using 
preparative 10% denaturing PAGE. 
The activity assay was performed using 75 pmol of transcript from each clone in 5 µL of the 
1x selection buffer including 40 mM MgCl2 and 200 µM. The samples were incubated at 
37°C, for 2 hours and quenched by adding 95 µL of TEN buffer and subjected to ethanol 
precipitation, the dried pellet was dissolved in 25 µL of milliQ water. About 3 pmol (1 µL) 
of the reacted RNA was added in 5 µL of 1x TBS buffer containing 1 µg of streptavidin and 
incubated at RT for 5 minutes. 1 µL of the 6x glycerol-based loading dye was added to the 
solution and the sample was resolved on a 10% PAGE, for 45 minutes under 200 V. After 
the gel was run, it was stained using SYBR green II and subjected to fluorescent imaging. 
 
6.3.3.5 Plasmid extraction 
Chosen colonies were grown overnight at 37°C, in 5-7 mL of LB medium containing 150 
µg/mL ampicillin. The cells were then pelleted and subjected to plasmid extraction using 
Qiagen miniprep plasmid extraction kit, according to the manufacturer’s procedure. 0.5-2 
µg of each plasmid in 25 µL of milliQ buffer, were submitted to Microsynth for sanger 
sequencing. The results were analyzed with the aid of the Snapgene Viewer software. 
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6.3.4 Next-generation sequencing sample preparation 
50 µL PCR reactions were setup using 50 pmol of the extended NGS reverse primer and the 
forward primer containing the random 8 nucleotide unimolecular identifier sequence. 2 µL 
of round 7 or round 12 backup samples were added to each reaction as template. 2 µL of 
these PCR reactions were used as templates in 100 µL PCR reaction each containing 100 
pmol of the forward primer with the common NGS index. The reverse primer of each 
selection rounds had a unique index sequence and was added to the respective reaction (100 
pmol). The conditions and cycling parameters of each of these PCR steps were as described 
in 6.3.2.6. The 100 µL PCR reactions were then precipitated and purified using 2% agarose 
gel and Qiagen QIAquick Gel Extraction Kit. The samples were submitted to Core Unit 
Systems Medicine (Uni Würzburg) for amplicon sequencing (NextSeq-500 HighOutput 75nt 
single end). 
 
6.3.5 Characterization of the chosen variants 
6.3.5.1 General kinetic assay protocol 
Kinetic assays were performed under single turn-over conditions with a 10:1 ratio of 
ribozyme: substrate sequence. Generally, 10 pmol of the fluorescently labeled RNA 
substrate was mixed with 100 pmol of the ribozyme in a total volume of 10 µL of the 
selection buffer including 40 mM MgCl2. For FH ribozymes NTP analog concentration in 
these experiments was 200 µM. for FJ ribozymes TenDP analog concentrations were 
adjusted to 300 µM. To ensure proper folding of the ribozyme and efficient pairing of the 
recognition arms with the substrate sequence, an annealing step (95°C for 3 min, room 
temperature for 10 min) was performed before addition of MgCl2 and the NTP substrate. 
The reaction mixtures were incubated at 37°C. 1 µL aliquots were taken from the samples 
at certain time-points and quenched immediately by adding to 4 µL of stop solution. 2.5 µL 
of each time-point sample was resolved on 0.4 mm, 20 % denaturing analytical gel under 
constant power of 35 W for 32 cm gel plates, and 25 W for 20 cm gel plates. The running 
times were generally 1 hour. For experiments in which unmodified tenofovir was included 
the running time was increased to 1.5 hours. The gel was then imaged using a Bio-Rad 
Chemidoc gel documentation device. The settings for imaging were chosen based on the 
fluorophore. The shifted bands were quantified using Imagelab software. Data-points were 
plotted using kaleidagraph software and the curve-fits were made using the pseudo-first 
order kinetics function: Y= Ymax (1-exp(-kobst)). 
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6.3.5.2 Characterization of the reaction product 
6.3.5.2.1 Preparative scale modification of the reaction product for mass analysis 
To prepare the sample for mass spectrometry, 1 nmol of the R 594 and 1.2 nmol of the 
ribozyme was dissolved in a final volume of 25 µL of the selection buffer including 40 mM 
MgCl2. For FH14 ribozyme N6-aminohexyl ATP (400 µM) was used as the modification 
substrate and for the FJ1 N6-TenDP-biotin (500 µM) was used as the modification substrate. 
After incubation (37°C, overnight) the reaction was resolved on a 20%, 0.4 mm denaturing 
PAGE for 2 hours under constant power of 35 W. The band corresponding to the modified 
substrate sequence was then extracted from the gel and ethanol precipitated. 200 pmol of 
this sample was then dissolved in 8 µL of water and was submitted to ESI-mass 
spectroscopy. 
 
6.3.5.2.2 Preparative scale modification of the 5'-5FAM-R660 
For each reaction 1 nmol of the 5FAM-R660 and 1.3 nmol of the ribozyme were dissolved 
in 25 µL of the 1x selection buffer including 400-500 µM of the ribozyme’s cognate 
biotinylated substrate and 40 mM MgCl2. The reaction was incubated at 37°C overnight. 
The reaction was then quenched by adding 25 µL of the stop solution and resolved on a 20% 
analytical denaturing PAGE. The band corresponding to the modified RNA was excised and 
isolated. 
 
6.3.5.2.3 RNase T1 probing 
RNase T1 probing was performed by dissolving 5 pmol of the modified or unmodified 
substrate sequence in a final reaction volume containing 50 mM Tris pH=7.5 and 1 Unit of 
RNase T1. The sample was incubated at 37°C for approximately 30 seconds before 
quenching by addition of 5 µL of stop solution. A volume corresponding to 1.25 pmol of the 
substrate sequence, from each of these samples were resolved on a 20% analytical denaturing 
PAGE for 1 hour under constant power of 35W and subjected to fluorescent imaging. 
 
6.3.5.2.4 Alkaline hydrolysis probing 
Alkaline hydrolysis was performed under three different concentrations of NaOH with 
samples taken at different time points. 10 pmol of modified or unmodified substrate 
sequence was dissolved in 10 µL of 10, 25, or 50 mM NaOH. The samples were incubated 
134 
at 95°C and 2 µL aliquots were taken from each sample at 1, 2.5- and 5-minutes time-points 
and quenched by adding to 3 µL of the stop solution and placing on ice. 2.5 µL of each time-
point sample were resolved on a 20% analytical denaturing PAGE for 1 hour, under constant 
power of 35W, and subjected to fluorescent imaging. 
 
6.3.5.2.5 Debranching resistance assay 
5 pmol of 5'-fluorescein-labeled substrate sequence modified using FJ1 or FH14 was 
dissolved in 5 µL of Dbr1 reaction buffer including 1, 5, 10, or 100 µM MnCl2 and 0.5 ng/µL 
of recombinant Dbr1. Reaction conditions were adopted from (Carrocci et al., 2017) with 
slight modifications. The sample was incubated at 37°C and 1 µL timepoint samples were 
taken at 0, 15, 30, and 60 minutes and quenched by adding to 4 µL of stop solution and 
placing in liquid nitrogen. 2.5 µL of each of these samples were then resolved on a 20% 
analytical denaturing PAGE for 1 hour under constant power of 25W. The gel was then 
subjected to fluorescent imaging. 
 
6.3.6 Application of the ribozymes 
6.3.6.1 FH14 catalyzed labeling of the in vitro transcribed 5S rRNA and RyhB 
RNA 
Reactions were set up with 100 pmol of either of the FH14 variants and 10 pmol of their 3'-
fluorescein-labeled of their cognate transcripts (5S rRNA or RyhB). The reactions were 
performed in 5 µL total volume of the selection buffer including 40 mM MgCl2 and 200 µM 
N6-ATTO550-ATP. The reactions were incubated at 37°C. 1 µL aliquots were taken at 0, 2, 
and 4 hours and quenched by adding to 4 µL of stop solution. 2.5 µL of each of these samples 
was resolved on a 10% denaturing PAGE under constant power of 25 W for 1hour. The gel 
was then subjected to dual-channel fluorescent imaging. 
For simultaneous labeling of target positions in 5S rRNA, reactions were set up with 5 pmol 
of the non-labeled 5S rRNA in vitro transcript and 50 pmol of FH14_5S-A45 alone, 
FH14_5S-A45 and FH14_5S-A66 or all three ribozymes together. The reactions were 
performed in 5 µL of the 1x selection buffer including 200 µM N6-ATTO550-ATP and 40 
mM MgCl2. The reactions were quenched by adding 20 µL of stop solution after 4h 
incubation at 37°C. 2.5 µL of each of the quenched samples were then resolved on a 0.4 mm, 
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10% denaturing PAGE next to the 3'-fluorescein-labeled in vitro transcribed 5S rRNA as 
size marker. 
 
6.3.6.2 Labeling 5S rRNA and RyhB RNA in total cellular RNA context 
50 ng of cellular RNA was therefore mixed with 50 pmol of either of the three FH14 
ribozymes in a final volume of 5 µL of the 1x selection buffer including MgCl2 and 200 µM 
N6-ATTO550-ATP. The reactions were incubated at 37°C for 4 hours before quenching by 
addition of 95 µL of TEN buffer followed by ethanol precipitation. The pellet was then 
dissolved in 2 µL of milliQ water and 2 µL of stop solution. The whole sample from all three 
experiments were resolved on 10% analytical PAGE for 1 hour. 1 pmol of the in vitro 
transcribed 3'-fluorescein-labeled 5S rRNA was also resolved on a neighboring well as a 
size marker. The gel was subjected to dual-channel fluorescent imaging to reveal the bands. 
 
6.3.6.3 Mutually orthogonal double labeling of the synthetic model substrate 
6.3.6.3.1 Labeling reaction 
20 pmol of the double labeling substrate sequence was mixed with 50 pmol of each ribozyme 
in a total volume of 5 µL of selection buffer containing 40 mM MgCl2 and 200 µM of either 
Cy5-TenDP or 6-FAM-ATP or both. The FJ1 ribozyme was targeted towards the parent 
substrate sequence while the FH14 was designed to target the mutated segment. Time-point 
samples (0.5 µL) were taken 0, 5 h, and after overnight incubation and quenched by adding 
to 99.5 µL of TEN buffer. The samples were then subjected to ethanol precipitation, and the 
pellet was dissolved in 5 µL of the stop solution. 2.5 µL of these samples were then resolved 
on a 15% analytical denaturing PAGE for 45 minutes and subjected to dual-channel 
fluorescent imaging. 
 
6.3.6.3.2 8-17NG mediated cleavage reaction 
To perform the 8-17NG mediated cleavage experiment, an aliquot (3.5 µL) of the labeling 
reactions explained above was subjected to ethanol precipitation. The pellet was then 
dissolved in 10 µL of 1x 8-17NG reaction buffer including 10 mM MnCl2, 10 mM MgCl2, 
and 200 pmol of the corresponding 8-17NG deoxyribozyme. The reaction was then 
incubated at 37°C and 1.4 µL timepoint samples were taken at 0, 0.5, and 1 hour and mixed 
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with 3.57 µL of the stop solution. 2.5 µL of these samples were resolved on the same gel as 
the double labeling reaction. And subjected to dual-channel fluorescent imaging. 
 
6.3.6.4 FH14 and FJ1 mediated labeling of 16S and 23S rRNA 
20 ng of total cellular RNA from Top10 E. Coli cells (NEB) was mixed with 50 pmol of the 
corresponding ribozyme(s). The reaction was performed in 5 µL of the selection buffer 
including 40 mM MgCl2 and 200 µM of the fluorescently labeled TenDP and/or ATP 
analogs. After 6h incubation at 37°C, the reaction was precipitated twice using isopropanol. 
The resulting pellet was washed using ice cold 70% ethanol. The dried pellet was dissolved 
in 2 µL of stop solution and 1 µL of milliQ water. The sample was then resolved on 1.3% 
agarose gel under 90 V for 45 minutes. The gel was then subjected to dual-channel 
fluorescent imaging. SYBR Gold staining was then performed to reveal the rest of the total 
cellular RNA. 
 
6.3.6.5 Superscript III primer extension experiment 
6.3.6.5.1 Preparation of the 5S rRNA modified using FH14 and FJC9 ribozymes 
20 pmol of the 5S rRNA transcript was mixed with 30 pmol of either of the three 5S rRNA 
targeting FH14 ribozymes or the 5S rRNA targeting FJC9 ribozyme in 5 μL of 1x selection 
buffer including 40 mM MgCl2. In the samples in which FH14 ribozymes were present N6-
biotin-ATP was included at 200 μM and in the reaction in which FJC9 ribozyme was present 
N6-biotin-TenDP was used at 300 μM. The samples were incubated overnight at 37°C. 
Afterwards the reactions were ethanol precipitated and the dried pellet was dissolved in 5 
μL of milliQ water. 
 
6.3.6.5.2 Preparation of the 16S and 23S rRNA modified using FJ1 and FH14 
200 ng of E. coli total cellular RNA and 20 pmol of individual ribozymes were dissolved in 
a total volume of 10 μL of the selection buffer including 40 mM MgCl2 and the ribozyme’s 
cognate substrate. For FH14 type ribozyme N6-biotin-ATP (200 μM final concentration) was 
used, and for the FJ1 type ribozyme Biotin-Tenofovir-DP (340 μM final concentration). The 
reactions were incubated at 37°C for 5 h and were subjected to ethanol precipitation. The 
pellet was dried and directly used in the primer extension reaction. 
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6.3.6.5.3 Primer extension protocol 
For primer extension experiments on the in vitro transcribed 5S rRNA, 5 pmol of the 32P-
labeled primer and 5 pmol of the modified or non-modified transcript were annealed in 5 μL 
of the were dissolved in 5 μL of the annealing buffer (Tris 5 mM pH= 7.5, EDTA 0.1 mM). 
The sample was then placed at 95°C for 3 minutes followed by incubation at room 
temperature for 10 minutes. For the experiments performed on 16S and 23S rRNA, 5 pmol 
of the 32P-labeled primer and 200 ng of the ribozyme-modified or non-modified total cellular 
RNA were annealed in 1x annealing buffer. 
2 μL of the 5x First-strand synthesis buffer (Invitrogen), 0.5 μL of 0.1 M DTT, 0.5 μL of 10 
mM dNTP mix and 50 units of superscript III reverse transcriptase was then added to the 
reactions and the final reaction volumes of were then adjusted to 10 μL by adding milliQ 
water. The reactions were then incubated at 55°C for 1 hour. 1 μL of 2 N NaOH was then 
added to each reaction and the samples were then incubated for 5 minutes at 95°C. The 
reactions were then ethanol precipitated. The dried pellets were dissolved in 10 μL of high 
dye loading buffer. 2.5 μL of each sample was resolved using 15%, analytical 45 cm long 
PAGE, under constant power of 45 W for 2 hours and 15 minutes. The gel was dried at 80°C 
under vacuum for 30 minutes and exposed to the phosphorus screen overnight. Scanning of 
the exposed screen was performed using Typhoon phosphorimager. 
 
6.3.6.5.4 Sequencing ladder preparation 
The sequencing reactions were performed according to (Shahn et al., 1989) with some 
modification. Reactions were set up by annealing 5 pmol of the 32P-labeled primers with 5 
pmol of the non-modified 5S rRNA transcript or with 200 ng of the non-modified total 
cellular RNA in 5 μL of the annealing buffer. for the A sequencing ladder ddTTP, was added 
to the reaction to a final concentration of 0.5 mM and dTTP at 0.05 mM. The rest of the 
dNTPs were adjusted to a final concentration of 0.5 mM. For G sequencing ladder ddCTP 
was included in the reaction at a concentration of 0.5 mM and dCTP at 0.05 mM. The rest 
of the dNTPs had a final concentration of 0.5 mM. All the other reagents such as the buffer 
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Table 8-1 List of primers used in this thesis project 
Description 5'-Sequence-3' 
T7 Promoter CTGTAATACGACTCACTATA 




Pool reverse primer GGTAAGGTGGACATACTG-N40-GCCTTCAAGGATGGTAGGCTGG 
Selection reverse primer GGTAAGGTGGACATACTG 
1st PCR forward primer CTTCAACCAGCCTACCATCC 
Cloning forward primer TAAATAAAATAACTGTAATACGACTCACTATAGGACATACTGAGC 
Forward primer for substrate 
sequence deletion 
CTGTAATACGACTCACTATAGGCCAGCCTACCATCC 




E. coli 5S rRNA reverse primer ATGCCTGGCAGTTCCCTACTCTCGCATGGGGAGACCCCACACTACC
ATCGGCGCTACGGCGTTTCACTTCTGAGTTCGG 
E. coli RyhB forward primer CTGTAATACGACTCACTATAGGCGATCAGGAAGACCCTCGCGGAGA
ACCTGAAAGCACGACA 
E. coli RyhB reverse primer AAAAAAAAGCCAGCACCCGGCTGGCTAAGTAATACTGGAAGCAATG
TGAGCAATGTCGTGCTTTCAGGTT 




1st PCR NGS reverse primer GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGAAGGTCGACATA
CTG 




Indexed reverse primer 
I7_N703 (Round 12) 
CAAGCAGAAGACGGCATACGAGATTTCTGCCTGTCTCGTGGGCTCG
G 
Indexed reverse primer 
I7_N704 (Round 7) 
CAAGCAGAAGACGGCATACGAGATGCTCAGGAGTCTCGTGGGCTCG
G 
RT primer 16S 344-361 (A325) CCCACTGCTGCCTCCCGT 
RT primer 16S 413-430 (A383) TACAACCCGAAGGCCTTC 
RT primer 16S 687-704 (A649) TCTACGCATTTCACCGCT 
RT primer 23S 322-339 (A272) ACGGGGCTGTCACCCTGT 
RT primer 23S 653-672 (A637) GGTCTATACCCTGCAACT 



















Parent -UAG TTGAAGGCTAAGTATGTCCTATAGTGAGTCGTATTACAG 
Parent -CAG TTGAAGGCTGAGTATGTCCTATAGTGAGTCGTATTACAG 
Parent -GAA TTGAAGGTTCAGTATGTCCTATAGTGAGTCGTATTACAG 
Parent -GAU TTGAAGGATCAGTATGTCCTATAGTGAGTCGTATTACAG 








































































































































































































Parent -UAG GGACAUACUUAGCCUUCAA 
Parent -CAG GGACAUACUCAGCCUUCAA 
Parent -GAA GGACAUACUGAACCUUCAA 
Parent -GAU GGACAUACUGAUCCUUCAA 





E. coli 5S rRNA 




E. coli RyhB RNA  


















































































































































Figure 8-1 ESI-mass spectrum and the deconvolution of the R549 modified using FH14 and N6-











Table 8-6 Details of the ten main clusters identified from the NGS analysis of the round 12 pool 
Cluster Unique Reads RPM 
1 1407 86635 761012.5 
2 407 84781 74472.2 
3 259 55156 48449.4 
4 158 21523 18905.9 
5 28 3697 3247 
6 38 3943 3463 
7 20 2733 2400 
8 26 2401 2109 
9 10 1268 1113.8 
10 6 720 632.4 
 
 
Table 8-7 First sequence of fist ten clusters ordered by log2 (enrichment). 




38.8 33325.9 9.74 
>8-4-1-0=FJ1 AACCAGCCTACCATCCTTGAAGGC 
CCACCCTCATAAAACTGAAGATCCTTTGGCAAGGGTCTA CAGTA 










130185 502593 1.95 
>48-7-1-0 (a) AACCAGCCTACCATCCTTGAAGGC T CAGTATGTC 
GACCTTCTGTCTCTTATACACATCTCCGAGCCCA 
474.2 1586.4 1.74 
>26-5-1-0 (b) AACCAGCCTACCATCCCTGAAGGC CGAATGCCACCGAA 
CAGTATGTC GACCTTCTGTCTCTTATACAC 





39964.6 30094.3 -0.41 
>56-8-1-0 AACCAGCCTACCATCCTTGAAGGC 
ACTGGTGTTACAAGTAAACGCAACCTTAATTTTACGATCC CAGT 
4264.5 1258.8 -1.76 
>32-6-1-0 (c) AACCAGCCTACCATCCTTGAAGGC 
ATCGGTGTAACATAAACGAAACCTTAGGTCCCTTGGCCCC CAGT 
34139.0 2206.6 -3.95 
>126-10-1-0 AACCAGCCTACCATCCTTGAAGGC 
ATAGTTTCACAATAGCCACTTTAAGCTTATCCAAAGCTCA CAGT 
11488.7 577.1 -4.32 
* RPM(X)= Round 7 and RPM (Y)= Round2 
(a) extended complement to the substrate sequence 
(b) reveals a fully complementary binding arm after 14 nt in the center of the N40 core 
(c) related to FJ8 
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Figure 8-2 ESI-mass spectrum and the deconvolution of the R549 modified using FJ1 and N6-biotin-











AMP adenosine monophosphate 
APM acrylaminophenyl mercuric acid 
ATP adenosine triphosphate 
BHQ black hole quencher 
BiP 2-2'- bipyridine 
bp base pair 
BW binding-washing 
C cytosine/cytidine 
Cas CRISPR-associated complex 
Cbl cobalamin 
cDNA complementary DNA 
CoA coenzyme A 
CRISPR clustered regularly interspaced short palindromic repeats 
CTP cytidine triphosphate 
CuAAC Copper(I)- catalyzed alkyne-azide cycloaddition 
Cy cyanine 
dATP deoxyadenosine triphosphate 
dCTP deoxycytidine triphosphate 
ddCTP dideoxycytidine triphosphate 
ddNTP dideoxynucleoside triphosphate 
ddTTP dideoxythymidine triphosphate 
dGTP deoxyguanosine triphosphate 




DNA deoxyribonucleic acid 
dNTP deoxynucleotide triphosphate 
dsDNA double-stranded DNA 
DTT dithiothreitol 
dUTP deoxyuridine triphosphate 
EDTA ethylenediaminetetraacetic acid 
ESI-mass electrospray ionization mass spectrometry 
et al et alii (english: and others) 
FAM carboxy fluorescein 
FISH fluorescent in situ hybridization 
163 
FLAP fluorogen activating aptamer 
Flu fluorescein 
FP fluorescent protein 
G guanine/guanosine 
GFP green fluorescent protein 
GMP guanosine monophosphate 
gRNA guide RNA 
GTP guanosine triphosphate 
h hour 
HBI hydroxybenzilydene imidazole 
HEPES 4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid 
HNE human neutrophil elastase 
HPLC high-performance liquid chromatography 
iEDDA inverse electron demand Diels-Alder reaction 
IVT in vitro transcription 
L liter 
LG leaving group 
lncRNA long non-coding RNA 
LY-CH lucifer-yellow carbohydrazide 
M molar 
MBS MS2 coat-protein binding-site 






mRNA messenger RNA 




NTP nucleoside triphosphate 
O/N overnight 
PAGE polyacrylamide gel electrophoresis 
PAM protospacer adjacent motif 
PBS PP7 coat-protein binding-site 
PCP PP7 coat-protein 
PCR polymerase chain-reaction 
pH potential of hydrogen 
R purine nucleotide 
RISC RNA-induced silencing complex 
RNA ribonucleic acid 
ROI RNA of interest 
RPM read per million 
164 
rRNA ribosomal RNA 
RT reverse transcriptase/reverse transcription 
SAM S-adenosyl-methionine 
sec second 
SELEX systematic evolution of ligands by exponential enrichment 
SiR silicon rhodamine 
siRNA small-interfering RNA 
SPAAC strain promoted alkyne-azide cycloaddition 
SRB sulforhodamine B 
ssDNA single-stranded RNA 
TAMRA tetramethyl rhodamine 
Taq Thermus aquaticus 
tBuOH tert-butanol 
TEN Tris/EDTA/NaCl 
TenDP tenofovir diphosphate 
TetFC tetramolecular fluorescence complementation 
TGT tRNA guanine transglucosylase 
Tias tRNA(ile2)-agmatidine synthetase 
TM transition mutation 
TO1 thiazole orange 1 
TriFC trimolecular fluorescence complementation 
Trm tRNA methyltransferase 
tRNA transfer RNA 
TV transversion mutation 
U uracil/uridine 
UTP uridine triphosphate 
UTR untranslated region 
UV ultraviolet 
W: C Watson-Crick 
X-gal 5-bromo-4-chloro-3-indolyl-b-D-galactopyranoside 
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